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1. Abbreviations: 
 
ASC                       ascorbate 
AKAP12 A-kinase anchor protein 12 
ALAS2 5-aminolevulinate synthase 2 
ARNT  aryl hydrocarbon receptor nuclear translocator  
ATF-4                   activating transcription factor 4 
BNIP3 BCL2/adenovirus E1B interacting protein 1 
CAIX carbonic anhydrase IX 
CAD carboxyterminal transactivation domain 
CBP CREB binding protein 
CDR2 onconeuronal cerebellar degeneration-related protein 2 
CHO chinese hamster ovary 
CPX ciclopirox olamine 
DHA dehydroascorbate 
DMOG dimethyloxalylglycine 
DTT dithiothreitol 
DFX desferrioxamine  
EDTA ethylenediaminetetraacetic acid 
EGL-9 Egg-laying abnormal-9 
EPAS endothelial PAS protein 
EPO erythropoietin 
EDNRB endothelin receptor type B 
FCS fetal calf serum 
FH fumarate hydratase 
FIH factor inhibiting HIF 
FKBP38 FK506-binding protein 38 
GLUT1 glucose transporter 1 
GLRX glutaredoxin 
GSH L-γ-glutamyl-Lcysteinyl-glycine, glutathione 
GST glutathione-S-transferase 
GULO gulono-1,4-lactone oxidase 
HAT hypoxantine, aminopterin, thymidine  
Abbreviations 
 
 
 
5
HIF hypoxia-inducible factor 
HLH helix-loop-helix 
HSP90 heat shock protein 90 
IC50 inhibitory concentration 50% 
ID inhibitory domain 
IGF-2 insulin growth factor 2  
IOP1 iron-only hydrogenase-like protein 1 
IKKβ inhibitor of NF-Κb kinase-β 
IL-1β interleukin 1β 
ING4 inhibitor of growth family member 4 
IPAS inhibitory PAS protein 
IPC ischemic preconditioning 
IRP2 iron regulatory protein 2 
KIF1Bβ kinesin family member 1Bβ 
L28 ribosomal protein L28 
OS-9                      osteosarcoma amplified 9 
PAS Per/Arnt/Sim 
PHD prolyl-4-hydroxylase domain protein 
MAGE-11 melanoma antigen 11 
MAPK mitogen-activated protein kinase 
MMP3 matrix metallopeptidase 3 
MnTMPyP manganese(III) tetrakis(1-methyl-4-pyridyl) porphyrin 
pentachloride 
MORG1 mitogen-activated protein kinase organizer 1 
mRNA messenger ribonucleic acid 
NTA nitrilotriacetic acid 
NAC N-acetyl cysteine 
NAD aminoterminal transactivation domain 
NF-κB                   nuclear factor 'kappa-light-chain-enhancer' of activated B-cells 
NO  nitric oxide 
N-OG N-oxalylglycine 
NOS nitric oxide synthase 
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NDRG1 N-myc downstream regulated gene 1 
ODDD oxygen dependent degradation domain 
PDGF platelet derived growth factor 
PDK1 pyruvate dehydrogenase kinase, isoenzyme 1 
REDD1 regulated in development and DNA damage response 1 protein 
ROS  reactive oxygen species 
RLU relative luciferase units 
RpB1 ribonucleic acid polymerase II subunit B1  
S12  ribosomal protein S12 
SDH succinate dehydrogenase 
SEM standard error of the mean 
Sf9 Spodoptera Frugiperda 9 
SIAH2 seven in absentia homolog 2 
SOD superoxide dismutase 
SVCT1 sodium-dependent vitamin C transporter 1 
SVCT2 sodium-dependent vitamin C transporter 2 
TGF-β1                 transforming growth factor-β 1 
TMB 3,3',5,5'-tetramethylbenzidine 
TRiC tailless complex polypeptide -1 ring complex 
TNFα tissue necrosis factor 
VBC von Hippel Lindau, Elongin B, Elongin C 
VEGF vascular endothelial growth factor 
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2. Zusammenfassung 
 
Eine genaue Rezeption des zellulären Sauerstoffgehalts durch Prolyl-4-Hydroxylase 
Domänen (PHD) enthaltende Sauerstoff-Sensorproteine ist für viele physiologische 
Prozesse im menschlichen Körper von grosser Bedeutung. Dieselben Signalwege 
spielen aber auch bei der Ausbildung von Krankheiten eine entscheidende Rolle. 
Hypoxie-induzierbare Faktoren (HIFs) sind das vorrangige Hydroxylierungssubstrat 
für PHDs und fungieren als Sauerstoff-regulierte Transkriptionsfaktoren, indem sie 
die Expression von mehr als 100 Zielgenen kontrollieren. Die wichtigsten Beispiele 
für HIF-regulierte Genprodukte sind unter anderem das für die Neubildung von 
Erythrozyten verantwortliche Erythropoietin (EPO), aber auch pro-angiogene 
Wachstumsfaktoren wie  VEGF und Proteine des zellulären Glukose-Stoffwechsels 
(z.B. GLUT1, PDK1). Die enzymatische Aktivität von PHDs ist unmittelbar an die 
Verfügbarkeit von Sauerstoff gekoppelt, aber auch andere Kofaktoren und 
Kosubstrate beeinflussen ihre spezifische Hydroxylierungskapazität. Die Nutzung 
eines Hydroxylierungsassays als rekonstituiertes System erlaubte uns, die 
Abhängigkeit aller drei PHD Isoformen von verschiedenen einfachen, potentiell 
inhibierenden oder aktivierenden Substanzen („small molecules“) zu untersuchen. 
Während die enzymatische Aktivität von PHDs in Gegenwart von Eisen(II), 2-
Oxoglutarat und Ascorbat dosisabhängig gesteigert war, inhibierten Substanzen wie 
Succinat oder polyphenolische Antioxidantien die Hydroxylierungs-aktivität der 
PHDs. Übergangsmetalle wie Kobalt(II) und Zink(II), chelierende Agenzien (DFX, 
EDTA) und reaktive Sauerstoffspezies (Wasserstoffperoxid) waren weitere effiziente 
Hemmstoffe der PHDs. Mechanistisch funktionieren diese Substanzen zumindest 
teilweise durch die Abreicherung oder Inaktivierung eines oder mehrerer der für die 
Hydroxylierungs-reaktion notwendigen Kofaktoren. In diesem Zusammenhang 
konnten wir zeigen, dass Kupfer(II), jedoch nicht Kobalt(II) oder Eisen(II), die 
Oxidation von Ascorbat zu Dehydroascorbat katalysieren kann, wobei letzteres keinen 
aktivierenden Einfluss mehr auf die PHDs ausübt. Eine Mangelversorgung mit 
Ascorbat (Vitamin C) verursacht die als Skorbut bekannte Systemerkrankung mit 
unzureichender Quervernetzung des Kollagens im Bindegewebe, der eine verminderte 
Aktivität der Kollagen-Prolyl-4-Hydroxylasen zugrunde liegt. Da PHDs zur gleichen 
Untergruppe von Enzymen wie Kollagen-Prolyl-4-Hydroxylasen gehören, wurde in 
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dieser Arbeit ein möglicher Einfluss von Ascorbat auf Mechanismen der Sauerstoff-
Rezeption in vivo untersucht.   
Hierzu fand ein genetisch modifiziertes Tiermodell mit Mäusen Verwendung, die eine 
biallelische Inaktivierung des L-Gulonolacton Oxidasegens (Gulo) aufweisen, das für 
ein Schlüsselenzym zur körpereigenen Synthese von Ascorbat kodiert. Folglich sind 
diese Tiere abhängig von der Aufnahme von Ascorbat mit der Nahrung. Im Vergleich 
zu Tieren, die Ascorbat mit dem Trinkwasser erhielten, zeigten Gulo-/-  Mäuse, denen 
fünf Wochen lang eine Ascorbat-freie Diät gefüttert wurde, keine wesentlichen 
Änderungen in der Expression von HIF Zielgenen. Ausserdem konnten keine 
merklichen Unterschiede zwischen beiden Behandlungsgruppen in der Expression 
von EPO mRNA in der Niere und zirkulierendem EPO Protein im Plasma nach einer 
24-stündigen hypoxischen Episode mit einer inspiratorischen Sauerstoffkonzentration 
von ca. 8% O2 festgestellt werden. Unsere Daten legen nahe, dass eine Ascorbat-
Defizienz keinen Einfluss auf die systemische Adaptation an 
Sauerstoffmangelzustände hat und die Rolle von Ascorbat im Organismus durch 
andere Antioxidantien kompensiert werden kann. Diese Hypothese findet zusätzlich 
Unterstützung in der Beobachtung, dass humane Zervixkarzinom-Zellen, die unter 
vollständig Ascorbat-freien Kulturbedingungen gehalten wurden, eine identische 
hypoxische HIF-1α Stablilisierung und transkriptionelle HIF Aktivität zeigten wie 
Zellen, die in Gegenwart von 50 μM Ascorbat wuchsen. Glutathion (GSH) ist das 
weitaus verbreitetste Antioxidant in menschlichen Zellen, weswegen wir den Einfluss 
von GSH auf die enzymatische Aktivität von PHDs in vitro untersucht haben. 
Tatsächlich wurden alle drei PHD Isoformen in dosisabhängiger Weise durch GSH 
aktiviert. Analog zur Behandlung mit Ascorbat zeigten humane Hepatomazellen in 
Gegenwart von GSH einen reduzierten HIF-1α Proteingehalt, wie auch die 
transkriptionelle Aktivität von Kobalt(II)-induziertem HIF vermindert war. 
Desweiteren veringerte Glutathion die durch Fenton-Reaktion bzw. Kobalt(II)- und 
Wasserstoffperoxid-vermittelte Proteinoxidation von rekombinantem PHD2 Enzym, 
wie durch das Messen der Proteinkarbonylierung bestimmt wurde. Interessanterweise 
konnte die Mutation des Cysteinrestes an Position 201 des Proteins zu Serin die basale 
Hydroxylierungsaktivität von PHD2 erhöhen und steigerte die Resistenz des 
rekombinanten Proteins gegenüber oxidativen Noxen. Dieser strukturell zugängliche 
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und konservierte Cysteinrest stellt daher einen möglichen Angriffspunkt zur 
antioxidativen Aktivierung von PHDs durch Vitamin C und Glutathion dar. 
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3. Summary 
Oxygen sensing by prolyl-4-hydroxylases domain (PHD) proteins is involved in many 
physiological as well as pathophysiological processes in the human body. Hypoxia-
inducible factors (HIFs) are the prime hydroxylation targets of PHDs and function as 
oxygen regulated transcription factors controlling the expression of more than 100 
target genes. Genes involved in erythropoiesis (e.g. EPO), angiogenesis (e.g. VEGF) 
as well as glucose transport and metabolism (e.g. GLUT1, PDK1) are the most 
prominent examples of HIF-regulated genes. PHD activity is regulated primarily by 
the availability of oxygen but also other co-factors and co-substrates can affect their 
hydroxylation capacity. Using a reconstituted hydroxylation assay we attempted to 
investigate the dependency of all three PHDs isoforms on different types of small 
molecule activators and inhibitors. While addition of  iron (II), 2-oxoglutarate and 
ascorbate was enhancing PHD activity in a dose-dependent manner, other compounds 
such as succinate or polyphenolic antioxidants were inhibiting hydroxylation activity 
of all three PHDs. Transition metals (cobalt (II), zinc (II)), metal chelators (DFX, 
EDTA) and reactive oxygen species (hydrogen peroxide) were efficient inhibitors of 
PHD activity. The mechanisms of action of these compounds could be explained at 
least partially by depletion of one of the co-factors necessary for the hydroxylation 
reaction. We could show that copper (II), but not cobalt (II) and iron (II) catalysed 
oxidation of ascorbate to dehydroascorbate, which is incapable to activate PHDs. 
Ascorbate deficiency is known to cause a systemic disorder called scurvy, resulting 
from insufficient hydroxylation of collagen by collagen prolyl-4-hydroxlases in 
connective tissues. PHDs belong to the same subclasses of enzymes as collagen 
prolyl-4-hydroxylases, therefore we attempted to investigate whether ascorbate 
deficiency can affect oxygen sensing mechanisms in vivo. We used a knock-out 
mouse model lacking the key enzyme involved in ascorbic acid synthesis, Gulono-
1,4-lactone oxidase (Gulo) and as a consequence the animals depend on ascorbate 
supplementation in the diet. When Gulo-/- mice were kept for 5 weeks at an ascorbate-
free diet, expression of HIF-target genes was unchanged if compared to control 
animals receiving ascorbate with the drinking water. Moreover, when Gulo-/- mice 
were exposed to inspiratory hypoxia (8% oxygen for 24 hours) after 5 weeks of 
ascorbate depletion, no significant changes to the ascorbate fed control group between 
Epo mRNA in the kidney and EPO plasma protein levels were observed. These data 
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suggest, that ascorbate deficiency might be compensated by other antioxidants in vivo. 
In support with this notion, HeLa cells grown in the absence of ascorbate showed 
equal hypoxic stabilization of HIF-1α protein and HIF activity as cells supplemented 
with 50 μM ascorbate.  The most abundant intracellular antioxidant in human cells is 
glutathione (GSH). Therefore we tested its influence on PHDs activity in vitro. All 
three PHDs were robustly activated by GSH in a dose-dependent manner. Similarly to 
ascorbate, GSH could reduced HIF1-α protein levels and HIF transcriptional activity 
in cobalt (II) treated hepatoma cells. Glutathione protected recombinant PHD2 
enzyme from oxidation by Fenton reaction and cobalt (II) as measured by 
carbonylation of the PHD2 protein. Interestingly, a C201S mutation in PHD2 
increased basal hydroxylation rates of the enzyme and conferred resistance to 
oxidative damage in vitro, suggesting that this structurally conserved and surface 
accessible cysteine residue could be a target of antioxidative protection of PHDs by 
vitamin C and glutathione. 
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4. Introduction 
Oxygen (O2) was first discovered in 1772 by Carl Wilhelm Scheele, the Swedish 
chemist (Scheele, 1777). Shortly after this discovery, the British clergymen Joseph 
Priestley and the French scientist Antoine Lavoisier succeeded to purify the "air 
responsible for combustion”, which Lavoisier named “oxygen”, respectively, and thus 
together with Carl Wilhelm Scheele are credited for the discovery of oxygen 
(Priestley, 1775). Since that time, the physical and chemical properties of oxygen 
were fully characterized. The function of oxygen in processes such as oxidative 
phosphorylation and photosynthesis further emphasized its important role in 
physiology and cell metabolism. Since then, oxygen has become the “life” gas, which 
drives many physiological processes in the living organisms. Interestingly, oxygen 
starvation, termed “hypoxia” is occurring at physiological and pathophysiological 
conditions. Such conditions include exposure to high altitude, where O2 partial 
pressures (pO2) are much lower than at sea level. Moreover, organs and tissues in the 
human body require constant oxygen supply to maintain their function and balanced 
energy homeostasis, and as such are affected by insufficient oxygen supply by 
mechanisms including ischemia or inflammation. It was first reported in the 19th 
century by Denis Jourdanet and Paul Bert, that the concentration of red blood cells in 
humans and animals depends on the O2 supply to the tissue (Bert, 1878; Bert, 1882; 
Jelkmann, 2007). With the discovery of a factor, which was later characterized as a 
polypeptide hormone called erythropoietin, it was elucidated that this hormone 
regulates red blood cell proliferation and differentiation (Erslev, 1953; P Carnot, 
1906). However, understanding of the molecular mechanisms that underlie effects of 
hypoxia on erythropoiesis remained unresolved until the end of the 20th century. 
 
4.1 The hypoxia-inducible factor (HIF) 
4.1.1 Discovery of HIF 
The mechanism of induction of erythropoietin and enhanced red blood cell production 
upon oxygen deprivation was a long discussed phenomenon in the scientific 
community. The mechanism was later elucidated with the discovery that a hypoxia-
inducible nuclear factor was binding to a regulatory enhancer element located 3´-to 
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the human erythropoietin gene (Semenza et al., 1991). The hypoxia inducible factor, 
named HIF, was later described as a transcription factor induced by hypoxia via de 
novo protein synthesis and binding to  the human erythropoietin gene enhancer, 
causing transcriptional induction of this gene (Semenza and Wang, 1992). In 1995, 
the same group purified and characterized HIF-1 (Wang and Semenza, 1995). HIF 
was also described in other mammalian cells cultured under reduced oxygen tension, 
necessary for transcriptional activation of erythropoietin and other genes, providing 
evidence for a universal oxygen-sensing mechanism (Maxwell et al., 1993). 
 
4.1.2 Composition of HIF complexes 
Hypoxia-inducible factors are composed of two subunits: a constitutively active HIF-
β subunit and the oxygen-regulated HIF-α subunit, which form the transcriptionally 
active heterodimer (Wang et al., 1995). Both subunits are members of the basic helix-
loop-helix/Per-Arnt-Sim (bHLH/PAS) family of transcription factors (Jiang et al., 
1996). HIF-α subunits exist in three isoforms: HIF-1α, HIF-2α and HIF-3α (Figure 1). 
The first two (HIF-1α and HIF-2α) form heterodimers with HIF-1β resulting in 
transcriptionally active hypoxia-inducible factors (HIF). The third isoform, HIF-3α 
does not form functional transcription factors, but is known to inhibit HIF-1 and HIF-
2 mediated transcription (Lisy et al., 2008; Gu et al., 1998). Moreover, an alternative 
splicing isoform of HIF-3α, termed inhibitory PAS domain protein (IPAS), is known 
to be hypoxia-inducible and provides a negative feedback loop suppressing HIF 
activity (Makino et al., 2001). The N-terminal part of HIFα consist of a bHLH and 
PAS domain, which are responsible for DNA binding and dimerization with the HIF-
β subunit. The HLH motifs of both subunits (HIF-1α and HIF-1β) contact the DNA. 
An oxygen-dependent degradation domain (ODDD) contains two distinct proline 
residues, which are the target for hydroxylation by prolyl-4-hydroxylases, thus 
regulating HIF-α protein stability (for detailed mechanism of HIF-α stability control, 
see below). In the C-terminal portion of HIF-α two transactivation domains are 
located, which recruit transcriptional coactivators to form an inititation complex 
(Pugh et al., 1997; Lisy et al., 2008). HIF-1α and HIF-2α contain a C-terminal 
transactivation domain (CAD) and more centrally located a N-terminal transactivation 
domain (NAD). Notably, transcriptional activity of the CAD domain is also regulated 
in an oxygen-dependent manner and an inhibitory domain (ID), located between the 
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two transactivation domains, is required for normoxic repression of the CAD (Lisy et 
al., 2008).  
 
 
Fig. 1. Composition of HIF-α, IPAS and HIF-1β subunits (adapted from (Lisy et al., 
2008)). 
 
4.1.3 Function of HIF 
The primary function of HIF is to regulate cellular responses to lowered oxygen 
concentrations. HIF acts as a transcription factor and regulates the expression of genes 
involved in adaptation to low oxygen concentrations. HIF binds to conserved hypoxia 
response elements (HREs) often found in the promoter (though not exclusicely) 
region of its target genes. The actual HIF binding site is a conserved sequence of  5'-
[A/G]CGTG-3' (Wenger et al., 2005). So far, around 100 HIF target genes have been 
identified, which regulate adaptation to hypoxia on both, cellular and systemic levels 
(Wenger et al., 2005). Amongst others, these genes include vascular endothelial 
growth factor, glycolytic enzymes, glucose transporters, heme oxygenase-1, inducible 
nitric oxide synthase and transferrin (Forsythe et al., 1996; Semenza et al., 1994; Lee 
et al., 1997; Melillo et al., 1997; Rolfs et al., 1997). 
4.1.4 Tissue distribution of HIF isoforms 
HIF isoforms display tissue-dependent expression patterns. The HIF-1α isoform is 
ubiquitously expressed in all cells of the body and shows tissue-specific regulation 
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(oxygen-dependent protein stability regulation) under hypoxic conditions (Stroka et 
al., 2001). Similarly, the HIF-1β subunit shows ubiquitous expression. HIF-2α, 
initially known as EPAS1 (endothelial PAS protein 1) was first identified in 
endothelial cells of embryonic and adult mice as well as in highly vascularized tissues 
(Tian et al., 1997). Later, HIF-2α expression was described in other cell types and 
organs (Wiesener et al., 2003). The third isoform, HIF-3α is expressed in adult 
thymus, lung, brain, heart, and kidney (Gu et al., 1998). 
4.1.4.1 Genetic ablation of HIF 
Knock-out of HIF-1α in mice leads to embryonic lethality by day 11 due to 
cardiovascular malformation and open neural tube defects (Iyer et al., 1998; Kotch et 
al., 1999). HIF-2α knock-out mice show different phenotypes, varying from 
embryonic death between 12.5-16.5 days after gestation due to bradycardia caused by 
impaired catecholamine homeostasis (Tian et al., 1998) or neonatal death due to 
respiratory distress syndrome (Compernolle et al., 2002). Using a different mouse 
strain (129S6/SvEvTac) Scortegagna et al. reported viable HIF-2α knock-out mice 
which displayed multiple organ pathologies, biochemical abnormalities and changes 
in gene expression (Scortegagna et al., 2003).  Interestingly, some of these phenotypes 
could be reversed by treatment of HIF-2α knock-out mice with SOD (superoxide 
dismutase) mimetic, suggesting involvement of HIF-2α in antioxidative defense and 
mitochondrial homeostasis. Also HIF-1β knock-out mice die in the embryonic stage at 
day 10.5, presumably due to placental, vascular and haematopoietic defects (Kozak et 
al., 1997).  
 
4.1.5 Regulation of HIF 
HIF expression and protein stability is regulated in both, oxygen-dependent and 
independent manners. Oxygen-dependent regulation is the primary mechanism by 
which HIF serves as a regulator of the transcriptional response to lowered oxygen 
concentrations. Moreover, HIF transcription and translation can be regulated by 
several other factors, which contribute to the primary mechanism of HIF regulation by 
oxygen-deficiency. 
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4.1.5.1 Oxygen-dependent regulation of HIF protein stability 
HIF-α subunits are constitutively expressed and translated in cells. However, the half-
life of the protein under normoxic conditions is less than 5 minutes (Lisy et al., 2008; 
Wang et al., 1995; Yu et al., 1998). The rapid degradation of HIF-α under normoxic 
conditions is mediated by enzymes called HIF prolyl-4-hydroxylases. These enzymes 
require molecular oxygen and other co-factors to catalyze hydroxylation of two 
distinct proline residues within HIF-α (Huang et al., 2002; Ivan et al., 2001; Jaakkola 
et al., 2001). Human HIF-1α is hydroxylated at Pro402 and Pro564 and HIF-2α at 
Pro405 and Pro531, respectively. Hydroxylated HIF-α is recognized by the von 
Hippel-Lindau - elongin B - elongin C ubiquitin E3 ligase complex and targeted for 
proteosomal degradation. When oxygen concentration is reduced, HIF prolyl-4-
hydroxylases are inhibited, HIF-α is stabilized and translocates to the nucleus. There it 
heterodimerizes with the constitutively expressed HIF-β subunit and the functional 
HIF complex regulates the expression of its target genes. Moreover, another 
hydroxylase, factor inhibiting HIF (FIH) is responsible for hydroxylation of Asn803 
within CAD of human HIF-1α and Asn851 of HIF-2α, which inhibits recruitment of 
the transcriptional co-activators p300/CBP (Hewitson et al., 2002; Lando et al., 2002; 
Mahon et al., 2001; Nagel et al., 2010). 
4.1.5.2 Oxygen–independent regulation of HIF transactivation 
In addition to oxygen-dependent hydroxylation of proline and asparagine residues, 
HIF-α can also undergo other posttranslational modifications. HIF-α has been 
reported to be phopshorylated at Thr796 (Gradin et al., 2002). It has been also 
reported, that phosphorylation of serine residues (641-643) by MAPK within HIF-1α 
promotes its transcriptional activity (Mylonis et al., 2006; Richard et al., 1999; Sang 
et al., 2003). S-nitrosylation of Cys800 was shown to increase HIF transcriptional 
activity via enhancement of CAD-CBP/p300 interaction (Yasinska and Sumbayev, 
2003). SUMOylation of HIF-1α has been reported, however the effect of this 
modification is unclear, giving contradictory effects on its transactivation activity 
(Berta et al., 2007; Carbia-Nagashima et al., 2007). Besides above mentioned 
modifications, HIF has been shown to be regulated by several growth factors, 
cytokines and hormones such as Insulin, IGF-2, TNFα, IL-1β, PDGF and thrombin 
(Dery et al., 2005; Stiehl et al., 2002). Also inhibitors of heat shock protein 90 
(HSP90) have been shown to promote HIFα degradation (Ibrahim et al., 2005; Isaacs 
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et al., 2002). Unlike oxygen-dependent regulation, hypoxia-independent regulation of 
HIF is based on an increase in HIF translation but not in protein stabilization (Dery et 
al., 2005). Recent reports also showed an increase in HIF-1α mRNA expression upon 
stimulation with reactive oxygen species (ROS), which is presumably mediated via 
NFκB (Bonello et al., 2007; Belaiba et al,  2007; Frede et al., 2006).  
4.2 HIF prolyl-4-hydroxylases (PHDs) 
4.2.1 Discovery of PHDs 
Prolyl-hydroxylation of HIFα subunits was first described in 2001 (Bruick and 
McKnight, 2001; Epstein et al., 2001; Ivan et al., 2002; Ivan et al., 2001; Jaakkola et 
al., 2001; Yu et al., 2001). It was observed that hydroxylation of HIF-α triggers its 
recognition by the pVHL – elongin B – elongin C complex and subsequent 
degradation. Later findings showed that HIF-α contains two prolines residues, which 
are both targets for hydroxylation by prolyl-4-hydroxylases, and that both residues 
can independently interact with pVHL complex (Lando et al., 2002; Masson et al., 
2001). 
4.2.2 Isomers of HIF-PHDs 
So far three isoforms of HIF-prolyl-4-hydroxylases have been described in humans, 
namely PHD1, PHD2 and PHD3. These proteins are encoded by human EGLN2, 
EGLN1 and EGLN3 genes, respectively. The proteins differ in size, intracellular 
localization and tissue distribution (Wenger et al., 2009). Under experimental in vitro 
conditions, preferences of respective isoforms to the two target proline substrates 
within the HIF-α molecule have been observed (Appelhoff et al., 2004; Chan et al., 
2005). A new putative prolyl-4-hydroxylase was identified in the endoplasmic 
reticulum, which, when overexpressed can suppress HIF protein levels activity 
similarly to PHDs (Koivunen et al., 2007; Oehme et al., 2002). However, further 
studies must be performed to elucidate the physiological function of this isoform. C. 
elegans and D. melanogaster have a single PHD isoform called Egl9 and Fatiga, 
respectively (Kaelin and Ratcliffe, 2008). All three human and HIF-prolyl-4-
hydroxylases have a high sequence similarity in the catalytic domain as shown on 
Figure 2. 
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Fig. 2. Sequence alignment of three human HIF-PHDs. The scoring scheme works 
from 0 for the least conserved alignment position, up to 10 for the most conserved 
alignment position (alignment performed with the help of PRALINE program,             
  indicates catalytic triade involved in iron coordination).  
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4.2.3 Cellular localization and tissue pattern of PHDs expression 
HIF-PHDs show differences in both sub-cellular and tissue localization. Cellular 
localization of HIF-PHDs is somewhat controversy because of contradictory results 
between different groups. Immunofluorescence of exogenously expressed EGFP-
PHDs in U2OS cells revealed that PHD1 is mainly localized in the nucleus, PHD2 
and FIH are most abundant in the cytoplasm and PHD3 is distributed between both 
compartments (Metzen et al., 2003). However, another study showed that all three 
isoforms are located mainly in the cytoplasmatic compartment (Soilleux et al., 2005). 
These discrepancies might be explained by different methods used in the detection of 
PHDs. In the first study confocal fluorescence microscopy (detecting EGFP-PHDs) 
was used versus monoclonal antibodies raised against PHDs used in the second study. 
Moreover, nuclear localization of PHD2 have been reported in two independent 
studies suggesting a new regulatory function for PHD2 in the nuclei (Berchner-
Pfannschmidt et al., 2008; Ozer et al., 2005). Among different tissues, the most 
abundant is PHD2, which is ubiquitously expressed in most tissues and is responsible 
for normoxic hydroxylation of HIFs (Berra et al., 2003) (Appelhoff et al., 2004; Stiehl 
et al., 2006). PHD1 shows highest expression in testis and PHD3 in the heart (Oehme 
et al., 2002; Soilleux et al., 2005). Moreover, PHD2 and PHD3 have been 
characterized as HIF target genes and their expression can be regulated by HIF, 
providing a negative feedback loop mechanism (Ginouves et al., 2008; Metzen et al., 
2005; Minamishima et al., 2009; Pescador et al., 2005; Stiehl et al., 2006). 
4.2.3.1 Genetic ablation of PHDs 
Genetic ablation of only PHD2 (but not PHD1 and PHD3) leads to embryonic 
lethality (Takeda et al., 2006). Lethality of PHD2 knock-out mice occurs after 
embryonic day 12.5 due to placental and heart defects (Takeda et al., 2006). Somatic 
inactivation of PHD2 results in increased erythropoiesis and angiogenesis via HIF 
stabilization and induction of erythropoietin and vascular endothelial growth factor 
(Takeda et al., 2007). Interestingly, combined knock-out of both PHD1 and PHD3 
shows a slight increase in hematocrit, hemoglobin concentration and red blood cell 
counts which supposedly resulted from increased EPO expression in the liver of adult 
mice (Takeda et al., 2008). PHD1 knock-out mice are viable, however their skeletal 
muscles show lower oxygen consumption and are protected against ischemic injury 
(Aragones et al., 2008). A similar protective effect of loss of PHD1 has been recently 
Introduction 
 
 
 
21
reported also for the liver (Schneider et al., 2010). PHD3 knockout mice are viable but 
show abnormal sympathoadrenal development demonstrated by reduced  adrenal 
medullary secretory capacity, sympathoadrenal responses and systemic hypotension 
(Bishop et al., 2008).  
4.2.4 Enzymatic activity of PHDs 
HIF prolyl-4-hydroxylases belong to the larger superfamily of 2-oxoglutarate and iron 
(II) dependent di-oxygenases. These enzymes use molecular di-oxygen and 2-
oxoglutarate as co-substrates to hydroxylate target prolyl-residues within HIF-α. Iron 
(II) is incorporated into the active site of these enzymes and is bound by the catalytic 
triade (His313, Asp315 and His374 for PHD2) (McDonough et al., 2006). In the 
reaction catalyzed by PHDs, hydroxylation of the proline substrate is coupled to 
oxidative decarboxylation of 2-oxoglutarate in a stoichiometrical manner to give 
succinate and carbon dioxide as co-products (Chowdhury et al., 2009). One of the 
oxygen atoms is incorporated into succinate and the other into the hydroxyl-group of 
the proline substrate (Myllyharju, 2008). Iron (II), which binds the proline substrate 
and the oxygen molecule, undergoes oxidation with Fe (III) and Fe (IV) as 
intermediate states. The role of ascorbate in this reaction has not been fully explained, 
however it is proposed that ascorbate maintains iron in the active site of the PHDs in 
the reduced (ferrous) state. Moreover, in the absence of the proline substrate, prolyl-4-
hydroxylases can catalyze an uncoupled reaction, in which 2-oxoglutarate is 
decarboxylated to succinate. It has been shown for the related collagen prolyl-4-
hydroxylases that ascorbate is consumed stoichiometrically in uncoupled reaction 
cycles and can serve as an alternative oxygen acceptor in the absence of the proline 
substrate (Myllyharju, 2008; Myllylä et al., 1984). However, if uncoupled reaction 
cycles also occur with HIF prolyl-4-hydroxylases is not known and the actual role of 
ascorbate in the oxygen sensing prolyl hydroxylation is rather speculative.  
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Fig. 3. Schematic cycle of HIF proline hydroxylation by PHDs (Nagel et al., 2010). 
 
4.2.4.1 Homology to collagen-prolyl-4-hydroxylases. 
HIF prolyl-4-hydroxylases belong to the same class of enzymes as collagen prolyl-4-
hydroxylases (EC 1.14.11.2). However, the substrate for collagen prolyl-4-
hydroxylases is a proline within collagen molecules where the role of hydroxyproline 
is to thermally stabilize the triple structure of collagen helixes. Both HIF and collagen 
prolyl-4-hydroxylases require oxygen, 2-oxoglutarate, iron (II) and/or ascorbate for 
activity, but they differ in Km values for these compounds. Structurally, collagen 
prolyl-4-hydroxylases are formed as α2β2 tetramers while PHDs presumably form α 
monomers in solution (known at least for PHD2), (McDonough et al., 2006; 
Myllyharju, 2008). Interestingly, HIF-PHD1-3 share 42-59% sequence identity to 
each other but only little sequence similarity to collagen prolyl-4-hydroxylases 
(Myllyharju, 2008) (Figure 4). However, the critical residues involved in binding of 
iron (II) and 2-oxoglutarate are conserved between both subclasses. Collagen prolyl-
4-hydroxylases require only a X-Pro-Gly tripeptide as recognition site for 
hydroxylation, while HIF-PHDs recognize the longer sequence Leu-X-X-Leu-Ala-Pro 
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(Myllyharju, 2008). Accordingly, Pro 402 and Pro 564 of HIF-1α are not 
hydroxylated by collagen prolyl-4-hydroxylases (Bruick and McKnight, 2001). 
 
 
 
 
Fig. 4. Comparison of the human Collagen (I), (II) and (III) α subunits and 
transmembrane P4H with human PHD1-3 (Myllyharju, 2008). H-histidine, D-aspartic 
acid, K-lysine.  
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4.2.4.2 Co-factors for HIF prolyl-4-hydroxylases 
Availability of oxygen, 2-oxoglutarate, iron (II) and/or ascorbate influences the 
hydroxylation capacity of PHDs. Therefore, changes in the concentration of these 
compounds can regulate PHDs activity and thus HIF protein abundance:  
 
Oxygen 
All three PHDs have a rather low affinity for oxygen with a Km of 230-250 μM, 
which is slightly above the atmospheric oxygen concentration (around 200 μM) 
(Hirsilä et al., 2003). This feature of HIF prolyl-4-hydroxylases enables them to 
respond to even small changes in oxygen concentration and activate the mechanism 
by which HIF can mediate responses to hypoxia. In comparison, collagen prolyl-4-
hydroxylases have a roughly six-fold lower Km for oxygen (40 μM). Interestingly, 
FIH has also a lower Km for oxygen (90 μM) than PHDs, suggesting that its function 
is preserved even at reduced oxygen concentrations where HIF-α protein is already 
stabilized. However, the specific Km value of these enzymes can vary, depending on 
the enzyme purity and source (insect cell, bacteria) and substrate peptide length used 
in the study (Kaelin and Ratcliffe, 2008).  
 
2-oxoglutarate 
2-oxoglutarate is one of the intermediates of the Krebs cycle, thus any change in 
oxidative cell metabolism principally could affect its availability for PHDs. HIF-
PHDs 1-3 have Km values for 2-oxoglutarate around 60 μM, which is roughly 3-fold 
higher than those reported for collagen prolyl-4-hydroxylase (20 μM) (Hirsilä et al., 
2003). However, it has been shown, that PHD2 co-purifies with 2-oxoglutarate with a 
binding constant <<2 μM, suggesting that 2-oxoglutarate abundance is not a major 
physiological regulator of the HIF hydroxylation reaction (McNeill et al., 2005).   
 
Iron (II) 
The third compound necessary for the activity of PHDs is iron (II). The Km values 
estimated for HIF-PHDs were 30 nM for PHD1 and PHD2 or 100 nM for PHD3, 
respectively (Hirsila et al., 2005). Somewhat surprisingly, PHD2 co-purifies at oxic 
conditions as a complex with ferrous iron, even in the absence of ascorbate, 
suggesting that the enzyme itself provides an anti-oxidative scaffold for iron. The iron 
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binding constant for PHD2 was estimated as <<1 μM (McNeill et al., 2005). This high 
affinity of PHD2 for iron (II) and 2-oxoglutarate is unusual among other studied 
prolyl-4-hydroxylases (Chowdhury et al., 2009). 
 
Ascorbate 
Historically, ascorbate was described as an essential co-factor for the activity of 
collagen prolyl-4-hydroxylases. Ascorbate deficiency is known to cause a disease 
called scurvy, which symptoms, amongst others, include bleeding gums and internal 
hemorrhages resulting from insufficient hydroxylation of collagen triple helixes 
building up connective tissues (Linster and Van Schaftingen, 2007). However, HIF-
PHDs have roughly 2-fold lower Km values (140-180 μM) for ascorbate than collagen 
prolyl-4-hydroxylases (300-370 μM) and there is no evidence in the literature that 
lack of ascorbate affects oxygen sensing in vivo  (Hirsilä et al, 2003; Nagel et al., 
2010). Of note, ascorbate does not co-purify with PHD2 like 2-oxoglutarate and iron 
(II) (McNeill et al., 2005). The role of ascorbate in the reaction catalyzed by HIF 
prolyl-4-hydroxylases is still not clear. As mentioned earlier, it is postulated, that 
ascorbate reduces the iron intermediate (IV) to its active (II) form, however it requires 
further investigation in the context of HIF-prolyl-4-hydroxylases. 
 
Effect of the peptide length on the activity of PHDs 
It was reported that PHDs (at least known for PHD1 and PHD2) hydroxylate Pro402 
within human HIF-1α much less effectively than Pro564 (Hirsilä et al., 2003; Villar et 
al., 2007). This difference cannot be explained by the sequence differences 
surrounding the hydroxyl-acceptor proline residue (Hirsilä et al., 2003). In contrary to 
collagen prolyl-4-hydroxylases, none of the PHDs is able to hydroxylate short 
peptides between 3-7 aminoacids in vitro  (Hirsilä et al., 2003). The Km value 
estimated for a 19-residue peptide corresponding to the C-terminal HIF-1α 
hydroxylation site was around  5-10 μM (Hirsilä et al., 2003). Shortening of the 
peptide at the C-terminus had an inhibitory effect on PHD1 and PHD2 and a smaller 
effect on PHD3. Peptides shorter than 11 residues were not hydroxylated by any of 
the isoforms (Hirsilä et al., 2003).   
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4.2.4.3 Regulation of PHDs activity by small molecules 
 
Reactive oxygen species 
The inhibitory effect of reactive oxygen species (ROS) on PHDs activity is not fully 
understood. ROS can either directly oxidize amino acid residues within the enzyme or 
indirectly deplete or inactivate one of the essential co-factors by oxidation (iron (II), 
ascorbate). There have been several reports showing that hypoxic cells generate 
higher levels of ROS, which could inhibit PHD activity. Moreover, cells lacking 
mitochondrial DNA have been reported to not respond to hypoxia by activating HIF-
target gene expression, suggesting involvement of these organelles in oxygen sensing 
(Chandel et al., 1998). Of note, these hypotheses were not confirmed by other 
independent studies, which showed that oxygen sensing does not require functional 
mitochondria (Srinivas et al., 2001; Vaux et al., 2001). An example of indirect co-
factor depletion was shown in JunD knock-out cells, which have increased amounts of 
ROS and PHDs activity is inhibited by reduced amount of available iron (II). 
Consequently, these cells activate HIF and HIF-target genes (Gerald et al., 2004). 
 
Nitric oxide 
Similarly to ROS, nitric oxide (NO) has been reported to modulate HIF stability, most 
likely due to inhibition of PHDs. It has been shown that nitric oxide can contribute to 
responses to hypoxia in D. melanogaster (Wingrove and O'Farrell, 1999). 
Interestingly, eNOS (endothelial NOS) is a HIF target gene, which could provide an 
additional feedback loop to oxygen sensing via HIF-PHDs (Kaelin and Ratcliffe, 
2008). However, opposing effects of NO on HIF have been reported. It was shown 
that NO can induce HIF stabilization and target gene expression (Kimura et al., 2001). 
Contrarily, NO was shown to have bi-modal effects on HIF-1α protein accumulation: 
In a first instance, NO administration inhibits PHD activity leading to a rapid 
induction of HIF-1α protein. With some delay, HIF-dependent de novo PHD2 protein 
synthesis finally destabilizes HIF-1α, thus counteracting the initial NO response. 
(Berchner-Pfannschmidt et al., 2007). A similar model of bi-phasic responses to 
notoriously instable intermediates as ROS is also attractive to explain the many 
controversial results reported for this molecule group with respect to the oxygen 
sensing pathway. 
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Antioxidants 
As ascorbate is required for full activity of HIF prolyl-4-hydroxylases in vitro, it was 
suggested that their activity is dependent on the presence of antioxidative agents. 
Whether the function of ascorbate is specific or can be replaced by other antioxidants 
is still unclear. A tumor-suppressive role of ascorbate - at least partially mediated by 
the HIF/PHD pathway - has been demonstrated in vivo (Gao et al., 2007). In this 
study, xenografted tumors grown in mice treated with ascorbate (5g/l) were 
significantly smaller than those of non-treated animals. Authors attributed this effect 
to the presence of HIF-1α, because tumors overexpressing HIF-1α were more resistant 
to ascorbate treatment. The same effects were observed when mice were treated with 
N-acetyl cysteine (40 mM). N-acetyl cysteine is an antioxidant but can also increase 
the intracellular pool of glutathione, as it serves as a precursor for this compound. 
Moreover, it was reported by Knowles et al., that ascorbate can decrease HIF-1α 
levels in cancer cells that have been treated with cobalt chloride and DFX. 
Nevertheless, ascorbate had no effect on hypoxia-treated cells (Knowles et al., 2003). 
Ascorbate administered at physiological concentration (25 μM) reduced normoxic 
levels of HIF-1α and prevented its induction by growth factors (IGF-1 and insulin) in 
a PHD dependent manner (Knowles et al., 2003). Recently, it was shown that REDD1 
knock-out cells have increased production of ROS and loss of REDD1 confered 
tumorigenicity to mouse embryonic fibroblasts, which was dependent on the presence 
of HIF-1α. Antioxidant treatment with ascorbate reduced HIF-1α protein levels and 
inhibited tumorigenic growth of REDD1−/− cells in vivo (Horak et al., 2010; Knowles 
et al., 2003). Interestingly, catalase is routinely added to in vitro hydroxylation assays, 
however the function of this enzyme in the reaction is unclear. It is possible that 
catalase (and other antioxidants) scavenges some reactive oxygen species generated 
during catalytic cycle, or it might simply take part in the reduction of iron (IV) to iron 
(II). Suprisingly, it has been shown, that other antioxidants, such as gallate or n-propyl 
gallate exert opposite effects on PHDs. For example it was reported, that gallate, but 
not n-propyl gallate, could inhibit PHDs and stabilize HIF (Tsukiyama et al., 2006). 
This effect was explained by binding of the carboxyl group of gallate to Arg383 of 
PHD2 and chelation of iron (II) within the catalytic domain of PHD2. This binding 
would be inhibited by the n-propyl group of n-propyl gallate. Similarly, another plant-
derived flavonoid, quercetin has inhibiting activity on PHD2 (Dao et al., 2009). Such 
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contradictory effects of different antioxidants could suggest different mechanisms by 
which these compounds activate/inhibit PHDs and act on HIF. 
 
Transition metals 
Transition metals and metal chelators have been implicated in the regulation of the 
HIF pathway. It has been shown that cobalt, nickel and zinc inhibit all three PHDs. 
Mechanistically, transition metals a thought to act either by replacement or oxidation 
of PHD bound iron (II). Alternatively, oxidation of ascorbate to dehydroascorbate 
catalyzed by transition metals has been proposed to activate the HIF pathway (Hirsilä 
et al., 2003; Salnikow et al., 2004). Another explanation for the inhibitory mechanism 
of cobalt could be direct binding to HIF-1α and therefore an inhibition of HIF-1α 
protein degradation by the VHL ubiquiutin ligase complex (Yuan et al., 2003). In 
comparison to collagen prolyl-4-hydroxylases and FIH, most metals were less 
effective inhibitors of PHDs, in particular PHD2 (Hirsilä et al., 2003). Among other 
metals, cadmium inhibited all three PHDs, whereas magnesium and manganese were 
the least potent inhibitors with half maximal inhibitory concentrations (IC50) ranging 
from 50 to1 mM (Hirsilä et al., 2003). Also cupric copper is a potent inhibitor of PHD 
activity, inducing HIF activity and target gene expression (Martin et al., 2005). This 
can be explained by the fact that copper is a potent catalyst of ascorbate oxidation by 
air (Nytko et al., 2007). 
 
2-oxoglutarate analogs 
Many 2-oxoglutarate analogs serve as potent inhibitors of PHD activity. Since binding 
of 2-oxoglutarate to the enzyme is required for normal turnover of the enzyme, these 
compounds block the reaction by binding to the 2-oxoglutarate pocket and inhibiting 
enzyme activity. N-Oxaloylglycine (NOG) and its cell-permeable analogon dimethyl-
oxalylglycine (DMOG) are the widest used small molecule inhibitors of PHD activity 
(Nagel et al., 2010; Oehme et al., 2004). Moreover, other Krebs cycle intermediates, 
such as succinate, fumarate, malate and pyruvate, have been shown to inhibit the 
activity of PHDs in vitro or in cell culture (Koivunen et al., 2007; Nytko et al., 2007; 
Pan et al., 2007). Interestingly, germline mutations in fumarate hydratase (FH) and 
succinate dehydrogenase (SDH) predispose these individuals to different types of 
tumors, supposedly due to HIF-1α stabilization (Pollard et al., 2005; Pollard et al., 
2007). 
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4.2.5 Regulation of PHDs expression 
PHD2 and PHD3 transcription is regulated by HIF, as these genes contain functional 
HRE sequences in the promoter or first intronic region of their genes, respectively 
(Metzen et al., 2005; Pescador et al., 2005). This provides a negative feedback loop 
and enables cells/tissues to adapt to prolonged hypoxic exposure (Minamishima et al., 
2009; Stiehl et al., 2006). Moreover, PHD1 gene expression was reported to be 
induced by estradiol (Appelhoff et al., 2004). PHD2 expression is regulated by TGF-
β, which decreases PHD2 mRNA and protein levels and accordingly induces HIF-1 
transcriptional activity (McMahon et al., 2006). 
4.2.6 Other regulators of PHDs 
It has been reported that PHDs might interact with other molecules that may affect 
their stability and/or activity. One of the first characterized interactors for PHD1 and 
PHD3 was the RING finger E3 ubiquitin ligase Siah2, which regulates PHD1 and 
PHD3 protein stability. Moreover, Siah2 knock-out mice show an impaired response 
to hypoxia with reduced levels of hemoglobin, emphasizing the physiological 
relevance of the Siah2-PHD3 interaction (Nakayama et al., 2004). Another 
interaction, which was characterized in the course of the current thesis (see 
contribution to publications) is FK506-binding protein 38 (FKBP38), which 
specifically binds PHD2 and regulates its protein stability (Barth et al., 2007). A list 
of characterized interactors of PHDs are summarized in Table 1 (adapted from 
(Wenger et al., 2009). Some of the interactors are putative hydroxylation targets for 
PHDs.  
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Interactor PHD1 PHD2 PHD3 Reference 
Siah2   + (Nakayama et al., 2004) 
FKBP38  +  (Barth et al., 2007) 
TriC   + (Masson et al., 2004) 
OS-9  + + (Baek et al., 2005) 
AKAP  +  (Choi et al., 2007) 
Morg1   + (Hopfer et al., 2006) 
ING4  +  (Ozer et al., 2005) 
IOP1  +  (Huang et al., 2007) 
MAGE  +  (Aprelikova et al., 2009) 
Cdr2 +   (Balamurugan et al., 2009) 
ATF4*   + (Koditz et al., 2007) 
IKKβ* +   (Cummins et al., 2006) 
Myogenin*   + (Fu et al., 2007) 
KIFBβ*   + (Schlisio et al., 2008) 
Rbp1* + +  (Mikhaylova et al., 2008) 
 
Table 1. Characterized interactors of PHD1-3, asterisks indicate putative 
hydroxylation targets of PHDs (based on (Wenger et al., 2009)). 
4.2.7 Role of PHDs in physiology and pathophysiology  
Because PHDs are important factors regulating HIF stability, they also play a role in 
physiological and pathophysiological aspects of disorders in which HIF is involved.   
Mutations in PHD2 have been described in patients suffering from erythrocytosis and 
polycythemia (Percy et al., 2007; Percy et al., 2006). These mutations occur at 
residues Pro317, Arg371 and His374 and all of them are located in the catalytic 
domain of PHD2, causing inhibition of hydroxylation activity (Ladroue et al., 2008; 
Percy et al., 2007; Percy et al., 2006). This discovery emphasizes the important role of 
PHD2 in maintaining homeostasis of the erythropoietic pathway. Accordingly, 
diseases such as anemia could be potentially treated with PHDs inhibitors. 
Because the HIF/PHD pathway is also involved in ischemia-reperfusion conferred 
injury, PHD inhibitors have been tested in ischemic preconditioning (IPC) which 
protects myocardial tissue from subsequent ischemia (Nagel et al.; 2010). Besides 
myocardial tissue damage by ischemia, ischemic stroke is another possible candidate 
disease that could be treated with PHDs inhibitors used for IPC (Harten et al., 2010). 
Beneficial effects of PHD inhibitors have been also implicated in inflammatory bowel 
disease, as DMOG has been shown to be protective in a murine model of colitis 
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(Cummins et al., 2008). Moreover, PHDs inhibitors could be potentially used in other 
diseases involving abnormal vascularization such as in retinopathy of prematurity or 
in placental disease (Nagel et al., 2010).  
Recently, opposing effects describing the role of PHDs in the cancer have been 
reported. PHD2, as the main normoxic HIF-α regulator, was desribed to play a role in 
both, cancer progression or regression. On the one hand, PHD2 levels were shown to 
be decreased in human breast carcinomas samples which was accompanied by 
increased number of mature blood vessels in the tumor (Bordoli et al., 2010; Chan et 
al., 2009). This effect underlines an important role of PHD2 in tumor angiogenesis. 
However, PHD2 haplo-deficiency in tumor bearing mice was reported to increase 
vessel normalization, which is a quite opposite effect to the previous study (Mazzone 
et al., 2009). The discrepancies between both studies was explained by the effect of 
PHD2 deficiency in tumor cells itself, which results in an increased angiogenic 
response, while PHD2 deficiency in the host endothelium results rather in vessel 
normalization (Chan and Giaccia, 2010).  
Besides the essential co-factors 2-OG, iron (II) and/or ascorbate, only few compounds 
are known to activate PHDs (Nagel et al., 2010). PHD activators could potentially 
inhibit tumor growth by destabilizing HIF-α, as was shown for ascorbate and N-acetyl 
cystein in a tumor allograft model (Gao et al., 2007). Use of ascorbate in anti-cancer 
therapy became famous already in the 1970’s, when Linus Pauling claimed beneficial 
effects of this antioxidant in treatment of terminally ill cancer patients (Cameron and 
Pauling, 1976). Moreover, recent report showed for the fisrt time, that an aggressive 
tumor phenotype in endometrial cancer is associated with low ascorbate levels and 
increased HIF-1α activity (Kuiper et al., 2010). Another disorder, where PHDs 
activators could prove useful is hypoxia-induced pulmonary hypertension, since 
hypoxic stabilization of HIF is involved in pulmonary vasculature remodeling and 
causes high mortality among patients with lung diseases (Nagel et al., 2010).  
In summary, PHDs activators and inhibitors are potential candidates for novel 
treatments for a number of diseases. Several studies report on small molecule library 
screens where compounds have been analysed for their potential to block or stimulate 
PHD activity in order to modify HIF levels in patients. The major obstacle however, 
is that the similarity between PHDs isoforms and other prolyl-4-hydroxylases may 
prevent specific targeting of  PHDs, possibly leading to severe side effects when 
applied to the human body. 
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5. Aims of the study 
 
I. Characterization of hydroxylation activity of recombinant PHD isoforms in the 
context of requirements for essential co-substrates and co-factors using an in vitro 
hydroxylation assay. 
II. Studies on the influence of small molecule antioxidants, reactive oxygen 
species, transition metals and metal chelators on PHDs hydroxylation activity in vitro.  
III. Analysis of the role of ascorbate and other antioxidants in regulating cellular 
oxygen sensing via the HIF/PHDs pathway in living cells and in vivo.  
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Abstract 
Cellular oxygen is sensed by prolyl-4-hydroxylase domain (PHD) proteins that 
hydroxylate hypoxia-inducible factor (HIF) α subunits. Under normoxic conditions, 
hydroxylated HIFα is bound by the von Hippel-Lindau (pVHL) tumor suppressor, 
leading to ubiquitinylation and proteasomal degradation. Under hypoxic conditions 
hydroxylation becomes reduced, leading to HIFα stabilization. We recently showed 
that changes in PHD abundance and activity can regulate HIFα stability under 
normoxic as well as under hypoxic conditions. Thus, the PHD oxygen sensors 
themselves represent effectors of cellular signalling pathways as well as potential drug 
targets. Here, we applied a cell-free in vitro microtiter plate-based peptide 
hydroxylation assay to investigate the influence of ferrous iron, Krebs cycle 
intermediates, transition metals, vitamin C and other antioxidants on the activity of 
purified PHD1 to 3. PHD activity depends not only on oxygen availability but is also 
regulated by iron, vitamin C and Krebs cycle intermediates, suggesting a 
physiological relevance of their cellular concentrations. Copper but not iron, cobalt or 
nickel salts catalyzed vitamin C oxidation. While vitamin C is essential for PHD 
activity in vitro, N-acetyl-L-cysteine had no effect, and gallic acid or n-propyl gallate 
efficiently inhibited the activity of all three PHDs, demonstrating different functions 
of these antioxidants. 
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Introduction 
Oxygen availability affects many physiological and pathophysiological processes, 
including embryonic development, adaptation to high-altitudes, wound healing, 
inflammation, cancer and ischemic diseases such as infarction and stroke. Central to 
the understanding of these processes is the elucidation of the molecular mechanisms 
by which cells react and adapt to insufficient oxygen supply (hypoxia). Oxygen 
availability is measured by a family of oxygen-dependent protein hydroxylases that 
regulate the abundance and activity of hypoxia-inducible transcription factor (HIF) α 
subunits (Schofield and Ratcliffe, 2004). HIFs in turn control the expression levels of 
effector genes involved in either anticipatory metabolic changes, adaptive survival or 
programmed death of the affected tissue (Wenger et al., 2005). HIFs are heterodimeric 
transcription factors consisting of one out of three different oxygen-sensitive HIFα 
subunits (HIF-1α, HIF-2α or HIF-3α) and a common constitutive HIFβ subunit. 
While HIF-1 and HIF-2 αβ heterodimers function as transcriptional activators of 
oxygen-regulated target genes, the role of HIF-3α is less clear and a short splice 
variant of HIF-3α, termed inhibitory PAS protein (IPAS), functions as a 
transcriptional repressor (Wenger, 2002).  
 Dependent upon the cellular oxygen partial pressure (pO2), a family of prolyl-
4-hydroxylase domain (PHD) enzymes covalently modify two proline residues within 
the oxygen-dependent degradation (ODD) domain of HIFα subunits. The PHD family 
is comprised of three members called PHD1, PHD2, PHD3, or HIF prolyl 
hydroxylase (HPH) HPH3, HPH2, HPH1, respectively (Bruick and McKnight, 2001; 
Epstein et al., 2001). A fourth member, called PH-4, regulates HIFα under 
overexpression conditions only (Oehme et al., 2002). Upon hydroxylation under 
normoxic conditions, HIFα is bound by the von Hippel-Lindau (VHL) tumor 
suppressor protein and targeted for proteasomal destruction (Maxwell et al., 1999). 
Thus, the high turnover rate of HIFα subunits allows for an instantaneous stabilization 
under hypoxic conditions (Jewell et al., 2001). According to the current model, also 
the asparagine hydroxylase function of the factor inhibiting HIF (FIH) becomes 
impaired when oxygen availability is further decreased, resulting in a decrease in C-
terminal HIFα asparagine hydroxylation (Pouyssegur et al., 2006). This allows for the 
progressively increased recruitment of p300/CPB transcriptional co-activators, 
Author manuscript I published in Antioxid Redox Signal. 2007 Sep;9(9):1329-38 
 
 
 
46
leading to a successively higher transcriptional function of HIF (Lando et al., 2002; 
Mahon et al., 2001). 
 While all three PHDs can hydroxylate HIFα with similar efficiency, PHD2 has 
been suggested to play the main role for normoxic HIFα turnover (Berra et al., 2003). 
Consistent with these in vitro findings, PHD2 but not PHD1 or PHD3 knock-out mice 
die during embryonic development (Takeda et al., 2006). The three PHDs are 
expressed in most organs but there are strikingly high levels of PHD3 mRNA in the 
heart and of PHD1 mRNA in the testis (Stiehl et al., 2006). In addition to HIFα, there 
is some evidence that the iron regulatory protein IRP2, the RNApol II large subunit 
Rpb1, the heme synthesis enzyme ALAS2, and IκB kinase-β are regulated by PHDs 
(Abu-Farha et al., 2005; Cummins et al., 2006; Kuznetsova et al., 2003; Wang et al., 
2004; Wang and Pantopoulos, 2005). Of note, these experiments were mainly based 
on pharmacological inhibition of PHDs and no direct evidence for protein 
hydroxylation has been provided yet. Interestingly, ankyrin repeats within the NF-κB 
family (p105) and IκBα were shown to be efficiently hydroxylated by FIH (Cockman 
et al., 2000). The function of this FIH-dependent hydroxylation, however, is unclear 
up to date. 
 The regulation of PHD expression and activity has become of considerable 
interest in the recent past. Endogenous tricarboxylic acid cycle intermediates and 
reactive oxygen species (ROS) have been reported to inhibit PHD function and hence 
link mitochondrial function with PHD-dependent oxygen sensing (Dalgard et al., 
2004; Gerald et al., 2004; Pollard et al., 2005; Selak et al., 2005). Small molecule 
inhibitors that can be added exogenously are currently being developed for clinical 
tissue protection in diseases associated with oxygen deprivation. However, little is 
known on the differential regulation of the three PHD family members. We therefore 
set out to investigate the control of each PHD family member individually by small 
molecules as well as by newly identified protein interactors and by HIF-dependent 
feedback regulation. 
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Materials and methods 
Expression and purification of PHDs 
 GST-PHD1, GST-PHD2 and GST-PHD3 were expressed in baculovirus-
infected Sf9 insect cells and purified as described before (Stiehl et al., 2006). Briefly, 
after 80 to 110 hours of infection Sf9 cells were lysed in ice-cold 0.1% NP-40, 10 mM 
Tris-HCl pH 7.5, 100 mM NaCl, 100 mM glycine and 10 μM DTT. Cleared lysates 
were incubated with equilibrated glutathione-sepharose beads (Amersham, 
Dübendorf, Switzerland) for 2 hours at 4°C with gentle agitation. After washing of the 
beads three times with PBS, bound protein was eluted with 15 mM reduced 
glutathione, 50 mM Tris-HCl pH 8.0, and 2 μM FeSO4. Purity of recombinant fusion-
proteins was routinely estimated by SDS-PAGE and coomassie blue staining.  
 
In vitro prolyl-4-hydroxylation assays 
 Enzymatic activity of recombinant PHDs was determined as described before 
(Martin et al., 2005; Oehme et al., 2004). Biotinylated peptides (100 ng/well) derived 
from human HIF-1α amino acids 556 to 574 (either wild-type or P564A mutant) were 
bound to NeutrAvidin-coated 96-well plates (Pierce, Perbio, Lausanne, Switzerland). 
Purified recombinant PHD enzymes were used to hydroxylate the peptides in the 
presence of 0.5 mM 2-oxoglutarate, 2 mM ascorbate, 10 μM FeSO4 in 20 mM Tris-
HCl pH 7.5, 5 mM KCl, 1.5 mM MgCl2 for 1 hour at room temperature. A 
polycistronic expression vector for His6- and thioredoxin-tagged pVHL/elongin 
B/elongin C (VBC) complex was kindly provided by S. Tan (Pennsylvania, PA). VBC 
was expressed in bacteria, purified by nickel affinity chromatography followed by ion 
exchange chromatography and buffer exchange gelfiltration. VBC complex was 
allowed to bind to the hydroxylated peptides and bound VBC complex was detected 
by rabbit anti-thioredoxin antibodies followed by secondary horseradish peroxidase-
coupled anti-rabbit antibodies (Sigma, Buchs, Switzerland), using the TMB (3,3’,5,5’-
tetramethylbenzidine) substrate kit (Pierce). The peroxidase reaction was stopped by 
adding H2SO4 to 1 M and absorbance was determined at 450 nm in a microplate 
reader.  
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Ascorbate oxidation assays 
 Ascorbate oxidation to dehydroascorbate was measured 
spectrophotometrically as described (Stait and Leake, 1996). Therefore, the decrease 
in absorbance at 265 nm was measured in a 100 μM ascorbate solution in 20 mM 
Tris-HCl pH 7.5, 5 mM KCl, 1.5 mM MgCl2 using open cuvettes with free access to 
air.  
 
Hypoxia reporter cells 
 The chinese hamster ovary (CHO) cell line stably transfected with a hypoxia-
responsive firefly luciferase reporter gene (termed HRCHO5) has been described 
before (Wanner et al., 2000). Cell lysis and determination of luciferase activity was 
performed according to the manufacturer's instructions (Promega, Wallisellen, 
Switzerland). Relative light units were measured in a 96-well luminometer (Berthold, 
Regensdorf, Switzerland) and normalized to the protein concentration determined by 
the Bradford assay (Biorad, Reinach, Switzerland). 
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Results 
Ferrous iron availability is essential for the function of all three PHDs 
 GST-tagged PHD1, PHD2 and PHD3 were purified from Sf9 insect cells to 
80-90% purity and their activity was analyzed by a VBC binding assay. All three 
PHDs induced VBC binding to the wild-type P564 but not to the mutant P564A-
containing peptide derived from the HIF-1α ODD (Fig. 1a). The PHD preparations 
were calibrated with hydroxyproline (Hyp)564 peptide-containing hydroxylation 
assays and subsequently diluted to obtain solutions with similar specific activities 
which were then used for all following experiments.  
 Although 2 μM FeSO4 was initially present in the elution buffer, the PHDs did 
not display full activity without additional ferrous iron in the reaction buffer (Fig. 1b), 
suggesting that both active center and added iron was at least partially oxidized. An 
iron titration experiment revealed that the addition of ~ 10 μM FeSO4 was required 
for full induction of the hydroxylation activity of all three PHDs (Fig. 1c). This 
concentration was hence kept in the following experiments. The addition of ferric iron 
did not stimulate the activity of the PHDs (data not shown).  
 The sensitivity of the PHDs to the availability of "free" iron explains the long-
known feature of iron chelators to induce the HIFα subunits. Indeed, the hexadentate 
hydroxamic acid iron chelator desferrioxamine inhibited the in vitro hydroxylation 
activity of all three PHDs (Fig. 1d). Of note, PHD2 was somewhat less sensitive to 
desferrioxamine than PHD1 or PHD3 which were efficiently inhibited by 10 μM 
desferrioxamine, corresponding to the concentration of iron in the reaction solution. 
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Fig. 1 Regulation of PHD function by iron. PHD1, PHD2 and PHD3 (from left to 
right) were purified as GST-tagged fusion-proteins from Sf9 cells and their 
hydroxylation activity was estimated in microtiter plate-based VBC binding assays. 
(a) VBC binding is dependent on the presence of both functional PHD enzyme and 
Pro564. Mutant P564A peptides cannot be hydroxylated. (b) Ferrous iron 
supplementation is essential for full PHD function. (c) Titration of ferrous iron reveals 
that ~ 10 μM FeSO4 is required for full PHD function. (d) Inhibition of PHD function 
by iron chelation. Mean values ± SEM of representative experiments performed in 
triplicates are shown. 
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Requirement for 2-oxoglutarate and inhibition by succinate 
 2-Oxoglutarate is used as a co-substrate of all three PHDs which is oxidatively 
decarboxylated during target protein hydroxylation. Titration experiments with 2-
oxoglutarate revealed that all three PHDs required a similar 2-oxoglutarate 
concentration of ~ 10-100 μM for full activity (Fig. 2a). These data confirm previous 
estimates of Km values of 55-60 μM for all three PHDs (Hirsilä et al., 2003), and a 
PHD2 binding constant for 2-oxoglutarate of < 2 μM (McNeill et al., 2005). 
Therefore, a concentration of 500 μM 2-oxoglutarate was kept in all further 
experiments. Higher concentrations of 2-oxoglutarate inhibited the in vitro PHD 
activity in some experiments. Whether this effect is of physiological relevance is 
currently unknown.  
 It has been reported previously that succinate can inhibit PHD activity 
(Dalgard et al., 2004; Lu et al., 2005; Selak et al., 2005). We hence tested the effects 
of increasing succinate concentration on each PHD enzyme. In the presence of 500 
μM 2-oxoglutarate, addition of succinate only moderately inhibited the hydroxylation 
activity of purified PHDs and this effect was even reversed at higher concentrations 
(Fig. 2b). However, in the presence of 50 μM 2-oxoglutarate, succinate efficiently 
inhibited PHD activity with IC50 values of ~ 600 μM (Fig. 2c). 
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Fig. 2.  Regulation of PHD function by Krebs cycle intermediates. PHD1, PHD2 
and PHD3 (from left to right) hydroxylation activity was estimated in microtiter plate-
based VBC binding assays. Titration curves of the co-substrate 2-oxoglutarate (a) or 
the co-product succinate in the presence of 500 μM (b) or 50 μM (c) 2-oxoglutarate 
are shown as mean values ± SEM of representative experiments performed in 
triplicates. 
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Vitamin C oxidation impairs PHD function 
 Vitamin C is essential for the function of collagen hydroxylases as well as for 
HIFα hydroxylases because it protects the enzyme's amino acid residues and/or active 
center iron from oxidation in reactions uncoupled from target hydroxylation (Myllylä 
et al., 1984). Purified PHDs do not show any activity in the absence of ascorbate and 
the addition of at least 0.1 mM ascorbate was required to fully induce hydroxylation 
activity of all three PHDs (Fig. 3a). The addition of oxidized ascorbate 
(dehydroascorbate) did not induce PHD activity (data not shown). These data confirm 
previously reported similar ascorbate Km values (140 - 180 μM) for all three PHDs 
(Hirsilä et al., 2003). Therefore, an excess of freshly prepared ascorbate (2 mM) was 
added to all subsequent experiments. Anti-oxidative ascorbate function is specifically 
required by the PHDs and cannot be replaced by the antioxidant N-acetyl-L-cysteine 
(Fig. 3b).  
 The absolute requirement for ascorbate might also explain the function of 
previously reported agents inhibiting PHD activity. Ascorbate oxidation by air can be 
measured by the drop in absorbance at 265 nm. However, as shown in Fig. 3c, 
ascorbate oxidation is negligible during the reaction period of 1 hour. Even in the 
presence of equimolar ferrous iron the ascorbate levels dropped only by 20% after 1 
hour (Fig. 3c, left graph). The transition metals cobalt and nickel are well known 
inducers of HIFα protein stability due to PHD inhibition. Of note, even a two-fold 
molar excess of CoCl2 or NiSO4 did not catalyze more ascorbate oxidation than 
FeSO4 (Fig. 3c, middle graph). In contrast, copper efficiently catalyzed ascorbate 
oxidation: 5 μM CuCl2 destroyed more than 90% of 100 μM ascorbate within 10 
minutes (Fig. 3c, right graph). 
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Fig. 3. Regulation of PHD function by vitamin C. PHD1, PHD2 and PHD3 (from 
left to right) hydroxylation activity was estimated in microtiter plate-based VBC 
binding assays. (a) Titration of vitamin C reveals that 0.1 mM ascorbate is minimally 
required for PHD function. (b) The anti-oxidant N-acetyl-L-cysteine (250 μM) cannot 
replace ascorbate (2 mM) for PHD function. (c) Ascorbate is slowly oxidized by air 
(dehydroascorbate does not absorb light at 265 nm). Ferrous iron slightly catalyzes 
this reaction (left graph), whereas the effects of the known PHD inhibitors cobalt and 
nickel are negligible (middle graph). However, cupric copper strongly catalyzed 
ascrobate oxidation (right graph). Mean values ± SEM of representative experiments 
performed in triplicates are shown. 
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The antioxidants gallic acid and n-propyl gallate efficiently inhibit the activity of 
all three PHDs 
 A number of natural nutrient compounds has been suggested to induce HIF-
1α; among them flavonoid and non-flavonoid polyphenols. Catechins are non-
flavonoid polyphenols found in green tea leaves which have been reported to induce 
HIF-1α (Zhou et al., 2004). Only catechins containing a 3-gallate moiety activate 
HIF-1 and have been shown to inhibit PHD2 activity (Thomas and Kim, 2005; 
Tsukiyama et al., 2006). Thus, we tested the sensitivity of PHD-dependent peptide 
hydroxylation on gallic acid or n-propyl gallate. Remarkably, all three PHDs were 
efficiently inhibited by 33 - 100 μM gallic acid (Fig. 4a) or by 3.3 - 10 μM n-propyl 
gallate (Fig. 4b). As shown in Fig. 4c, n-propyl gallate also induced HIF-dependent 
luciferase reporter gene activity in cultured CHO cells. In contrast to the in vitro 
results, gallic acid treatment of cells only marginally affected luciferase expression 
(data not shown). 
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Fig. 4. Regulation of PHD function by gallate. The effects of gallic acid (a) and n-
propyl gallate (b) on PHD1, PHD2 and PHD3 (from left to right) hydroxylation 
activity were estimated in microtiter plate-based VBC binding assays. (c) CHO cells 
stably transfected with a HIF-dependent luciferase reporter gene were treated with the 
indicated concentrations of n-propyl gallate for 24 hours. Relative light units (RLU) 
were normalized to the protein content of the lysates. Mean values ± SEM of 
representative experiments performed in triplicates (quadruplicates for the reporter 
gene assays) are shown. 
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Discussion 
Oxygen sensing by protein hydroxylation is a regulated process 
 Sensing cellular pO2 is probably not the only function of the PHDs. Otherwise, 
an excess of a single sensory protein simply regulated by oxygen availability would 
be all that was required for this task. However, there is ample evidence that the PHD 
oxygen sensors fulfill additional functions. First, different tissues are differently 
vascularized, unequally perfused and show spatially and temporally variable oxygen 
consumption rates. Thus, the mean pO2 varies from tissue to tissue, if not from cell to 
cell. Nevertheless, every cell is capable of sensing a reduction in oxygenation and 
adequately responds to such a reduction by inducing HIF-dependent gene expression. 
Therefore, also hypoxia thresholds vary both spatially and temporally and the PHD 
oxygen sensors evolved to meet these requirements by showing a variable tissue-
specific expression pattern. Second, every successful adaptation to hypoxia eventually 
results in re-oxygenation of the affected tissue. Because following hypoxia there are 
much higher levels of HIFα in the cell, the oxygen-dependent hydroxylation and 
degradation machinery must increase its capacity to cope with the degradation of the 
increased protein mass. Third, HIFα is also induced by a variety of stimuli under 
normoxic conditions. How can HIFα protein stabilization occur in the presence of 
active PHDs and sufficient oxygen supply? A plausible explanation lies in the limited 
expression levels of PHDs which are finely counterbalanced by HIFα levels. If either 
one is upregulated it overcomes the function of the other. Thus, as well as an increase 
in PHD synthesis leads to HIFα degradation, an increase in HIFα synthesis leads to 
its stabilization even under normoxic conditions. We have previously demonstrated 
that these mechanisms work even under hypoxic conditions, since PHD-dependent 
HIFα hydroxylation was reduced but still functional in direct proportion to the 
decrease in available oxygen (Stiehl et al., 2006). 
 
Regulation of the three PHD oxygen sensors by small molecules 
 In this work, we have analyzed the effects of several small molecules on PHD 
function in vitro. Addition of ferrous iron was essential for PHD activity. Hirsilä et al. 
reported iron Km values for PHD1, PHD2 and PHD3 of 30 nM, 30 nM and 100 nM, 
respectively (Hirsila et al., 2005), and McNeill et al. reported a ferrous iron binding 
constant of highly purified PHD2 of << 1 μM (McNeill et al., 2005). Our data support 
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an increased iron affinity of PHD3 that reached maximal activity already in the 
presence of 1 μM FeSO4 whereas PHD1 and PHD2 required 10 μM FeSO4 for full 
activity. The iron chelator desferrioxamine efficiently inhibited PHD1 and PHD3 
activity at concentrations corresponding to the iron concentrations in the reaction 
buffer. PHD2 inhibition was somewhat less efficient but a drop in activity was 
observed with similar desferrioxamine concentrations. Interestingly, it has previously 
been suggested that desferrioxamine inefficiently inhibited crude PHD enzymes in 
vitro: in the presence of 5 μM Fe2+ up to 1 mM desferrioxamine inhibited crude PHDs 
by < 20% whereas inhibition of pure PHDs was much more efficient (Hirsila et al., 
2005). Thus, the efficiency of inhibition of the PHDs by desferrioxamine might allow 
to draw some conclusions on the purity of the enzyme preparation. 
 We previously determined an iron concentration in the FCS of 148 μM and in 
the cell culture medium of 16 μM (Wanner et al., 2000). The intracellular 
concentration of chelatable iron has been reported to be 3-6 μM, depending on the cell 
type (Rauen et al., 2000). Thus, the estimated concentration of "free" iron for optimal 
PHD activity in vitro corresponds to the iron concentrations in vivo, suggesting that 
iron availability is indeed able to regulate the HIF system by influencing PHD 
activity. This assumption has been confirmed by experimentally changing the "labile 
iron pool" in cancer cells (Jones et al., 2006; Knowles et al., 2006; Knowles et al., 
2003). Interestingly, important iron uptake and transport proteins are among the 
targets of HIF-1 that might hence function also as a regulator of iron homeostasis in 
addition to oxygen homeostasis (Wenger et al., 2005). These values also explain why 
~ 100 μM of the hexadentate extracellular iron chelator desferrioxamine but only ~ 10 
μM of the bidentate intracellular iron chelator cyclopirox olamine were required to 
induce the HIF system by inhibiting PHD activity (Linden et al., 2003). 
 Krebs cycle intermediates such as succinate and fumarate are known to induce 
the HIF system by inhibiting PHD activity (Isaacs et al., 2005; Pollard et al., 2005; 
Selak et al., 2005). Moreover, 2-oxoacids such as pyruvate and oxaloacetate also 
induce HIFα (Dalgard et al., 2004; Lu et al., 2005). These findings link mitochondrial 
function and cellular metabolism with the PHD/HIF oxygen sensing system. Mutation 
of the tumor suppressor succinate dehydrogenase has been reported to increase 
cellular succinate concentration from 120 μM to ~ 440 μM (Selak et al., 2005). The 
IC50 values for succinate have been reported to be in the range of 510 - 830 μM for 
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purified PHDs (Koivunen et al., 2007). We obtained similar IC50 values (~ 600 μM) 
for succinate when the assays were performed in the presence of 50 μM 2-
oxoglutarate. Succinate competes for 2-oxoglutarate binding to the PHDs (16, 26), 
explaining why we observed only weak succinate inhibition of PHD activity in the 
presence of high (500 μM) 2-oxoglutarate concentrations. 
 We demonstrated that ascorbate is essential for the function of all three PHDs. 
It has been shown that physiological concentrations (25 μM) of ascorbate suppress 
HIF-1α protein levels in cancer cells, suggesting that intracellular ascorbate 
concentrations indeed respresent a major regulator of PHD function (Knowles et al., 
2003). Ascorbate depeletion thus could also explain how transition metals induce 
HIF-1α. Interestingly, Salnikow and colleagues reported that cellular ascorbate 
depletion causes NiSO4 and CoCl2 induced HIF-1α stabilization (Karaczyn et al., 
2006; Salnikow et al., 2004). However, the authors attributed this effect to inhibition 
of cellular ascorbate uptake. Moreover, we could not observe any relevant nickel or 
cobalt-mediated degradation of ascorbate in vitro. In contrast, we observed a rapid 
copper-mediated ascorbate oxidation which most likely explains the previously 
reported CuCl2 induced HIF-1α stabilization via PHD inhibition in cultured cells 
(Martin et al., 2005). 
 We have found that the antioxidant compounds gallic acid and n-propyl gallate 
efficiently inhibited all three PHDs in vitro and the esterified gallate also induced a 
HIF-dependent reporter gene in cell culture. Tsukiyama et al. hypothesized that two 
phenolate oxygen atoms of gallate chelate with the active center iron and the carboxyl 
group of gallate forms a strong ionic/hydrogen bonding with Arg383 of PHD2 
(Tsukiyama et al., 2006). In the hands of these authors, n-propyl gallate was effective 
only in cell culture but not in cell-free PHD assays, which was attributed to the 
esterified carboxyl group of n-propyl gallate. However, in our hands n-propyl gallate 
was even more efficient in PHD inhibition in vitro than gallic acid. A likely reason for 
this discrepancy was the use of crude cell lysates in a 2-oxoglutarate conversion assay 
by these authors. We recently found that 2-oxoglutarate turnover using crude lysates 
is independent of PHD function (Wirthner R. et al., submitted for publication). 
 What might be the mechanism of PHD inhibition by gallate-containing 
antioxidants in comparision to other antioxidants such as N-acetyl-L-cysteine? The 
use of molecular dioxygen for oxidative decarboxylation-coupled protein 
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hydroxylation requires short-lived, highly reactive transition states of oxygen. 
Antioxidants fitting into the active center of PHDs might scavenge these ROS, 
thereby blocking the PHD reaction cycle. Similarly, exogenously produced ROS 
potentially could interfere with these reactive transition states of oxygen. It has been 
suggested that the increase in ROS content in junD-/- or mucin 1 (MUC1) knock-down 
cells leads to a decrease in PHD activity and hence to HIF-1α accumulation (Gerald et 
al., 2004; Yin et al., 2007). Thus, antioxidants paradoxically would have the potential 
to do both: protect PHD function from exogenous ROS and block PHD activity by 
destruction of PHD-inherent ROS intermediates. The effective function of a given 
antioxidant would depend on the accessibility to the active center, interference with 
transition metals and ascorbate, and the scavenging efficiency of mitochondrial and/or 
NADPH oxidase-derived ROS. 
 
Regulation of the PHD oxygen sensors by other mechanisms 
 Up to date, only few reports deal with the regulation of PHDs by protein-
protein interactions. The E3 ubiquitin ligase Siah2 regulates PHD1 and PHD3, but not 
PHD2, protein stability (Nakayama et al., 2004). PHD3, but not PHD1 or PHD2, 
appears to be a substrate for the TRiC chaperonin (Masson et al., 2004). OS-9 
apparently is simultaneously interacting with both HIFα and PHD2 or PHD3, but not 
PHD1, thereby enhancing HIFα hydroxylation and degradation (Baek et al., 2005). 
MORG might provide the molecular scaffold for HIFα interaction specifically with 
PHD3 (Hopfer et al., 2006). Finally, we recently reported that FKBP38 specifically 
regulates the stability of PHD2 (Barth et al., 2007). These examples demonstrate two 
things: first, abundance and function of PHDs can also be regulated by specific 
proteins; and second, the three different PHDs are regulated in non-identical ways, 
further supporting their non-redundant role in oxygen sensing. While the cell-free in 
vitro assay used in this work provides useful informations on the regulated function of 
each PHD individually, it can of course not take into account the manifold additional 
modes of PHD regulation, e.g. by protein-protein interaction, found within a cell. 
 PHD2 and PHD3, but not PHD1 or FIH, are transcriptionally induced under 
hypoxic conditions (Aprelikova et al., 2004; Berra et al., 2003; Cioffi et al., 2003; 
D'Angelo et al., 2003; del Peso et al., 2003; Epstein et al., 2001; Marxsen et al., 
2004). It could be shown that HIF is required for hypoxic induction of PHD2 and 
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PHD3 gene expression and hypoxia response elements were identified in the 
regulatory regions of the corresponding genes (Metzen et al., 2005; Pescador et al., 
2005). Because the essential co-factor oxygen is basically lacking under hypoxic 
conditions, the HIF-dependent hypoxic increase in PHD abundance is somewhat 
paradoxical. It has been suggested that increased PHD levels accelerate the 
termination of the HIF response following re-oxygenation (Appelhoff et al., 2004; 
Aprelikova et al., 2004; Epstein et al., 2001; Marxsen et al., 2004). Indeed, 
biochemical in vitro studies revealed Km values of purified PHDs for oxygen close to 
the pO2 in air, suggesting that the kinetics of specific HIFα hydroxylation under 
hypoxic conditions are rather slow (Hirsilä et al., 2003). However, tissues in situ have 
to deal with a great variability of generally very low pO2 values, even when the 
inspiratory pO2 is considered to be “normoxic”. Thus, the PHD oxygen sensors need 
to operate at different pO2 setpoint values in different tissues. We recently 
demonstrated that a self-regulatory loop defines a specific threshold for HIFα-
activation as a function of the actual pO2 (Stiehl et al., 2006). As schematically 
outlined in Fig. 5, this negative feedback-loop includes: i) a HIF-dependent induction 
of PHD2 and PHD3 upon a reduction in oxygen supply; ii) a PHD-dependent, partial 
reduction of HIFα even under very low pO2; iii) the subsequent partial reduction of 
the PHD2 and PHD3 levels; iv) the definition of a novel setpoint for oxygen sensing 
by leveling off the HIF/PHD ratio; v) a secondary response to a further, more severe 
hypoxic insult; and vi) the triggering by iron, ascorbate, Krebs cycle intermediates, 
ROS and antioxidants. Small molecule regulators of PHD activity are thus 
functionally relevant under normoxic as well as hypoxic conditions. 
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Fig. 5. Regulation of PHD-dependent oxygen sensing. Upon a hypoxic insult, the 
HIF-dependent transcriptional increase of PHD2 and PHD3 levels provides a negative 
feedback mechanism that defines a novel, adpated oxygen sensing setpoint capable of 
reacting to a second hypoxic insult. Small molecules contribute to the regulated 
oxygen sensing by triggering PHD function, leading to an inverse regulation of the 
HIF levels (for details see text). 
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Abstract 
Prolyl-4-hydroxylation is necessary for proper structural assembly of collagens and 
oxygen-dependent protein stability of hypoxia-inducible transcription factors (HIFs). 
In vitro function of HIF prolyl-4-hydroxylase domain (PHD) enzymes requires 
oxygen and 2-oxoglutarate as cosubstrates with iron (II) and vitamin C serving as co-
factors. While vitamin C deficiency is known to cause the collagen-disassembly 
disease scurvy, it is unclear whether cellular oxygen sensing is similarly affected. 
Here we report that vitamin C deprived Gulo-/- knock-out mice show normal HIF-
dependent gene expression. The systemic response of Gulo-/- animals to inspiratory 
hypoxia, as measured by plasma erythropoietin levels, was similar to animals 
supplemented with vitamin C. Hypoxic HIF induction was also essentially normal 
under serum and vitamin C-free cell culture conditions, suggesting that vitamin C is 
not required for oxygen sensing in vivo. Glutathione was found to fully substitute for 
vitamin C requirement of all three PHD isoforms in vitro. Consistently, glutathione 
also reduced HIF-1α protein levels, transactivation activity and endogenous target 
gene expression in cells exposed to CoCl2. A C201S mutation in PHD2 increased 
basal hydroxylation rates and conferred resistance to oxidative damage in vitro, 
suggesting that this surface accessible PHD2 cysteine residue is a target of 
antioxidative protection by vitamin C and glutathione. 
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Introduction 
Oxygen is essential for a number of physiological processes, particularly for 
cellular respiration and energy metabolism. On the molecular level, response to 
hypoxia is mediated by hypoxia-inducible transcription factors termed HIFs. Under 
continuous oxygen supply, two distinct prolyl residues within the oxygen-dependent 
degradation domain (ODD) of HIFα subunits are hydroxylated by prolyl-4-
hydroxylase domain-containing enzymes (PHDs). Hydroxy-HIFα is recognized by 
the von Hippel-Lindau tumor suppressor protein (pVHL) and subsequently targeted 
for proteasomal degradation (Ivan et al., 2001; Jaakkola et al., 2001). When oxygen is 
limited, PHD activity ceases, non-hydroxylated HIFα is stabilized and 
heterodimerizes with the HIFβ subunit to activate expression of numerous target 
genes (Wenger et al., 2005). Moreover, an asparaginyl hydroxylase termed factor 
inhibiting HIF (FIH) hydroxylates a C-terminal Asn residue of HIF-α subunits in an 
oxygen-dependent manner, thereby regulation co-factor recruitment and HIF’s 
transcriptional activity (Hewitson et al., 2002).  
 Three PHD isoforms have been characterized so far, termed PHD1, PHD2 and 
PHD3, which differ in size, subcellular localization and tissue distribution (Kaelin and 
Ratcliffe, 2008). PHD2 is the most ubiquitously expressed isoform, responsible for 
the normoxic control of HIFα (Berra et al., 2003). Accordingly, genetic ablation of 
PHD2 but not PHD1 or PHD3 results in embryonic lethality in mice (Takeda et al., 
2006). Suggesting a fundamental role in the hematopoietic and circulatory systems, 
somatic inactivation of PHD2 leads to increased erythropoiesis and angiogenesis as a 
result of HIFα stabilization followed by activation of its target genes, including 
erythropoietin (EPO) and vascular endothelial growth factor (VEGF) (Takeda et al., 
2007). Knock-out of either PHD1 or PHD3 had no effect on hematological 
parameters. However, combined PHD1/PHD3 knock-out animals showed a slight 
increase in hematocrit, hemoglobin and red blood cell counts (Takeda et al., 2008). 
Clinical data on patients with erythrocytosis revealed P317R or R371H mutations in 
the gene encoding for PHD2, altering the hydroxylation efficiency of the mutant 
protein (Percy et al., 2007; Percy et al., 2006). A third point mutation in PHD2 
(H374R) was found in a patient suffering from erythrocytosis and paraganglioma 
(Ladroue et al., 2008). These case reports emphasize the critical role of PHD2 in 
regulating erythropoiesis and maintaining red blood cell homeostasis also in humans. 
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 PHDs belong to a larger superfamily of 2-oxoglutarate and Fe(II)-dependent 
di-oxygenases. Similar to collagen prolyl-4-hydroxylase (C-P4H, EC 1.14.11.2), 
PHDs require molecular oxygen and 2-oxoglutarate as co-substrates, as well as 
ferrous iron and probably vitamin C as co-factors for enzymatic activity (Hirsilä et al., 
2003). Km-values of PHDs for oxygen are strikingly higher than those of other prolyl-
4-hydroxylases (Hirsilä et al., 2003). The relatively low oxygen affinity is essential 
for effective oxygen sensing, since even small changes in oxygen partial pressure can 
influence hydroxylation activity (Flashman et al., 2010; Hirsilä et al., 2003; Stiehl et 
al., 2006).  
 In a previous study we reported on the dose-dependent regulation of the in 
vitro activity of all three PHD isoforms by their essential co-substrates and co-factors, 
including vitamin C (Nytko et al., 2007). Primates, including humans, lost the ability 
to de novo synthesize vitamin C and thus depend on dietary vitamin C intake. Since 
ascorbate is an essential co-factor for C-P4Hs which hydroxylate proline residues to 
stabilize the collagen triple helix structure, persistent ascorbate deficiency results in 
disassembly of connective tissue structures, a common symptom of the nowadays rare 
disease scurvy (Mandl et al., 2009). With Km-values ranging from 140-180 μM, the 
requirement of PHDs for vitamin C in vitro is only two fold lower than for C-P4H, 
suggesting that also HIF hydroxylases could well be affected by vitamin C 
malnutrition (Hirsilä et al., 2003). Mice lacking a functional Gulo gene have been 
described as a model to study vitamin C deficiency (Maeda et al., 2000). Gulo 
encodes for L-gulono-1,4-lactone-oxidase (GLO, EC 1.1.3.8), a key enzyme involved 
in the final step of L-ascorbic acid (vitamin C) biosynthesis. Dietary vitamin C 
deprivation leads to body weight loss, anemia, aortic wall damage and internal 
hemorrhages in these mice (Maeda et al., 2000).  
 While the interaction between the target prolyl residue, molecular oxygen, 2-
oxoglutarate and iron during the reaction cycle in the active center of PHDs has been 
described in detail, the apparently inevitable presence of vitamin C for the in vitro 
function of the PHDs remains elusive (Bruick and McKnight, 2001; Chowdhury et al., 
2009). Due to its antioxidative properties, vitamin C might maintain ferrous iron in 
the reduced state. Given the enzymatic relationship between HIFα and collagen 
prolyl-4-hydroxylases, we set out to investigate the effect of dietary vitamin C on the 
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regulation of the PHD-HIF oxygen sensing pathway in Gulo-/- mice under 
normoxaemic and hypoxaemic conditions. 
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Materials and methods 
Cell culture. HeLa human cervix carcinoma cells were adapted to Ham´s 
Nutrient Mixture F12 (Sigma), free of ascorbate and FCS, containing the following 
supplements: EGF (50 ng/ml, Sigma), insulin (5 μg/ml, Sigma), apo-transferrin (5 
μg/ml, Sigma), hydrocortisone (100 nM, Sigma) buffered with 15 mM Hepes (pH 7.4) 
as well as 100 IU/ml penicillin and 100 μg/ml streptomycin. HepG2 human hepatoma 
cells stably transfected with a HIF-dependent firefly luciferase reporter gene termed 
HRG1 have been described before (Stiehl et al., 2002). If not indicated otherwise, all 
cells were maintained in Dulbecco's Modified Eagle Medium with 10% FCS, 100 
IU/ml penicillin and 100 μg/ml streptomycin. Cell number and viability was 
determined using a ViCell Counter (Beckman). 
 
HIF transactivation activity. 5×105 HeLa cells were co-transfected with 500 
ng of the HIF-dependent pH3SVL reporter vector containing a total of 6 HIF binding 
sites derived from regulatory elements of the transferrin gene (Wanner et al., 2000) 
and 40 ng of pRL-CMV Renilla luciferase expression plasmid (Promega) essentially 
as described before (Stiehl et al., 2006). 24 hours post transfection, cells were split 
and exposed to graded oxygen concentrations (21%-0.2% oxygen) for 24 hours using 
cross-calibrated oxygen-controlled CO2 incubators (Binder CB 150). Stably 
transfected HRG1 HIF reporter cells were adapted to 1% FCS overnight and treated 
with 50 μM desferrioxamine mesylate (DFX, Sigma) or 100 µM CoCl2 and 1-10 mM 
reduced glutathione (GSH, 250 mM stock solution adjusted to pH 7.0) or 0.2-2 mM 
ascorbate for 24 hours. For hypoxic experiments, cells were grown under 2% O2 for 
24 hours and treated with GSH or ascorbate. HRG1 cells were transfected with pRL-
SV40 Renilla luciferase to control for non-HIF mediated effects of ascorbate and 
GSH on the heterologous SV40 minimal promoter present in both constructs. Cells 
were lysed using passive lysis buffer and luciferase activities were determined 
according to the manufacturer's instructions (Promega) using a 96-well luminometer 
(Berthold). Data are expressed as relative luciferase activities per total cellular protein 
of experiments performed in triplicates by calculating the ratio of firefly/renilla 
activities per well. 
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Expression and purification of recombinant PHD enzymes. Recombinant 
PHD proteins were expressed and purified as glutathione-S-transferase (GST)-fusion 
proteins from baculovirus-infected Sf9 insect cells as described earlier (Stiehl et al., 
2006). Untagged enzyme preparations were obtained by introducing a PreScission 
protease cleavage site between the GST-tag and the PHD open reading frame. A 
C201S point mutation was introduced into the human PHD2 expression plasmid by 
site-directed mutagenesis (Stratagene). Untagged PHD2 was expressed in Sf9 cells 
and purified by conventional ion-exchange chromatography (kind gift of Dr. Felix 
Oehme, Bayer Healthcare, Wuppertal, Germany). Purity of the enzyme preparations 
was analyzed by SDS-PAGE followed by Coomassie staining or immunoblotting. 
 
Prolyl-4-hydroxylation assay. Activity of recombinant PHD enzymes was 
measured by a microtiter plate-based peptide hydroxylation assay as described before 
(Wirthner et al., 2007). Briefly, recombinant PHDs were used to hydroxylate a 
biotinylated peptide derived from HIF-1α (amino acid residues 556 to 574) coupled to 
streptavidin-coated 96-well plates. Hydroxylation reaction was performed for 1 hour 
at room temperature in the presence of 10 μM FeSO4, 0.5 mM 2-oxoglutarate and 2 
mM ascorbate in 20 mM Tris-HCl pH 7.5, 5 mM KCl and 1.5 mM MgCl2. 
Hydroxylated peptides were detected by recombinant, thioredoxin-tagged von Hippel-
Lindau/elongin B/elongin C (VBC) complex. Reactions were stopped by removing 
the reaction mix and adding 1 mM H2O2. Bound VBC complex was detected by rabbit 
anti-thioredoxin antibodies and secondary HRP-conjugated anti-rabbit antibodies 
(Sigma) using the 3,3,5,5-tetramethylbenzidine substrate kit (Pierce). The peroxidase 
reaction was stopped by adding 2 M H2SO4 and absorbance was determined at 450 
nm in a microplate reader. Background values as determined by using a mutant HIF-
1α (P564A) peptide were subtracted for each experiment. 
 
Ascorbate determination. Ascorbate content of in vitro hydroxylation assay 
samples was quantified by HPLC as described before (Simoes et al., 2003). Briefly, a 
10-fold dilution of the enzyme reaction mix containing 2 mM ascorbate was analyzed 
before and after 1 hour of hydroxylation reaction. Following dilution in the mobile 
phase (60 mM phosphoric acid, pH 3.1), a 20 μl sample was injected onto a Nucleosil 
C18 column and eluted applying an acetonitrile gradient (0-60%). Ascorbate elution 
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was monitored at 254 nm, corresponding to 96% absorbance of ascorbate and only 
4% of dehydroascorbate (Mody et al., 2005). Chromatograms and standard curve of 
pure ascorbate ranging from 25-200 μM were used to calculate the content of 
ascorbate in study samples (Supplementary Fig. 2). Ascorbate levels in plasma 
samples of mice were determined by HPLC (Swiss Vitamin Institute, Epalinges, 
Switzerland). 
 
Immunoblot analyses. Total soluble cellular proteins were extracted with a 
high salt extraction buffer containing 0.4 Μ NaCl, 0.1% Nonidet P-40, 10 mΜ Tris-
HCl (pH 8.0), 1 mΜ EDTA, 1 mM dithiothreitol, 1 mΜ phenylmethylsulfonyl 
fluoride and protease inhibitor cocktail (Sigma). Protein concentration was measured 
by the method of Bradford and 60-70 μg of cellular protein was subjected to 
immunoblot analyses. Membranes were probed using the following dilutions of 
mouse monoclonal (mAb) or rabbit polyclonal antibodies: mAb anti-HIF-1α (BD 
Transduction Laboratories, 1:1000), mAb anti-CA9 (M75, kindly provided by S. 
Pastorekova, Bratislava, Slovak Republic), mAb anti-β-actin (Sigma, 1:5000), rabbit 
anti-PHD1 (Genway, 1:2000), rabbit anti-PHD2 (Novus, 1:1000) or rabbit anti-PHD3 
(Novus, 1:1000), followed by secondary HRP-conjugated antibodies (all Pierce, 
1:2000). 
 
mRNA quantification. Total RNA purification and mRNA determination by 
real-time PCR has been described before (Stiehl et al., 2006). Transcript levels of the 
HIF-dependent and -independent genes were quantified by reverse transcription (RT) 
quantitative (q) PCR using SybrGreen qPCR reagent kit (Sigma) in combination with 
an MX3000P light cycler (Stratagene). Initial copy number of each sample was 
calculated by comparison with serial dilutions of a calibrated standard. For mouse 
tissues, ribosomal protein S12 mRNA was used as a housekeeping gene while 
ribosomal protein L28 mRNA served as control for samples from human cell lines. 
Primer sequences are given in Supplementary Table 1. 
 
Oxyblot detection of protein oxidation. PHD2 carbonylation was determined 
with a protein oxidation detection kit (Oxyblot, Millipore). Briefly, 50 ng/μl of 
recombinant PHD2 was exposed to either 100 μM CoCl2, 10 μM FeSO4, 2 mM 
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ascorbate, 0.5 mM 2-oxoglutarate or 1 mM H2O2 in the presence of 400 nM wild-type 
or P564A mutant HIF-1α peptide in 20 mM Tris-Cl, 5 mM KCl and 1.5 mM MgCl2 
for 1 hour at room temperature. Five μl of the reaction mix were mixed with 5 μl 12% 
SDS and carbonyl groups were derivatized with 10 mM 2,4-dinitrophenylhydrazine 
(DNPH) for 15 minutes. DNP groups were detected by immunoblotting using rabbit 
anti-DNP antibodies (1:150) followed by secondary goat anti-rabbit HRP-conjugated 
antibodies (1:300). For loading controls, PHD2 was detected using rabbit anti-PHD2 
antibodies (Novus).  
 
Animal studies. Gulo-/- mice were maintained on vitamin C–supplemented 
water containing 0.33 g/L of L-ascorbic acid and 0.01 mM EDTA as described earlier 
(Maeda et al., 2000). At 3 months of age, ascorbic acid supplement was withdrawn 
from six Gulo-/-  males while continued for the control males. After 5 weeks, mice 
were killed with an overdose of 2,2,2-tribromoethanol, and tissues were collected and 
stored in RNAlater (Applied Biosystems Inc, Foster City, CA) at -20oC until use. For 
hypoxia studies, 22 Gulo-/- males with an average age of 16 weeks were allocated to 
four groups so that no significant changes were observed in mean body weight and 
age of the animals at the beginning of the experiment. The body weight was 
determined every second day. After 36 days of ascorbate withdrawal, mice were 
exposed to 8% oxygen for 24 hours in a hypoxia tent (Coy Laboratory Products Inc.). 
Control animals were maintained at ambient oxygen concentration. Heparinized 
whole blood was collected from all mice by cardiac puncture after intraperitoneal 
injection anaesthesia using 4 mg/ml xylazine and 20 mg/ml ketamine at a dosage of 
0.1 ml/20 g of body weight. Blood samples of hypoxic animals were collected inside 
the hypoxic tent. Animal experiments were conducted at two centers with the 
appropriate consent by the Institutional Animal Care and Use Committees of the 
University of North Carolina–Chapel Hill for breeding and normoxic gene expression 
studies or the Veterinary Office of the Canton Zürich (119/2010) for hypoxia studies, 
respectively. 
 
Blood parameters and plasma EPO concentrations. Plasma EPO levels 
were measured by ELISA following the procedures recommended by the 
manufacturer (Quantikine, R&D Systems). EPO concentrations were determined by 
Author Manuscript II published in Blood, 2011 Feb 23. [Epub ahead of print].    
PMID: 21346252 
 
 
 
78
comparison to a calibrated recombinant mouse EPO standard. Hematologic 
parameters of mouse whole blood were analyzed by the Division of Hematology 
(University Hospital, Zürich, Switzerland). 
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Results 
Ascorbate is not required for HIF induction by hypoxia in HeLa cells.  
HeLa cells have been described previously to grow in serum-free medium 
supplemented with hormones and growth factors (Hutchings and Sato, 1978). To 
achieve cell culture conditions avoiding ascorbate contamination derived from animal 
sera, Hela cells were adapted to a chemically defined medium free of ascorbate for at 
least 2 weeks. Control cells were grown in the same medium supplemented with 50 
μM ascorbate. Both cell groups proliferated at the same rate with no differences 
noticed between ascorbate-free and supplemented cells (Fig. 1A). Despite its need for 
PHD activity in vitro, hypoxic HIF-1α protein accumulation was similar in ascorbate 
containing and deficient cells. However, a faint normoxic induction of HIF-1α could 
be observed in ascorbate-free cells only (Fig. 1B). Accordingly, cells transfected with 
a HIF-responsive reporter gene (pH3SVL) and subsequently exposed to graded 
oxygen concentrations (0.2, 1, 3 or 21% O2, respectively) revealed similar induction 
levels of luciferase activity under both culture conditions (Fig. 1C).  
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Fig 1. Cellular oxygen sensing by the PHD/HIF pathway does not require 
vitamin C. (A) Proliferation of HeLa cells growing in FCS-free, chemically defined 
medium containing either no or 50 μM ascorbate. (B) Stabilization of HIF-1α protein 
in HeLa cells maintained in FCS-free medium containing either no (-Asc.) or 50 μM 
ascorbate. Cells were exposed to 21 and 0.2% oxygen for 6 hours and protein levels 
analysed by immunoblotting. (C) Induction of HIF dependent luciferase activity 
(pH3SVL vector) in HeLa cells maintained in FCS-free medium containing either no 
or 50 μM ascorbate and exposed to 0.2%-21 % oxygen for 24 hours. 
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GSH can substitute for vitamin C in the hydroxylation reaction catalyzed by 
PHDs.  
Because HeLa cells grown in a medium containing no ascorbate maintained 
hypoxic HIF-1α stabilization, we speculated that other antioxidants could compensate 
for vitamin C loss in these cells. Thus, a number of compounds with antioxidative 
properties were tested for their effects on PHD hydroxylation activity using a 
previously described in vitro hydroxylation assay (Wirthner et al., 2007). 
Surprisingly, some compounds such as n-propyl gallate and the superoxide dismutase 
mimetic Mn(III) tetrakis (1-methyl-4-pyridyl) porphyrin pentachloride (MnTMPyP) 
were potent inhibitors of PHD enzymes ((Nytko et al., 2007) and Supplementary Fig. 
1A). However, reduced L-γ-glutamyl-L-cysteinyl-glycine (glutathione; GSH) 
enhanced HIFα hydroxylation by all three PHDs. Since the recombinant enzyme 
preparations in the initial experiments were expressed and purified as glutathione-S-
transferase (GST) fusion proteins, we could not exclude interference of the tested 
antioxidants, particularly GSH, with the GST tag. Therefore, a PreScission protease 
cleavage site was engineered in between the two fusion partners. Chimeric GST.PHD 
and tag-free PHD enzymes showed comparable hydroxylation activity 
(Supplementary Fig. 1B). GSH increased the activity of all three untagged PHD 
isoforms, even in the complete absence of ascorbate (Fig. 2A). Addition of GSH ("+5 
mM" in Fig. 2B) to 2 mM ascorbate increased the reaction rate when compared with 
ascorbate alone (“control” in Fig. 2B), suggesting two independent reaction modes of 
GSH, one replacing vitamin C and an additional one enhancing the reaction rate. Of 
note, only minor changes in ascorbate oxidation were found before and after one hour 
of PHD2-mediated substrate hydroxylation (Fig. 2C). The minor decrease in reduced 
ascorbate was most likely due to air-dependent oxidation rather than enzymatic 
consumption since it was independent of the presence of the hydroxyl-acceptor 
substrate (Fig. 2C, right panel). In conclusion, as shown previously for collagen P4H 
(Myllylä et al., 1984), ascorbate is not consumed during coupled PHD-catalyzed 
hydroxylation reactions.  
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Fig. 2. GSH substitutes for vitamin C as a co-factor in HIF-α hydroxylation in 
vitro. (A) GSH can enhance PHD hydroxylation activity in the absence of ascorbate  
(-Asc.) in a dosedependent manner. Hydroxylation activity was determined using a 
multi-well VBC binding assay. (B) PHD-dependent hydroxylation reaction rate in the 
presence of 2 mM ascorbate (control) or 2 mM ascorbate combined with 5 mM GSH 
(+5 mM GSH). Shown are mean values ± SEM of triplicates. (C) Ascorbate 
determination by HPLC before and after 1 hour of PHD2-dependent hydroxylation 
reaction (left panels). Ascorbate content is only slightly decreased after 1 hour of 
incubation and independent of target hydroxylation (right panel). Shown are mean 
values ± SEM of three independent experiments normalized to values measured at 
time point zero. 
 
        
Author Manuscript II published in Blood, 2011 Feb 23. [Epub ahead of print].    
PMID: 21346252 
 
 
 
83
GSH decreases HIF activity in CoCl2-treated hepatoma cells.  
In cell culture models, Co(II) and Ni(II) have been shown to substantially 
decrease cellular ascorbate content by catalyzing ascorbate oxidation to DHA 
followed by irreversible hydrolysis to diketogulonate (Salnikow and Kasprzak, 2005). 
Interestingly, exogenous ascorbate administration completely blunted the Co(II) 
induced hypoxic response in lung epithelial cells (Salnikow et al., 2004). To test if 
GSH could similarly compensate for reduced ascorbate levels after Co(II) stimulation, 
HIF transcriptional activity was further studied in HepG2 hepatoma cells stably 
transfected with a HIF-dependent luciferase reporter gene (HRG1 cells). We first 
determined the concentrations of CoCl2 required to activate HIF-dependent reporter 
gene expression to a similar extent as exposure of the cells to 2% oxygen or the 
hypoxia mimicking iron chelator desferrioxamine mesylate (Dfx; Fig. 3A). 
Subsequently, HRG1 cells were treated with 100 μM CoCl2 or 50 μM Dfx under 21% 
or 2% oxygen. Control cells were kept at ambient oxygen concentrations. All cells 
were co-treated with 1-10 mM GSH or 0.2-2 mM ascorbate. Indeed, ascorbate and 
GSH reduced HIF activity exclusively in CoCl2-treated HRG1 cells (Fig. 3B). A 
substantial increase of HIF activation was noted particularly when cells were treated 
with 2 mM ascorbate, which might be explained by the pro-oxidative function 
ascorbate exerts if applied at high concentration (Fig. 3B, upper panel) (Chen et al., 
2008). In line with these observations, both ascorbate and GSH reduced the 
expression levels of the endogenous HIF target genes CA9 and NDRG1 (Wenger et 
al., 2005) only in cells treated with CoCl2, whereas 2 mM ascorbate enhanced hypoxic 
activation of both genes by almost 2-fold (Fig. 3C). To evaluate if these effects 
reflected differential activities of cellular PHD enzymes, HIF-1α protein 
accumulation was analyzed by immunoblotting. As expected, only CoCl2-stabilized 
HIF-1α was down-regulated by co-treatment with ascorbate or GSH (Fig. 3D). 
Interestingly, 10 mM GSH was a more potent inhibitor of CoCl2-induced HIF-1α 
stabilization than 2 mM ascorbate, a concentration which showed saturated inhibition 
of the HIF-reporter in the same cell line (Fig. 3B, upper panel)  
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Fig. 3. GSH impairs HIF activation in cells. (A) Induction of HIF-dependent 
luciferase reporter gene activity in stably transfected HRG1 hepatoma cells by 2% O2, 
50 μM Dfx or 100 μM CoCl2 for 24 hours. (B) Effects of ascorbate (Asc, 0.2-2 mM; 
upper panel) or GSH (1-10mM; lower panel) in combination with hypoxia, Dfx or 
CoCl2 treatment on HIF-dependent luciferase activity relative to the protein 
concentration of the lysates. Shown are mean values ± SEM of three independent 
experiments normalized to the reporter activity in the absence of either ascorbate or 
GSH (control). (C) CA9 and NDRG1 HIF target gene mRNA levels in HRG1 cells 
following treatment with 2 mM ascorbate or 10 mM GSH combined with 2% O2 or 
100 μM CoCl2 for 24 hours. Shown are mean values ± SEM of three independent 
experiments relative to the mRNA content of ribosomal protein L28. (D) HIF-1α and 
CA9 protein levels in HRG1 cellsfollowing treatment with 2 mM ascorbate or 10 mM 
GSH combined with 2% O2 or 100 μM CoCl2. (E) Oxyblot analyses of recombinant 
PHD2 protein carbonylation. GSH (5 mM) reduced PHD2 carbonylation by either 2 
mM ascorbate/10 μM FeSO4 or 100 μM CoCl2 (left panel). PHD2 oxidation is 
independent of target hydroxylation as shown by using a wild-type or a P564A mutant 
HIF-1α hydroxyl-proline acceptor peptide in in vitro hydroxylation reactions (right 
panel). 
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GSH protects PHD2 from metal-catalyzed oxidation.  
Enzymatic activity of the PHDs is sensitive to reactive oxygen species (ROS) 
and transition metal ions (Acker et al., 2006). However, the mechanism(s) by which 
ROS or metal ions inhibit hydroxylase activity remained speculative. Besides its 
general antioxidative properties as radical scavenger, vitamin C actively interferes 
with the oxidation state of metal ions by serving as electron donor in a redox reaction. 
As such it largely differs from GSH which is a major cellular antioxidant protecting 
cysteinyl and methionyl residues in proteins from oxidative modifications. Both, 
CoCl2 and H2O2 inhibited all three PHD isoforms in vitro with PHD2 being slightly 
more resistant to CoCl2 (Supplementary Fig. 3). To directly determine protein 
oxidation by these compounds, carbonyl group formation in PHD2 was estimated by 
Oxyblot technology. As shown in Fig. 3E (left panel), 2 mM ascorbate and 10 μM 
FeSO4 (as used in the standard reaction buffer for in vitro hydroxylation) substantially 
increased carbonylation of recombinant PHD2 during one hour of hydroxylation 
reaction. Surprisingly, CoCl2 increased carbonylation of PHD2 whether 
ascorbate/FeSO4 was present or not. Following addition of 5 mM GSH, oxidation of 
PHD2 by ascorbate/FeSO4 and CoCl2 was markedly reduced. To examine whether 
PHD2 protein oxidation is coupled to its di-oxygenase activity, the reaction was 
performed in the presence of a mutant P564A HIF-1α peptide substrate. As shown in 
Fig. 3E (right panel), PHD2 protein oxidation was independent of the presence of a 
hydroxylation acceptor proline, providing evidence that protein oxidation is not 
caused by the hydroxylation reaction cycle. 
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Cysteine 201 affects PHD2 hydroxylation activity.  
Recently, cysteine residue C201 within the catalytic domain of PHD2 has been 
identified as a surface accessible, highly nucleophilic residue predominantly 
interacting with thiol compounds (Mecinovic et al., 2009). Moreover, C201 and C208 
were proposed to provide an additional metal binding site in PHD2 (Mecinovic et al., 
2008). Both, C201 and C208 are highly conserved among all three human and mouse 
PHD isoforms (Fig. 4A). To investigate the functional relevance of C201, 
recombinant PHD2, wild-type or C201S mutant, was purified from Sf9 cells. 
Surprisingly, the C201S mutation significantly (p<0.0001) increased the PHD2 
reaction rate by 2.5-fold (Fig. 4B, upper panel). Equal concentrations of wild-type and 
mutant PHD2 proteins were confirmed by Coomassie staining of the undiluted stock 
solutions and immunoblotting of the diluted assay solutions (Fig. 4B, lower panel). To 
further test the hypothesis that the C201S mutation might protect the PHD2 enzyme 
from oxidative damage, the effect of H2O2 on hydroxylation activity was measured. 
As shown in Fig. 4C, the half-maximal inhibitory concentration (IC50) for H2O2 was 
roughly 5-fold higher for the C201S mutant compared with wild-type PHD2 (IC50 of 
8.9×10-6 and 4.3×10-5 M H2O2 for wild-type and C201S mutant PHD2, respectively). 
We further tested if the H2O2 mediated loss of PHD2 activity could be rescued by 
sequential addition of GSH. For both enzyme preparations, pre-incubation with 1 mM 
H2O2 for 30 minutes inhibited subsequent substrate hydroxylation reactions, inspite of 
2 mM ascorbate being freshly added to start the hydroxylation reaction (Fig 4D). 
Interestingly, further addition of 5 mM GSH could similarly reactivate both enzyme 
preparations, though reaction kinetics were substantially slower for the reactivated 
enzymes. (Fig. 4D). 
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Fig. 4. A C201S mutation enhances PHD2-dependent hydroxylation reaction rate 
and protects from protein oxidation. (A) Conservation of cysteine residues (C201 
and C208 in human PHD2) in all three human (Hs) and mouse (Mm) PHD isoforms. 
(B) Increased reaction rate of C201S mutant PHD2 as measured by the hydroxylation-
dependent VBC binding assay. Shown are mean values ± SEM of three independent 
experiments. Linear regression analyses were performed, revealing highly different 
slopes (p<0.0001). (C) The C201S mutation confers resistance of PHD2 to H2O2-
mediated inhibition of hydroxylation activity. Shown are mean values ± SEM of a 
representative experiment performed in triplicates. (D) Reduced glutathione (GSH) 
can rescue PHD2 wt and C201S hydroxylation activities after H2O2 -mediated enzyme 
damage. Briefly, enzyme preparations were pre-incubated with 1 mM H2O2 for 30 
minutes(H2O2) or left untreated for a similar period (control). For rescue experiments, 
enzymes after H2O2 treatment were incubated with 5 mM GSH (H2O2+GSH) for 15 
minutes. Hydroxylation reactions were carried out at standard assay conditions for 60 
minutes. Note that all reactions contained 2 mM ascorbate freshly added when 
hydroxylation reactions were started. Data is given as mean values ± SEM of three 
independent experiments normalized to hydroxylation activities of control reactions 
obtained after 60 minutes. 
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Oxygen sensing is fully functional in ascorbate-deficient Gulo-/- mice.  
Gulo-/- mice received a diet with or without vitamin C for 5 weeks. Transcript 
levels of known HIF target genes (Bnip3, Ca9, Glut1, Pdk1, Phd2, Phd3, Ndrg1) as 
well as genes involved in antioxidative defense (Sod1, Sod2, Glrx), the ascorbate 
transporters Svct1 and Svct2 or oxygen-independent genes (Ednrb, Mmp3, Phd1) 
were determined by RT-qPCR in brain, lung, kidney, heart and liver. Similar tissue-
specific expression levels for most genes involved in different pathways were 
observed in both groups (Fig. 5A). Conclusive with our finding from cell culture 
experiments, expression levels of most of the HIF target genes remained largely 
unaffected by vitamin C deficiency or even showed reduced levels (blank and blue 
squares, respectively, in the heatmap shown in Fig. 5B). Expression of the ascorbate 
transporter Svct1, however, was moderately induced in animals fed without ascorbate, 
possibly reflecting compensatory mechanisms for ascorbate deprivation. 
To further test if the absence of ascorbate limits PHD function under hypoxic 
conditions, Gulo-/- males were deprived from vitamin C for 5 weeks, while control 
animals were supplemented with vitamin C. As described previously (Maeda et al., 
2000), the animals developed a scorbutic phenotype marked by a substantial loss of 
body weight after 35 days on a ascorbate-free diet, indicating that systemic stores of 
vitamin C have been exhausted (Fig. 5C, left panel). In line with this observation, 
plasma ascorbate levels in Gulo-/- mice fed an ascorbate-free diet were below the 
detection limit (≤1 μM), while plasma of control animals contained 40.3-123.8 μM of 
vitamin C (Fig. 5C, right panel), corresponding to ascorbate plasma levels in healthy 
humans (Levine et al., 1996).  
 Following 5 weeks of vitamin C deprivation, mice were breathing 8% oxygen 
for an additional period of 24 hours while control groups were kept under ambient 
oxygen concentration (see scheme in Fig. 5C). Both ascorbate-deficient and 
supplemented animals responded to the hypoxic treatment with a robust induction of 
Epo mRNA in the kidney which was higher in Gulo-/- males fed without ascorbate, 
though differences did not reach the level of significance (p = 0.07, Student’s t-test) 
(Fig. 5D, left panel). Circulating EPO protein levels in mouse plasma were induced by 
hypoxic exposure to a similar extent in both groups (Fig. 5C, right panel). Of note, no 
significant changes of the red cell lineage hematologic parameters were observed in 
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Gulo-/- mice after 5 weeks of ascorbate depletion, indicating that the oxygen transport 
capacity was similar in both treatment groups. Hypoxic increases in hematocrit values 
are known to be delayed and reach the level of significance not before 72 hours of 
continuous exposure to hypoxia (Seferynska et al., 1989), explaining the lack of an 
increase of either hematocrit values or red blood cell counts in our experimental 
setting with a hypoxic period of only 24 hours (Supplementary Table 2). 
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Fig. 5. The hypoxic response is fully functional in vitamin C depleted Gulo-/-  
mice. Gulo-/- male mice received a diet with (+Asc) or without (-Asc) ascorbate for 
five weeks. (A) Transcript levels of HIF target genes (Bnip3, Ca9, Glut1, Pdk1, Phd2, 
Phd2, Phd3, Ndrg1) as well as genes involved in antioxidative defense (Sod1, Sod2, 
Glrx), the ascorbate transporters Svct1 and Svct2 or oxygen-independent genes 
(Ednrb, Mmp3, Phd1) were quantified by RT-qPCR in brain, kidney, lung, liver and 
heart. Values are expressed relative to S12 mRNA levels and visualized in a heat map 
(Genepattern, Broad Institute, USA). Lowest and highest mRNA levels of each gene 
were arbitrarily defined as -3 (dark blue) and +3 (dark red), respectively. (B) Heat 
map of gene expression changes following a vitamin-C-deficient diet. Log2 (-
Asc/+Asc) ratios revealed that the majority of HIF target genes remained either 
unchanged or showed a slightly reduced expression pattern. Data ranged from -1.75 
(dark blue) and +1.79 (dark red), respectively. (C) Scheme depicting the experimental 
setup for hypoxic experiments with vitamin C depleted Gulo-/- animals (upper panel). 
Relative gain of body weight of Gulo-/- mice (n=11 animals per group) following 
ascorbate withdrawal (-Asc) or ascorbate supplementation (+Asc) for 36 days (left 
panel). Ascorbate levels in the plasma of Gulo-/- mice (n=6 animals per group) after 
five weeks of ascorbate withdrawal compared to mice kept on a ascorbate-
supplemented diet (right panel). (D) Epo mRNA (left panel) and circulating EPO 
protein (right panel) levels in Gulo-/- mice maintained on a diet with (+Asc) or without 
(-Asc) for five weeks followed by exposure to 8% or 21% oxygen for 24 hours. Data 
represent mean values ± SEM derived from at least 5 animals per group (n.s., not 
significant). 
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Discussion 
Ascorbic acid and ferrous iron have been reported as essential co-factors for PHD-
dependent HIFα hydroxylation in vitro (Hirsilä et al., 2003). Unexpectedly, we found 
a fully functional cellular oxygen sensing pathway in HeLa cells maintained under 
strictly ascorbate-free culture conditions, indicating that ascorbate is dispensable for 
HIFα hydroxylation in vivo. In search for the nature of antioxidative compounds 
substituting for ascorbate during prolyl-4-hydroxylation, we identified GSH as a 
potent activator of all three PHDs in vitro, increasing HIFα peptide hydroxylation in a 
dose-dependent manner. Notably, ascorbate and reduced glutathione are the most 
abundant reducing compounds within eukaryotic cells (Linster and Van Schaftingen, 
2007). Given the distinct antioxidative properties of vitamin C and GSH, the two 
compounds might affect prolyl-4-hydroxylation by different ways. Ascorbate might 
be required to reduce occasionally oxidized ferric Fe(III) generated in the active 
centre of PHDs by uncoupled reaction cycles as it has been described for collagen 
P4H (Myllylä et al., 1984). However, to the best of our knowledge, no experimental 
evidence has been reported for enzymatic activity of PHDs in the absence of a 
hydroxyl-acceptor substrate. Strikingly, the major iron form bound to purified PHD2 
is ferrous Fe(II) even when purified under oxygenated conditions (McNeill et al., 
2005), arguing against an essential role of ascorbate in reducing PHD iron. In support 
of this notion, iron and 2-oxoglutarate have been reported to co-purify with 50% and 
5-10% of PHD2, respectively, while ascorbate did not co-purify at all (McNeill et al., 
2005). Recent work by Flashman et al. showed that ascorbate does not directly 
interact with the catalytic domain of PHD2, however, its intrinsic ene-diol reducing 
moiety was found to be important to promote hydroxylation by PHD2 (Flashman et 
al., 2010).  
GSH fully stimulated in vitro PHD hydroxylation activity only at rather high 
concentrations, which is in line with findings previously reported for N-terminally 
truncated PHD2 (Flashman et al.). The millimolar GSH concentrations used in our 
study reflect physiologically relevant levels of this compound like they occur in living 
cells (Meister and Anderson, 1983). Moreover, we found that ascorbic acid is not 
consumed by coupled substrate hydroxylation, suggesting that exogenously added 
GSH does not simply regenerate potentially co-purified oxidized dehydroascorbate 
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(DHA). Our data rather favor an alternative function of GSH by preventing oxidative 
damage to the enzyme itself. Physiological concentrations of GSH were able to reduce 
transition metal- or peroxide-induced PHD enzyme carbonylation. Despite being 
generally referred to as antioxidant, ascorbate, together with oxygen and transition 
metals such as Fe(III) or Cu(II), also exerts pro-oxidative effects by generating 
hydroxyl radicals in a Fenton-like reaction (Stich et al., 1976). Indeed, we found 
increased PHD2 carbonylation by ascorbate/iron in vitro, suggesting that GSH might 
protect PHDs from the adverse effects of ascorbate. In line with two distinct reaction 
modes, addition of GSH to hydroxylation reactions containing saturating ascorbate 
concentrations markedly increased the hydroxylation rate of PHDs in vitro. Of note, 
Co(II) induced ascorbate depletion, as suggested for cultured cells (Salnikow et al., 
2004; Salnikow and Kasprzak, 2005), cannot account for PHD inhibition in our cell-
free assays, since we previously showed that Co(II) only inefficiently catalyses 
ascorbate oxidation by air under these assay conditions (Nytko et al., 2007). Direct 
interference of Co(II) with the enzymes is supported by the observation that Co(II) 
strongly carbonylated purified PHD2 even in the complete absence of ascorbate. 
Moreover, ascorbate and GSH exclusively blunted Co(II)-induced HIF activation in 
our cellular models, demonstrating a complementary function of GSH and ascorbate 
in oxygen sensing by living cells. While simple chelation of Co(II) by ascorbate and 
GSH cannot be fully excluded in cell culture experiments, it should be mentioned that 
metal chelators naturally occurring in serum (e.g. histidine, glutamic acid, albumin but 
also GSH) are essential to facilitate Co(II) induced ascorbate oxidation, since “free” 
Co(II) is unable to directly oxidize ascorbate in simple aqueous solutions at neutral 
pH (reviewed in (Salnikow and Kasprzak, 2005). Thus, the actual redox potential of 
the ion in such ternery complexes - rather than the intracellular concentration of “free” 
metal - determines its efficacy to act as a “hypoxia mimetic”.  
One of the specific GSH functions is to prevent or reduce inappropriate 
disulfide bond formation. Two recent reports identified PHD2 cysteinyl residues C201 
and C208 to be highly nucleophilic and surface accessible (Mecinovic et al., 2009; 
Mecinovic et al., 2008). Moreover, crystallographic analyses predicted that these two 
cysteines might form disulfide bonds (Mecinovic et al., 2009; Mecinovic et al., 2008). 
C201S mutation protects recombinant PHD2 from oxidative damage in vitro and 
results in a 2.5-fold higher specific hydroxylation activity. One might speculate that a 
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certain fraction of wild-type PHD2 enzyme constantly undergoes oxidative 
modification of C201, leading to reduced activity. As such, PHD enzymes could 
combine oxygen and redox sensing properties, providing a possible explanation for 
previous work on redox factors modulating PHD activity (Gerald et al., 2004; Lu et 
al., 2005; Pan et al., 2007). However, potentiation of PHD activity by GSH clearly 
involves mechanisms distinct from C201 oxidation, since both, wildtype and C201S 
mutated PHD2 enzymes could be efficiently reactivated from H2O2-induced damage 
by GSH.  
Translating our biochemical and cellular findings in a systemic context, we did 
not observe marked alterations in HIF target gene expression following dietary 
vitamin C deprivation in Gulo-/- mice, providing evidence that other antioxidants 
might substitute for vitamin C in vivo. Accordingly, the hypoxic response of Gulo-/- 
mice with low or undetectable ascorbate in the plasma was similar to mice receiving 
an ascorbate-supplemented diet. Consistent with antioxidant redundancy in vivo, a 
study using the same animals backcrossed to a BALB/c genetic background found 
vitamin C-independent de novo synthesis of collagen in allografted tumors and 
unchanged levels of hydroxyproline-collagen. Dermal hydroxyproline content of 
collagen was even increased (Parsons et al., 2006). Of note, treatment of vitamin C-
deprived guinea pigs with a cell permeable GSH monoethyl ester significantly 
attenuated the severity of scurvy-related symptoms, suggesting a cooperative function 
of both antioxidants for P4H function also in vivo (Martensson et al., 1993). 
Moreover, Gulo-/- mice have increased levels of total glutathione in brain and liver, 
possibly explained by a compensatory mechanism for antioxidative defense in these 
animals (Harrison et al., 2010).  
Interestingly, tumor growth and angiogenesis was retarded in a syngenic tumor 
model using vitamin C-deprived Gulo-/- mice, but no changes were observed for HIF-
1α protein levels in the respective tumor tissue (Telang et al., 2007). The possible 
value of vitamin C in cancer therapy recently experienced a renaissance, since it has 
been shown that pharmacological doses of vitamin C decrease growth of tumor 
xenografts in mice by increasing peroxide levels in neoplastic tissue (Chen et al., 
2005; Chen et al., 2008). Such tumoricidal effects of antioxidants might, at least 
partially, involve destabilization of HIFα following increased hydroxylase activity 
(Gao et al., 2007; Knowles et al., 2003). Our data support a model of cooperative 
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function of GSH and vitamin C in regulating the efficiency of PHD oxygen sensors. 
Translated to chemotherapy of cancers, combined treatment with both clinically 
approved molecules might even boost their antitumorigenic function.  
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Supplementary material to Nytko et al., “ Vitamin C is dispensable for oxygen 
sensing in vivo” 
 
Inventory of supplemental information 
 
 
Supplementary Table 1 relates to Material and Methods. Detailed primer 
information for quantitative PCR analyses. 
Supplementary Table 2 relates to Figure 5. Heamatologic blood parameters of 
Gulo-/-  mice kept on a vitamin C free diet. 
Supplementary Figure 1 relates to Figure 2. Generation and in vitro activity of 
untagged PHD enzymes. 
Supplementary Figure 2 relates to Figure 2. Determination of ascorbate 
concentration in hydroxylation reactions by HPLC. 
Supplementary Figure 3 relates to Figure 3. CoCl2 and H2O2 inhibit in vitro 
hydroxylation activity of PHD1-3. 
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Table S1. Sequence of human and mouse primers used for RT-qPCR 
measurements.  
Ca9, carbonic anhydrase IX; Ndrg1, N-myc downstream regulated gene 1; L28, 
ribosomal protein L28; Hif1a, hypoxia inducible factor 1, α subunit; Hif2a, hypoxia 
inducible factor 2, α subunit; Bnip3, BCL2/adenovirus E1B interacting protein 1; 
Glut1, glucose transporter, member 1; Pdk1, pyruvate dehydrogenase kinase, 
isoenzyme 1; Phd1-3, prolyl-4-hydroxylase domain 1-3; Sod1, superoxide dismutase 
1; Sod2, superoxide dismutase 2; Glrx, glutaredoxin; Ednrb, endothelin receptor type 
B; Mmp3, matrix metallopeptidase 3; Svct1, sodium-dependent vitamin C transporter 
1; Svct2, sodium-dependent vitamin C transporter 2; Epo, erythropoietin; S12, 
Ribosomal protein S12. 
 
Gene Species Accession 
No. 
Forward primer Reverse primer 
CA9 human NM_001216 5’- gggtgtcatctggactgtgtt -3’ 5’- cttctgtgctgccttctcatc -3’ 
NDRG1 human NM_006096 5’- atgtacccctccatggatca -3’ 5’- tgtggaccacttccacgtta -3’ 
L28 human NM_000991 5’- gcaattccttccgctacaac -3’ 5’- tgttcttgcggatcatgtgt -3’ 
FIH human NM_017902  5’- cagttcgagtgcctctac -3’ 5’ – atggccactttctgatgagc -3’ 
Hif1a mouse NM_010431 5’- ggttccagcagacccagtta -3’ 5’- aggctccttggatgagcttt -3’ 
Hif2a mouse NM_010137 5’- taaagcggcagctggagtat -3’ 5’- actgggaggcatagcactgt -3’ 
Bnip3 mouse NM_009760 5’- gctcccagacaccacaagat -3’ 5’- tgagagtagctgtgcgcttc -3’ 
Ca9 mouse NM_139305 5’- gctgtcccatttggaagaaa -3’ 5’- ggaaggaagcctcaatcgtt -3’ 
Glut1 mouse NM_011400 5’- tctctgtcggcctctttgtt -3’ 5’- gcagaagggcaacaggatac -3’ 
Pdk1 mouse NM_172665 5’- ggcggctttgtgatttgtat -3’ 5’- acctgaatcgggggataaac -3’ 
Phd1 mouse NM_053208 5’- ttgcctgggtagaaggtcac -3’ 5’- gctcgatgttggctaccact -3’ 
Phd2 mouse NM_053207 5’- agccatggttgcttgttacc -3’ 5’- ctcgctcatctgcatcaaaa -3’ 
Phd3 mouse NM_028133 5’- caacttcctcctgtccctca -3’ 5’- ggctggacttcatgtggatt -3’ 
Ndrg1 mouse NM_010884 5’- tcaagatggcagactgtgga -3’ 5’- gttgggggtgatgttgagac -3’ 
Sod1 mouse NM_011434 5’- ccagtgcaggacctcatttt -3’ 5’- cacctttgcccaagtcatct -3’ 
Sod2 mouse NM_013671 5’- ggccaagggagatgttacaa -3’ 5’- gaaccttggactcccaca -3’ 
Glrx mouse NM_053108 5’- aacaacaccagtgcgattca -3’ 5’- atctgcttcagccgagtcat -3’ 
Ednrb mouse NM_007904 5’- cagtcttctgcctggtcctc -3’ 5’- ggactgcttttcctcaaacg -3’ 
Mmp3 mouse NM_010809 5’- ctatacgagggcacgaggag -3’ 5’- ccacccttgagtcaacacct -3’ 
Svct1 mouse NM_011397 5’- tctttggcctcacactaccc -3’ 5’- tcctttttaccatgcccatc -3’ 
Svct2 mouse NM_018824 5’- tgccaggaagggtgtacttc -3’ 5’- ccggtaccaaatatgccatc -3’ 
Epo mouse NM_007942 5’- ggccatagaagtttggcaag -3’ 5’- cctctcccgtgtacagcttc -3’ 
S12 mouse NM_011295 5'- gaagctgccaaagccttaga -3' 5'- aactgcaaccaaccaccttc -3' 
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Table S2. Blood parameters of Gulo-/- mice. All mice received ascorbate free 
provender for 5 weeks. Control animals received vitamin C via their drinking water. 
Heparinized whole blood samples were collected from mice kept at ambient oxygen 
tension or in a hypoxic environment (8% oxygen for 24 hours) by cardiac puncture. 
The values represent mean values ± SD of at least three animals per group as 
indicated. 
20% oxygen [Fi O2] 8% oxygen [Fi O2]  
 +Asc (n=3) -Asc (n=4) +Asc (n=4) -Asc (n=5) 
Hemoglobin(g/dl) 12.57±0.6807 13.43±0.3304 12.33±2.022 12.20±1.030 
 
Hematocrit (%) 40.23±1.528 
 
42.88±0.3862 40.68±6.247 39.72±3.492 
Erythrocytes (106/µl) 
 
8.777±0.5724 9.250±0.09019 8.625±1.275 8.496±0.6687 
Retikulocytes (103/µl) 260.3±42.34 227.0±21.46 295.3±106.4 273.2±53.18 
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Fig. S1. Inhibition of PHDs by MnTMPyP and in vitro hydroxylation activity of 
untagged PHD1-3. (A) Inhibition of PHD1-3 hydroxylation activity by Mn(III) 
tetrakis (1-methyl-4-pyridyl) porphyrin pentachloride (MnTMPyP) measured by an in 
vitro hydroxylation assay. The presence of 50 μM MnTMPyP completely abolished 
hydroxylase activity of all three PHDs. Shown are mean values ± SEM of an 
experiment performed in triplicates. (B) Comparison of the purity (upper panels. IB, 
immunoblotting; Coomassie, protein staining by Coomassie blue) and hydroxylation 
activity (lower panels) of GST-tagged and untagged PHD1-3 enzyme preparations. 
Representative experiments performed in duplicates are shown. A Gateway-
Technology compatible expression vector for GST fusion proteins bearing the 
PreScission protease cleavage site was generated by introducing a Leu-Glu-Val-Leu-
Phe-Gln-Gly-Pro peptide into pDEST20 (Invitrogen) by site-directed mutagenesis. 
The C201S mutation was introduced into wild-type PHD2 by site-directed 
mutagenesis. PHD1, PHD2 and PHD3 expression vectors were generated by 
homologous recombination with respective Entry vectors (Invitrogen). For expression 
of recombinant proteins, Sf9 cells were infected with baculovirus stock and cultured 
in Grace's insect medium at 27ºC in a humidified incubator for 96-110 hours. Cells 
were collected by centrifugation and lysed in ice-cold 0.1% NP-40, 10 mM Tris-HCl 
pH 7.5, 100 mM NaCl, 100 mM glycine and 10 mM DTT. Cleared lysates were 
Author Manuscript II published in Blood, 2011 Feb 23. [Epub ahead of print].    
PMID: 21346252 
 
 
 
104
incubated with PBS-equilibrated GSH-sepharose beads (GE Healthcare) for 2 hours at 
4°C with gentle agitation. For cleavage, beads were washed twice with PBS and 
equilibrated twice with PreScission cleavage buffer (50 mM Tris-Cl pH 7.0, 150 mM 
NaCl). PreScission protease (GE Healthcare) was added to the protein-bound 
glutathione-sepharose beads (80 U in 960 ml cleavage buffer per 1 ml of bead 
volume) and incubated for 5 hours at 4ºC.  
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Fig. S2. HPLC determination of ascorbate concentrations. (A) Exemplary 
chromatograms derived from samples of blank (60 mM phosphoric acid, left), or 
spiked standard solutions containing 100 μM (middle) and 200 μM (right) ascorbate, 
respectively. Probes were loaded on a Nucleosil C18 column and eluted applying an 
acetonitrile gradient (0-60%). Arrows indicate the position of the peaks specific for 
ascorbate. (B) Standard curve as obtained after plotting the peak areas of ascorbate 
elutions (given in arbitrary units; AU) against known ascorbate concentrations in 
spiked samples. Regression analysis was performed using Prism 4.0 GraphPad 
software. 
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Fig. S3. CoCl2 and H2O2 inhibit the in vitro hydroxylation activity of PHD1-3. 
Dose-dependent inhibition of PHD activity by CoCl2 (upper panel) and H2O2 (lower 
panel). Shown are mean values ± SEM of a representative experiment performed in 
triplicates. 
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8. Book chapter: Antioxidants and PHD oxygen sensing 
function 
 
Katarzyna J. Nytko, Daniel P. Stiehl, Roland H. Wenger 
Institute of Physiology and Zürich Center for Integrative Human Physiology ZIHP, 
University of Zürich, CH-8057 Zürich, Switzerland  
 
Running title:  
ANTIOXIDANTS AND PHD OXYGEN SENSOR FUNCTION 
Significance: 
• Like the collagen prolyl-4-hydroxylases, oxygen-sensing HIF prolyl-4-
hydroxylases (PHDs) require vitamin C for their enzymatic activity  
• Vitamin C deficiency leads to scurvy, raising the question whether it also 
affects oxygen sensing?  
• There is evidence that antioxidants are essential to PHD function, but not 
necessarily vitamin C 
• Consequently, antioxidants play important roles in HIF-dependent 
physiological and pathophysiological processes 
• Detailed knowledge of antioxidant function will be necessary for the design of 
therapies of hypoxia-related diseases such as cancer  
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Antioxidants and reactive oxygen species (ROS) are powerful modulators of many 
cellular and systemic pathways involved in physiological and pathophysiological 
processes of the human body. ROS are continuously generated in living cells and 
normally excessive production of ROS is antagonized by a number of antioxidative 
mechanisms. Through evolution cells acquired mechanisms to fight destructive effects 
of ROS on DNA, proteins and lipids by developing systems that either enzymatically 
remove ROS (superoxide dismutase, catalase, glutathione peroxidase etc.) or act as 
direct acceptors of unpaired electrons from ROS, thereby “scavenging” their harmful 
effects (carotenoids, vitamins C and E, glutathione etc.). Many diseases including 
cancer, atherosclerosis or inflammatory disorders are accompanied by an imbalanced 
antioxidative defense, resulting in severe damage to intra- and extracellular 
compartments ultimately promoting cell death or transformation. Besides their rather 
unspecific protective effects, many antioxidants serve as co-factors or reducing agents 
for numerous metal-containing cellular enzymes necessary for their designated 
function. As such, many enzymes require vitamin C for optimal activity, with 
collagen prolyl-4-hydroxylases (C-P4Hs) being the first described (Tuderman et al., 
1977). Vitamin C further functions as a co-factor of other iron(II)-dependent 
dioxygenases as well as copper(I)-dependent monooxygenases involved in dopamine 
and tyrosine metabolism, carnitine synthesis, DNA repair, oxygen sensing and many 
others (Linster and Van Schaftingen, 2007; Mandl et al., 2009).  
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 1. Ascorbate as a co-factor for prolyl-4-hydroxylases 
Ascorbic acid is a water-soluble vitamin that can be found in cells either in the 
reduced form (ascorbate), as free radical (semidehydroascorbate) or fully oxidized as 
dehydroascorbate (DHA). At physiological pH, the most abundant form of ascorbic 
acid is ascorbate (Corti et al., 2010). Ascorbate and DHA are transported into cells by 
sodium-dependent transporters (SVCT) and glucose transporters (GLUT), 
respectively (Corti et al., 2010). Intracellular DHA can be reduced to ascorbate by 
enzymatic and non-enzymatic processes, mostly utilizing glutathione-dependent 
pathways. Interestingly, primates, guinea pigs and some species of bats and 
paseriform birds lost the ability to synthesize vitamin C due to a mutation of L-
gulono-1,4-lactone oxidase (Gulo) which catalyses the final step of ascorbate 
synthesis (Linster and Van Schaftingen, 2007; Nishikimi et al., 1988). Other 
vertebrates de novo synthesize ascorbate from D-glucuronate in the liver (mammals) 
or in the kidney (fish, amphibians and reptiles) (Linster and Van Schaftingen, 2007). 
Since ascorbate is an essential co-factor of C-P4Hs which hydroxylate proline residue 
to stabilize the collagen triple helix structure, persistent ascorbate deficiency results in 
disassembly of connective tissue structures, a common symptom of the nowadays rare 
disease scurvy. Scurvy is further characterized by apathy, weakness, bleeding gums 
and external and internal hemorrhages, which in severe cases often led to death 
(Baron, 2009). The disease occurred endemically amongst sailors at sea having no 
access to fresh food for a long period of time, and was first described by the French 
explorer Jacques Cartier in the16th century (Martini, 2002). More than 200 years later 
the Scottish physician James Lind discovered that lemon juice can prevent the 
symptoms of the disease and seamen were subsequently provided with extracts of 
citrus fruits to treat scurvy (Lind, 1753). Until the discovery of vitamin C in 1932 by 
the later Nobel laureate Albert Szent-Györgyi, the reason for scurvy remained 
enigmatic and it took another 35 years until it finally could be established that vitamin 
C is actually required for full activity of C-P4Hs (Hutton et al., 1967; Li and 
Schellhorn, 2007). As ascorbate is present in almost all types of diets worldwide, the 
full picture of scurvy became very rare nowadays.  
 HIF prolyl-4-hydroxylases (PHDs) belong to the same class of enzymes as C-
P4H, namely 2-oxoglutarate and non-heme iron(II)-dependent dioxygenases (EC 
1.14.11.2). The prime substrate for C-P4H are prolyl residues within the collagen 
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molecule while two specific prolines of the oxygen susceptible α-subunits of hypoxia-
inducible factors (HIFs) are targeted by PHDs (Epstein et al., 2001; Ivan et al., 2001; 
Jaakkola et al., 2001). So far three isoforms of oxygen sensing PHDs have been 
described in humans, namely PHD1, PHD2 and PHD3. These proteins are encoded by 
the human EGLN2, EGLN1 and EGLN3 genes, respectively. The proteins differ in 
size, intracellular localization and tissue distribution (Metzen et al., 2003; Stiehl et al., 
2006; Wenger et al., 2009). Under experimental in vitro conditions, preferences of 
each PHD isoform for the two target proline substrates within the HIF-α molecule 
have been observed (Appelhoff et al., 2004; Chan et al., 2005). A new putative prolyl-
4-hydroxylase was identified in the endoplasmic reticulum which, when 
overexpressed, can suppress HIF activity, too (Koivunen et al., 2007; Oehme et al., 
2002). However, further studies must be performed to elucidate the physiological 
function of this isoform. Moreover, an asparaginyl hydroxylase termed factor 
inhibiting HIF (FIH) hydroxylates a C-terminal Asn-residue of HIF-α subunits in an 
oxygen-dependent manner, thereby regulation co-factor recruitment and HIF’s 
transcriptional activity (Hewitson et al., 2002).  
 Structurally, C-P4Hs form α2β2 tetramers whereas soluble PHD2 was 
preferentially found as α-monomers (McDonough et al., 2006; Myllyharju, 2008). 
PHD3 can form homo and hetero complexes with other PHDs, and PHD1 and PHD2 
can form homo-dimers (Nakayama et al., 2007). Interestingly, PHD1-3 share 42-59% 
sequence identity but only little similarity with the primary structure of C-P4H, 
though critical residues involved in binding of iron(II) and 2-oxoglutarate are 
conserved between the two subclasses (Myllyharju, 2008). Both, C-P4Hs and PHDs 
require oxygen, 2-oxoglutarate, iron (II) and/or ascorbate for in vitro activity, 
however they differ in Km values for these compounds (Hirsilä et al., 2003). 
Interestingly, the Km value of ascorbate for C-P4H is higher (300-370 μM) than for 
PHDs (140-180 μM), suggesting different dependency of these enzymes on ascorbate 
supplementation (Nagel et al., 2010). In contrast to 2-oxoglutarate and iron(II), which 
are tightly bound to PHDs, ascorbate did not co-purify with PHD2, indicating a rather 
labile and transient interaction between the enzyme and ascorbate (McNeill, Flashman 
et al. 2005). The actual role of ascorbate in the reaction catalyzed by PHDs is still a 
matter of debate: it has been postulated for C-P4Hs that ascorbate reduces ferryl 
iron(IV) intermediates to the active ferrous form. However, a similar function in the 
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reaction cycle catalyzed by PHDs still awaits formal proof (de Jong et al., 1982; 
Kaelin and Ratcliffe, 2008). It has been shown for C-P4H that ascorbate is not 
consumed stoichiometrically during proline hydroxylation, and the enzymes can 
perform a number of reaction cycles without ascorbate (Myllyharju, 2008). Yet, in the 
absence of a proline hydroxy-acceptor substrate, C-P4H can catalyze uncoupled 
reactions characterized by decarboxylation of 2-oxoglutarate to succinate where 
ascorbate is then consumed stoichiometrically and serves as an alternative oxygen 
acceptor (Myllylä, Majamaa et al. 1984; Myllyharju 2008). 
 Among the factors that stabilize HIF-1α protein levels via ROS generation are 
angiotensin II and thrombin. Angiotensin II–induced generation of ROS (hydrogen 
peroxide) decreases intracellular ascorbate levels and thus leads to HIF-1α 
stabilization. Interestingly, ascorbate prevented ROS-induced HIF-1α under normoxic 
but not hypoxic conditions (Page et al., 2008). The role of ascorbate in modulation of 
HIF-1α protein levels has also been investigated in primary umbilical vein endothelial 
cells and in skin fibroblasts (Vissers et al., 2007). Addition of ascorbate to normoxic, 
hypoxic and cobalt chloride treated primary umbilical vein endothelial cells and skin 
fibroblasts cells decreased HIF-1α protein levels. As concluded in this study, 
normoxic cells showed stabilization of HIF-1α protein explained by the lack of 
ascorbate in the culture medium. However, the medium was supplemented with 20% 
FCS which might also be a source of ascorbate.  
 
 2. Ascorbate–independent prolyl-4-hydroxylase function 
Reducing equivalents for functional HIF-α hydroxylation do not seem to be limited to 
ascorbate as other antioxidants (e.g. reduced glutathione and DTT) independently 
support PHD activity in vitro and in vivo (Flashman et al., 2010, Nytko et al., 
unpublished data). Studies on the role of ascorbate and other reducing agents on 
PHD2 activity in vitro revealed that ascorbate can be substituted by its structural 
analogues if they contain the ene-diol portion conferring reducing properties 
(Flashman et al., 2010). Furthermore, reduced glutathione (GSH) and dithiothreitol 
(DTT) at high concentrations could partially replace ascorbate in in vitro 
hydroxylation reactions catalysed by PHDs (Flashman et al., 2010). GSH further 
enhanced hydroxylation of an artificial consensus ankyrin peptide by FIH, which 
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indicates its activating function also for other hydroxylases involved in oxygen 
sensing (Flashman et al., 2010).  
 To study the importance of vitamin C functions in vivo, a genetically modified 
mouse model incapable of synthesizing ascorbate has been generated. Animals with a 
bi-allelic disruption of the Gulo gene (Gulo-/-) developed scurvy-like symptoms after 
5 weeks of ascorbate withdrawal, evidenced by loss of body weight, internal 
hemorrhages, and disruption of elastic laminae building vessel walls (Maeda et al., 
2000). When Gulo-/- mice were kept on an ascorbate-free diet for more than 6 weeks, 
the animals die from aortic rupture, pointing out the absolute requirement for vitamin 
C (Maeda et al., 2000). Partially contradictory to this finding, vitamin C-deficient 
Gulo-/- mice with a different genetic background still showed ascorbate-independent 
skin collagen and proline hydroxylation, indicating that in vivo other factors might at 
least partially compensate for the lack of ascorbate (Parsons et al., 2006). Notably, 
administration of glutathione ester to ascorbate-deficient guinea pigs could delay 
scurvy symptoms, further supporting the in vivo redundancy of intracellular 
antioxidants in the process of collagen hydroxylation (Martensson et al., 1993). 
Interestingly, neutrophils known to generate high levels of ROS to execute their pro-
inflammatory function had defective apoptosis and increased HIF-1α levels when 
isolated from ascorbate depleted Gulo-/- mice (Vissers and Wilkie, 2007). Such 
observations may provide evidence for cell-type specific requirements of ascorbate in 
maintaining basal HIF activity, which is probably interlinked with the specific ROS 
burden in distinct cell types.  
 Whether ascorbate deficiency has an effect on other prolyl-4-hydroxylases in 
vivo at the systemic level is largely unknown. Recent work from our group showed 
that the physiologic response of ascorbate depleted Gulo-/- mice to oxygen deprivation 
was essentially normal when compared to vitamin C supplemented animals as 
evidenced by similar erythropoietin transcript and protein induction (Nytko et al., 
unpublished data). In line with this finding, ascorbate was also shown to be 
dispensable for carnitine synthesis in vivo (Furusawa et al., 2008). Taken together, 
these data strongly point towards a non-essential role of ascorbate for functional HIF-
α prolyl-4-hydroxylation at cellular and systemic levels and the possibility of other 
antioxidants to compensate for its lack. 
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3. Regulation of PHD activity by redox factors 
Interestingly, the β subunits of C-P4H have protein disulfide isomerase (PDI) activity 
which is required for the stable formation of the tetrameric enzyme (Kivirikko and 
Myllyharju, 1998). Since PHDs are active in the monomeric form (McDonough et al., 
2006), a similar redox-sensitive mechanism is unlikey to exist for PHDs. We noted 
that recombinant PHD proteins purified from bacterial expression systems generally 
have low specific activity, with PHD3 being notoriously inactive, indicating the 
requirement of structural modulators absent in bacteria. In support of this notion, TriC 
and Morg1 chaperoins have been described to interact and stimulate the activity of 
PHD3 and overexpression of the bacterial GroEL/ES chaperoin enhanced the activity 
of the enzyme from bacterial preparations (Fedulova et al., 2007; Hopfer et al., 2006; 
Masson et al., 2004). However, it is unclear if these complex partners of PHD3 
actively affect the protein structure by interference with intramolecular disulfide 
bonds.  
 For other antioxidants, e.g. the polyphenolic green tea ingredients gallic acid 
or its derivative n-propyl gallate, contradictory effects to ascorbate and glutathione on 
PHD acticity have been reported: Gallate, but not n-propyl gallate were claimed to 
inhibit PHDs in vitro while both compounds were stabilizing HIF-1α protein in rat 
heart muscle cells (Tsukiyama et al., 2006). Based on structural predictions of PHD2, 
inhibitory effects of gallate were attributed to the displacement of enzyme bound 2-
oxoglutarate by gallate’s carboxy moiety forming an ionic bond with Arg383, while 
its phenolate oxygen atoms chelate active centre bound iron(II) (Tsukiyama et al., 
2006). However, data from our group using purified human PHD isoenzymes showed 
that either of these compounds was efficiently inhibiting all three PHDs in a dose-
dependent manner in vitro (Nytko et al., 2007). The contradictory outcome of these 
experiments is likely explained by the use of crude cell extracts as enzyme source for 
in vitro HIF-α hydroxylation by Tsukiyama et al. We have shown previously that 
crude cell extracts catalyse non-PHD related turnover of 2-oxoglutarate to succinate 
and as such are inappropriate to determine specific PHD activity (Wirthner et al., 
2007). Similarly, the plant-derived flavonoid quercetin has been shown to inhibit the 
activity of PHD2 in vitro probably involving by chelating active site bound iron(II) 
(Dao et al., 2009; Jeon et al., 2007). Other flavonoids, such as baicalein, luteolin and 
fisetin, increased HIF-1α protein levels in HeLa cells but only weakly induced HIF 
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transcriptional activity (Triantafyllou et al., 2008). Despite an assumed role in HIF-α 
protein stabilization, these compounds paradoxically blunted deferoxamine (DFX) 
induced HIF transcriptional activity, probably by interfering with MAPK-dependent 
activation of the HIF pathway (Triantafyllou et al., 2008). In a screen for small 
molecule inhibitors of PHD2, baicalein was independently identified as potent 
inhibitor of PHD2 in vitro but also reduced asparaginyl hydroxylation of HIF-1α by 
FIH (Cho et al., 2008). Inhibitory effects of bicalein on PHD activity could be 
abrogated by an excess of 2-oxoglutarate and iron(II), suggesting a competitive 
mechanism. Spectroscopic measurements provided indirect evidence for binding of 
bicalein to PHD2, which was specific for the iron(II) containing enzyme (Cho et al., 
2008).  
Clearly, the variety of opposite effects reported for antioxidants on the PHDs' 
hydroxylation activity is caused by the different modes of activatory or inhibitory 
action (Fig. 1). One common inhibitory mechanism involves chelation of metal co-
factors required for PHD enzymatic activity, another mechanism might be the 
scavenging of some short-lived transition states of oxygen generated during the 
hydroxylation reaction cycle (Nytko et al., 2007). Moreover, phenolic antioxidants 
might contribute to the generation of reactive oxygen species such as hydrogen 
peroxide in cell culture models, subsequently inhibiting the cellular oxygen sensing 
pathway (Halliwell and Gutteridge, 2007).  
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Fig. 1. Crosstalk between different antioxidants affecting the activity of HIF prolyl 
and asparaginyl hydroxylases. ROS, reactive oxygen species; PHDs, prolyl-4- 
hydroxylase domain proteins; FIH, factor inhibiting HIF; DKG, diketogulonate; GSH, 
glutathione; GSSG, oxidized glutathione dimer; GLUT, glucose transporter; 
SVCT,sodium-dependent vitamin C transporter; ASC, alanine, serine, cysteine 
preferring transport system; RcGshT, rat canalicular GSH transporter. Bold arrows 
indicate the preferred direction of the reaction. 
 
 
 3.1 Ascorbate and transition metals  
Historically, cobalt(II) was described as a factor inducing erythropoiesis with medical 
applications in the treatment of anemia (Goldberg et al., 1988; Nagel et al., 2010; 
Wolf and Levy, 1954). However, mechanisms by which cobalt and other metals exert 
their inhibitory function on cellular oxygen sensing remained speculative. In vitro 
characterization of PHD isoenzymes confirmed that transition metals are potent 
inhibitors of PHD activity (Hirsilä et al., 2003). Given that PHD enzymes are iron(II)-
dependent dioxygenases, it is tempting to speculate that transition metals act via 
replacement of ferrous iron in the catalytic center of the enzyme as proposed for 
soluble nickel compounds (Davidson et al., 2006). Moreover, chromium(VI), 
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nickel(II) and cobalt(II) have been proposed to regulate HIF-1α protein levels by 
depletion of intracellular ascorbate in lung cells while neither soluble nickel(II) nor 
cobalt(II) changed intracellular iron levels (Kaczmarek et al., 2007; Salnikow et al., 
2004). Mechanistically, these metals are capable of catalyzing the oxidation of 
ascorbate to DHA, which can be enzymatically reverted to ascorbate within the cell or 
irreversibly oxidized to diketogulonate. Of note, in vitro oxidation of ascorbate by air 
is mainly catalyzed by copper(II) but oxidation is substantially slower by nickel(II) or 
cobalt(II) with a rate comparable to soluble iron(II), which does not inhibit PHD 
activity at all (Nytko et al., 2007). While this finding explains the PHD inhibiting 
effects observed for cupric copper (Martin et al., 2005; Nytko et al., 2007), the 
“ascorbate depletion” hypothesis by simple metal catalyzed oxidation should be 
marked by a touch of skepticism. Alternatively, nickel and cobalt could induce 
oxidative stress within the cell, as defined by the reduction of glutathione and 
malondialdehyde levels, thereby exhausting the intracellular ascorbate pool, instead of 
directly catalyzing ascorbate oxidation. Indeed, cobalt has been shown to induce 
oxidative stress in endothelial cells, which contributed to HIF-1α stabilization and was 
prevented by ascorbate treatment (Qiao et al., 2009). The increase in intracellular 
ROS and HIF-1α stabilization upon exposure to cobalt chloride in skeletal muscle 
cells was prevented by ascorbate treatment (Ciafre et al., 2007). Of note, cobalt 
chloride was found to robustly carbonylate recombinant PHD2 enzyme in vitro even 
in the complete absence of ascorbate, suggesting a direct redox interaction of the 
metal with iron-containing PHD enzymes (Nytko et al., unpublished data). Moreover, 
direct binding of cobalt to HIF-1α and subsequent inhibition of HIF-1α protein 
degradation by the pVHL ubiquitin ligase complex has been described, adding 
another layer of metal-dependent interference with the oxygen sensing pathway (Yuan 
et al., 2003). However, since 6xHis-HIF-2α proteins were used in above experiments, 
the binding of the cobalt to 6His-tagged HIF-2α could contribute to observed effect. 
Overall, in comparison to C-P4H and FIH, most transition metals were less effective 
inhibitors of PHDs, with PHD2 being particularly resistant to metal-induced 
regulation (Hirsilä et al., 2003).  
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 3.2 Ascorbate and nitric oxide 
It has been shown that nitric oxide can contribute to behavioural and developmental 
responses to hypoxia in D. melanogaster (Wingrove and O'Farrell, 1999). Moreover, 
as iNOS and eNOS (inducible and endothelial NO synthase, respectively) are direct 
HIF target genes (Coulet et al., 2003; Melillo et al., 1997; Palmer et al., 1998). NO 
signaling could provide an additional feedback loop to oxygen sensing via regulating 
PHD activity (Kaelin and Ratcliffe, 2008). However, a clear picture of how NO 
affects oxygen signaling has been blurred by numerous opposing reports showing 
either increase (Kimura et al., 2001) or decrease in HIF-1α protein levels and 
transcriptional activity upon NO treatment (Huang et al., 1999). A recent report offers 
an elegant explanation for this dilemma, providing evidence for bi-modal effects of 
NO on HIF-1α protein accumulation. First, NO administration inhibits PHD activity 
leading to a rapid induction of HIF-1α protein. With some delay, the cellular 
hydroxylation capacity increases by HIF-dependent de novo synthesis of PHD2 (and 
likely PHD3) protein, ultimately reducing HIF-1α levels and counteracting the initial 
NO response (Berchner-Pfannschmidt et al., 2007). A similar model of bi-phasic 
responses to the notoriously instable ROS intermediates might likewise explain the 
many controversial results reported for this molecule group with respect to oxygen 
signaling pathways. Adding more complexity, ascorbate has been shown to decrease 
the levels of HIF-1α protein in HUVECs cells induced by treatment with a NO donor 
(Muellner et al., 2010). Another study showed that NO-induced HIF-1α accumulates 
independently of PHD activity, proposing cystein nitrosylation of HIF-1α interfering 
with pVHL recruitment and asparagine hydroxylation to be responsible for its 
stabilization (Park et al., 2008). Adding even more complexity, ascorbate can 
stimulate NO release from intrinsic S-nitroso groups of the glypican-1 core protein 
(Mandl et al., 2009). Although this mechanism was primarily shown to play a role in 
NO-catalysed degradation of heparin sulphates, one could speculate about a similar 
role for ascorbate-induced NO generation in oxygen sensing (Mandl et al., 2009). 
 
 4. Expression of HIF-1α is affected by stress-activated pathways  
Besides an obvious role of antioxidants in the reaction catalyzed by PHDs and thus 
stability of HIF-1α protein, antioxidants have also been associated with the regulation 
of HIF expression. Transcript levels of HIF-1α were shown to be increased by 
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reactive oxygen species involving activation of NFκB signaling (Bonello et al., 2007). 
Both hydrogen peroxide and thrombin (shown previously to induce ROS production) 
likewise induced HIF-1α mRNA levels, an effect that was blunted in presence of N-
acetyl-cysteine (Belaiba et al., 2007; Bonello et al., 2007). Supporting these findings, 
the ubiquitous HIF-1α promoter contains a functional NFκB binding site, suggesting a 
role of this factor in the regulation of HIF-1α transcription (Bonello et al., 2007; Frede 
et al., 2006). Moreover, silencing of the antioxidant defense enzyme manganese-
superoxide dismutase (Mn-SOD) increased both HIF-1α mRNA and protein levels 
following intracellular ROS levels under normoxic and hypoxic conditions (Sasabe et 
al., 2010). In vivo studies using mice lacking IκB kinase (IKK)-β confirmed that basal 
NFκB activity is linked with HIF-1α protein accumulation in the liver and brain of 
hypoxic animals (Rius et al., 2008). 
Given the delicate balance of HIF-α production and proteasomal degradation, 
also regulated translation of HIF-α subunits has been suggested to affect the activity 
of the oxygen sensing pathway (Semenza, 2002; Yee Koh et al., 2008). Interestingly, 
the NO-donor NOC18 has been shown to increase the abundance of HIF-1α 
independent of its stability, which has been explained by concomitant activation of the 
protein translation regulatory mTOR/p70S6/eIF-4E pathway by NOC18 (Kasuno et 
al., 2004). Several other laboratories reported a role for PI3K and MAPK pathways in 
fine-tuning HIF-α accumulation and transactivation under normoxic and hypoxic 
conditions (Laughner et al., 2001; Richard et al., 1999; Sang et al., 2003; Stiehl et al., 
2002; Zhong et al., 2000). Both pathways are tightly connected to external stimuli 
including oxidative stress, therefore a disbalance in redox homeostasis, particularly 
occuring during hypoxia followed by reoxygenation, might well affect HIF-1α 
translation. Among the small cellular redox proteins, thioredoxin (Trx) has also been 
implicated in HIF regulation, as reduced Trx could enhance HIF-1α protein levels and 
transcriptional activity (Huang et al., 1996; Welsh et al., 2002). It has later been 
resolved that Trx1 and Trx2 exert opposing regulatory functions on HIF-
1α translation: while forced expression of cytosolic Trx1 enhanced HIF-1α protein 
levels in human embryonic kidney cells, the mitochondrial Trx2 attenuated hypoxic 
accumulation of HIF-1α. As an explanation, the authors referred to opposing effects 
of Trx1 and Trx2 on mitochondrial ROS production. Application of the mitochondria 
Book chapter: Tumor hypoxia: Molecular mechanisms and clinical implications, 
submitted. 
 
 
 
119
targeting antioxidant MitoQ indeed abolished reduced HIF-1α accumulation in cells 
with exogenous Trx2 expression (Zhou et al., 2007).  
 Sirtuin 1 (Sirt1), a redox-sensitive deacetylase, physically interacts specifically 
with HIF-2α and increases transcription of HIF-2 dependent target genes such as Epo 
in cells and mice (Dioum et al., 2009). While the actual acetylating event remains 
enigmatic, the same study reported on hypoxically induced acetylation of endogenous 
HIF-2α which was detectable in the presence of deacetylase inhibitors only. 
Extending these observations, deacetylation of human HIF-1α at Lys674 by SIRT1 
lead to impaired interaction of HIF-1α with p300 and consequently reduced HIF 
transcriptional activity (Lim et al., 2010). Interestingly, the plant derived polyphenolic 
antioxidant resveratrol has been described as potent regulator of sirtuin activity and 
hence could influence oxygen sensing via the HIF pathway (Howitz et al., 2003). 
Further strengthen the importance of acetylation in oxygen signaling, SIRT6 has been 
shown to function as a co-repressor of HIF-1α in the control of expression of several 
genes involved in glucose homeostasis (Zhong et al., 2010).  
 
 
 
 
 
 
 
 
 
Book chapter: Tumor hypoxia: Molecular mechanisms and clinical implications, 
submitted. 
 
 
 
120
 
 
Fig. 2. Regulation of HIF transcription, translation, protein stability 
andtransactivationby reactive oxygen species and antioxidants. PHDs, prolyl-4-
hydroxylase domain proteins; FIH, factor inhibiting HIF; HIF, hypoxia inducible 
factor; ROS, reactive oxygen species; NO, nitric oxide; GSH, glutathione; MAPK, 
mitogen activated protein kinase; NFkB, nuclear factor kappa light enhancer of 
activated B cells; mTOR, mammalian target of rapamycin; PI3-K, 
phosphatidylinositol 3-kinase; PAS, Per/Arnt/Sim; ODD, oxygen dependent 
degradation; TA, transactivation domain; TCA, tricarboxylic acid. 
 
 5. Oxidative stress and antioxidants in systemic oxygen sensing and 
disease 
Following the instant response to cellular hypoxia and acute reprogramming of cell 
metabolism, HIFs also mediate middle- and long-term adaptational responses at the 
systemic level. HIF-1α protein stabilization by ROS has been discussed in the process 
of hypoxia-induced pulmonary vascular leakage, which causes pulmonary edema as 
described in mountain sickness and acute respiratory distress syndrome (ARDS) 
(Irwin et al., 2009). Cultured bovine pulmonary artery endothelial cell monolayers 
exposed to 3% O2 for 24 hours showed increased permeability as measured by FITC-
labeled albumin diffusion (Irwin et al., 2009). An antioxidative cocktail containing 
ascorbic acid, glutathione and α-tocopherol reduced the permeability when added to 
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the cell monolayer, along with decreased hydrogen peroxide production and HIF-1α 
protein levels in these cells. Similar results were obtained in mice exposed to high 
altitude (18000 ft ≈ 5500 m above sea level) for 24 hours. The animals showed 
hypoxia-induced pulmonary vascular leakage and responded with increased HIF-1α 
and VEGF protein levels in pulmonary vessels, which could be reverted upon 
administration of antioxidants (Irwin et al., 2009). In human volunteers exposed to an 
altitude of 4300 m above sea level, corresponding to roughly 12% inspiratory oxygen 
concentration, HIF-1α protein levels and HIF-1 DNA binding were enhanced in 
circulating leukocytes and total glutathione levels in the plasma were strikingly 
decreased by 35% (Tissot van Patot et al., 2009). Such data might suggests that under 
hypoxic conditions the glutathione pool, serving as the major physiological 
antioxidant in humans, gets exhausted, which in turn could potentiate hypoxic HIF-1α 
activation.  
The role of antioxidants in erythropoiesis has been studied in cell culture 
models in vitro as well as in vivo. EPO secretion from isolated rat kidneys perfused 
with an arterial pO2 of 35 mm Hg was increased upon treatment with vitamins A, E 
and C (Jelkmann et al., 1997). Yet, vitamins E and C failed to increased Epo secretion 
from the human hepatoma cell lines Hep3B and HepG2 (Jelkmann et al., 1997). 
Oxidative stress has also been observed in haematopoietic disorders. Patients 
suffering for inherited forms of anemia such as sickle cell anemia, thalassemia and 
glucose-6-phosphate-dehydrogenase deficiency, levels of certain antioxidants 
(predominantly vitamins E and C) are often decreased (Chan et al., 1999).  
Physiological wound healing requires oxygen for an optimal healing process 
(Schreml et al., 2010). ROS produced during wound healing have been discussed to 
serve as signaling molecules in regulating cytokine release and cell proliferation, 
while they also contribute to killing harmful bacteria in the wound environment 
(Schreml et al., 2010). On the other hand, oxygen deprivation is supportive in wound 
healing as it stimulates VEGF expression and neovascularization (Hopf and Rollins, 
2007; Scheid et al., 2000). Importantly, levels of ascorbate, vitamin E and glutathione 
are decreased in healing skin wounds and reduced level of these antioxidants correlate 
with a delay in the healing process (Schafer and Werner, 2008). Consequently, 
detoxifying enzymes, such SODs, catalase and glutathione peroxidase and others, are 
involved in wound healing and responsible for maintaining a cellular redox balance 
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(Schafer and Werner, 2008). Very likely, hypoxia, ROS and antioxidative pathways 
interact with each other to contribute to successive wound healing, though 
experimental proof of such a hypothesis is required.  
 Antioxidants play also important role in aging and aging is associated with 
increased oxidative stress (Rockenfeller and Madeo, 2010). Mice lacking senescence 
marker protein 30, which functions as gluconolactonase and participates in ascorbate 
synthesis, displayed symptoms of scurvy and shortage in lifespan (Kondo et al., 
2006). Moreover, ascorbate was shown to prevent premature aging in mice displaying 
the phenotype of Werner syndrome due to lack of helicase of WRN homolog involved 
in DNA repair (Massip et al., 2009). Whether there is a direct link between HIF and 
antioxidants in context of aging remains to be investigated. 
 
 6. Antioxidants in HIF-mediated tumorigenesis 
In the 1970s, Linus Pauling reported that ascorbate can prolong the survival time of 
terminally ill cancer patients (Cameron and Pauling, 1976; Cameron and Pauling, 
1978). Moreover, he claimed that ascorbate is applicable in the prevention of common 
cold and schizophrenia (Pauling, 1971; Pauling, 1977). However, his hypotheses did 
not find general approval by the scientific community and other studies failed to 
confirm these results (Creagan et al., 1979; Moertel et al., 1985). An impressive 
number of studies on ascorbate and cancer has been performed since that time and the 
general idea of using ascorbate in cancer treatment has experienced a renaissace in 
recent years: growing a collection of tumor cell lines as subcutaneous tumors in mice 
revealed that ascorbate administed at “pharamcological doses” could decrease the 
growth of aggressive tumor xenografts (Chen et al., 2008). In these studies, and 
somehow paradoxically, ascorbate has been proposed to function as a pro-drug which 
facilitates the generation of hydrogen peroxide in a Fenton-like reaction and 
selectively kills cancer cells (Chen et al., 2005; Chen et al., 2007). Of note, millimolar 
doses of ascorbate can be achieved only by intravenous application of ascorbate and 
the findings have been perceived not without controversy (Borst, 2008; Frei and 
Lawson, 2008). Moreover, such studies do not consider the role of HIF-1/2α in cancer 
progression. It is known that high expression of HIF-1/2α correlates with high 
mortality of cancer patients, especially in the case of solid tumors (Semenza, 2010). 
Little is known, however, about the correlation between ascorbate levels in patients 
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and cancer progression in the context of HIF-1/2α expression and stability. It has been 
shown for endometrial cancers only that low ascorbate levels in cancer tissue is 
associated with increased HIF-1α activity and elevated expression of HIF-target genes 
(VEGF, GLUT-1 and BNIP3) (Kuiper et al., 2010). Endometrial cancers are 
associated with high expression of HIF-1/2α and increased angiogenesis, which is 
linked to poor prognosis of the patients (Sivridis et al., 2002). Therefore, finding a 
way to overcome HIF-driven effects in these tumors by antioxidants could be a 
potential therapy target. Ascorbate can suppress HIF-1α protein levels and secretion 
of VEGF in pancreatic tumor in athymic mice, but ascorbate could reduce tumor size 
only at early and middle stage of cancer progression (Chen et al., 2009). In cancer 
cells in vitro, ascorbate supplementation could reduce HIF-1α protein levels in 
normoxic prostate cancer cells, which have high basal levels of this protein (Knowles 
et al., 2003). Moreover, ascorbate decreased HIF-1α protein levels stimulated by 
insulin and insulin growth factor I (IGF-1) in human breast cancer cells (Knowles et 
al., 2003). Interestingly, ascorbate had no effect on hypoxia-induced HIF-1α protein 
levels. Since iron(II) is a crucial co-factor for the activity of PHDs, its depletion from 
cells results in the stabilization of HIF-1α and activation of target genes. It has been 
shown that inhibition of transferrin receptor by monoclonal antibodies and thus 
decrease in iron uptake leads to the stabilization of HIF-1α and upregulation of its 
targets in cancer cells (Jones et al., 2006). These effects were suppressed by 
physiological concentration of ascorbate (25 μM). At this point, it is important to 
mention that DHA, the oxidized form of ascorbate, can be transported to cells by 
glucose transporters (GLUT 1, 3 and 4) (Corti et al., 2010). Interestingly, GLUT1 and 
GLUT3 are also HIF-target genes, thereofore DHA uptake could be increased in 
hypoxia providing an additional feedback loop mechanism to balance HIF 
homeostasis, especially in cancer cells. 
 HIF-1α can mediate the inhibitory effects of antioxidants on tumor growth 
also in vivo. Benign prostatic hyperplasia (BPH) as well as prostate cancer are 
associated with hypoxia and angiogenesis. Moreover, testosterone induces HIF-1α 
levels in prostate cells (Mabjeesh et al., 2003). Ascorbate could reduce HIF-1α protein 
levels induced by testosterone treatment and decreased VEGF expression in prostate 
cells (Li et al., 2009). Moroever, ascorbate delayed prostate growth induced by 
testosterone in rats (Li et al., 2009). 
Book chapter: Tumor hypoxia: Molecular mechanisms and clinical implications, 
submitted. 
 
 
 
124
 Ascorbate deficiency had no effect on proline hydroxylation and collagen 
production in the mammary tumor cells (4TI) grown in Gulo-/- mice (Parsons et al., 
2006). In contrast, ascorbic acid deficiency delayed growth of Lewis lung carcinoma 
in Gulo-/- (Telang et al., 2007). However, HIF-1α protein levels were not altered 
between ascorbate-free and ascorbate-supplemented tumors (Telang et al., 2007). 
These opposing effects could be explained by the different genetic background of 
Gulo-/- mice used in these experiments (Parsons et al., 2006; Telang et al., 2007). 
P493 human B cell xenografts grown in mice treated with N-acetyl cysteine (NAC, 40 
mM) were significantly smaller than those in non-treated animals (Gao et al., 2007). 
Since P493 cells ectopically expressing non-degradable HIF-1α protein were more 
resistant to NAC treatment, HIF-1α might be involved in these effects (Gao et al., 
2007). Moreover, NAC did not affect chromosomal stability, therefore excluding 
ROS-induced genomic instability as the reason for tumor growth. Similar effects were 
observed in P493 tumor xenografts when mice obtained a high concentration of 
ascorbate with the drinking water (5 g/l) (Gao et al., 2007). NAC is an antioxidant 
itself but can also increase the intracellular pool of glutathione, since it is a precursor 
in the synthesis of this compound. Until recently, antioxidant effects on tumor growth 
were attributed to its ability to reduce antioxidative stress and therefore genomic 
instability (Sablina et al., 2005). For the first time these data suggested that 
antioxidants could also prevent or delay tumor growth via mechanism mediated by 
PHDs/HIF. Another protein linking HIF- and ROS-dependent pathways in cancer 
cells is REDD1, a transcriptional target of HIF. REDD1 is also known as RT801 and 
is involved in the regulation of cell survival as well as ROS production (Ellisen et al., 
2002; Shoshani et al., 2002). Increased ROS production and tumorigenesis has been 
shown for REDD1-/- cells, both mediated by HIF-1α, which can be blocked by treating 
the cells/animals with ascorbate and N-acetyl cysteine (Horak et al., 2010). JunD is a 
member of the AP-1 family of transcription factors and its lack in cells causes 
increased hydrogen peroxide generation and reduced antioxidative defense. As a 
result, these cells have increased HIF-1α levels which promotes angiogenesis and 
survival of tumor cells (Gerald et al., 2004). These effects have been shown to be 
dependent on PHD2 activity, but reduced in JunD-/- cells by oxidation of iron (II) in 
the catalytic center of the enzyme. Interestingly, hydrogen peroxide concentrations 
and levels of HIF-1α proteins in JunD-/- cells were reduced by treatment with 
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ascorbate, cysteine and reduced glutathione. These observations once again emphasize 
the role of these antioxidants in maintaing PHD activity and HIF-1α protein levels, 
especially under oxidative stress conditions.  
 Besides ascorbate and glutathione (or N-acetyl-cysteine) also vitamin E has 
been shown to exert antitumorigenic effects. Tocotrienol (unsaturated vitamin E) 
reduced hypoxia induced VEGF secretion from human colorectal adenocarcinoma 
cells (DLD-1) (Shibata et al., 2008). Considering that HIF-1α mediated angiogenesis 
is one of the major steps in cancer progression, these observation suggest vitamin E as 
a putative antitumorigenic agent.  
 As mentioned above, copper, nickel and other transition metals can deplete 
ascorbate (and other co-factors) required for PHD activity, stabilize HIF-1α and hence 
act as carcinogenic factors. These effects play an important role especially in cancers 
of the respiratory tract, since exposure to nickel(II), chromium(VI) and cobalt(II) via 
inhalation or ingestion causes primarily lung injury (Salnikow and Kasprzak, 2005). 
Moreover, advanced stages of lung cancer display decreased levels of ascorbate, 
reduced glutathione and other antioxidants (Esme et al., 2008).  
 
 7. Future perspectives 
Whether antioxidants will serve as anti-cancer drugs in the context of the PHD/HIF 
oxygen sensing pathway remains speculative. The complexity of HIF responses 
together with the fact that in some tumors HIF down- and up-regulation exerts 
differential effects must be considered in such a therapies. There is no doubt that HIF 
prolyl-4-hydroxylases require antioxidants for full activity. Whether this antioxidant 
is exclusively ascorbate, or if it can be replaced by other reducing compounds, needs 
to be elucidated. One has also to consider that there are three different PHD isoforms 
with partial redundancy but also distinct cellular and organ expression levels, 
inducibility and probably also function. Furthermore, the specificity of antioxidant 
action on cells is very low with many enzymes/pathways being regulated and 
therefore difficult to control. Another point to be considered is a concentration-
dependent dual function of ascorbate, either serving as ROS scavenger or as pro-
oxidant (Levine et al., 2009). The border between these two states is very tightly 
regulated and depends on many factors that are difficult to control in vivo. Moreover, 
the half-life of most antioxidants is very short with intermediate states which exert 
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differential effects. Thus, antioxidants can undergo rapid modifications/degradation 
while administered to organism. The route of administration of antioxidants must be 
also considered as well. In Linus Pauling's studies, patients received ascorbate both 
orally and intravenously and in the follow-up studies, which failed to confirm 
Pauling's hypotheses, ascorbate was only orally applied to cancer patients, potentially 
explaining the opposing effects. Intravenous administration of ascorbate can result in 
70 to 100-fold higher plasma concentrations of this compound (Levine et al., 2009). 
Overall, antioxidants have been proven to play an important role in the oxygen 
sensing pathway on almost all levels of HIF regulation: expression, stability and 
activity. However, further studies are required to elucidate their application in 
diseases mediated by PHDs/HIF oxygen sensing pathway.  
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Introduction 
 
Oxygen sensing via HIF prolyl-4-hydroxylases (PHDs) is a mechanism playing an 
important role in many physiological and pathophysiological processes including 
adaptation to high attitude, ischemia or cancer. Under normal oxygen supply PHDs 
hydroxylate two distinct proline residues (P564 and P402 in human HIF-1 α) within 
the HIF-α molecule, which targets HIF-α protein for proteosomal degradation (Ivan et 
al., 2001; Jaakkola et al., 2001). PHD activity declines as a function of oxygen. 
Consequently, when oxygen concentration is reduced, HIF-α becomes stabilized, 
translocates to the nucleus, where it homodimerizes with HIF-β subunits and in 
complex activates the expression of target genes involved in cellular and systemic 
adaptation to hypoxia (Wenger et al., 2005). HIF prolyl-4-hydroxylase enzymes 
belong to a larger superfamily of 2-oxoglutarate and iron (II) dependent di-
oxygenases (Kaelin and Ratcliffe, 2008). In humans, PHD enzymes are expressed as 
three isoforms (PHD1-3) with distinct genes, called EGLN2, EGLN1 and EGLN3, 
respectively . These three isoforms differ in size, intracellular localization as well as 
tissue distribution (Hirsilä et al., 2003). PHD3/EGLN3/HPH1 is the smallest out of 
the three isoforms of HIF prolyl-4-hydroxylases with only 239 aminoacids  (27.3 
kDa) and two alternative splice variants (24 and 17 kDa) (Cervera et al., 2006). 
Expression of this isoform is particularly high in the heart (Stiehl et al., 2006). In 
contrast to the other two isoenzymes, PHD3 hydroxylates preferentially P564 and has 
little activity on P402 located in the C-terminal part of HIF-1α. Moreover, a tendency 
of PHD3 towards the hydroxylation of HIF-2α has been reported (Chan et al., 2005; 
Katschinski, 2009; Villar et al., 2007). In line with these findings derived from cell 
culture experiments, mice with targeted disruption of both Phd3 allels have abnormal 
sympathoadrenal development, and intercrossing PHD3(-/-) mice with HIF-1α and 
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HIF-2α(+/-) heterozygous mice demonstrated an interaction with only HIF-
2α (Bishop et al., 2008). This phenotype might be caused by imbalanced cell survival 
of neuronal cells, since PHD3 was previously shown to play an important role in 
neuronal apoptosis (Rantanen et al., 2008).  
Interestingly, the genes encoding PHD2 and PHD3 are regulated by hypoxia in a HIF-
dependent manner and functional hypoxia response elements (HRE) have been 
identified in their promoter and first intronic regions, respectively (Metzen et al., 
2005; Pescador et al., 2005) . Thus, the oxygen sensing HIF/PHD system is coupled 
by a negative feedback loop, allowing cells to adapt to chronic hypoxia by decreasing 
HIF levels at least partially by increased expression of PHD2 and PHD3 enzymes 
(Minamishima et al., 2009; Stiehl et al., 2006).  
Understanding the molecular pathways, which underlies effects of PHD3 and HIF 
proteins is a milestone in developing potential treatment of hypoxia-related diseases. 
Therefore, monoclonal antibodies against PHDs are important tools to study their 
cellular and tissue expression pattern as well as involvement in number of 
physiological and pathophysiological processes. Antibodies against PHD1-3 are 
comercially available on the market, however, the quality and application of these 
antibodies is not always sufficient and depends on many factors, such as the cell line 
or technique used. Due to the lack of well working anti-PHD3 antibodies we 
attempted to generate monoclonal anti- PHD3 antibodies in mice. 
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Material and methods 
Antigen generation and immunization of mice 
Full length GST-tagged PHD3 was expressed in Sf9 and purified as described before 
(Stiehl et al., 2006). Briefly, after 110 hours of infection Sf9 cells were lysed in ice-
cold 0.1% NP-40, 10 mM Tris-HCl pH 7.5, 100 mM NaCl, 100 mM glycine and 10 
μM DTT. Cleared lysates were incubated with equilibrated glutathione-sepharose 
beads (Amersham, Dübendorf, Switzerland) for 2 hours at 4°C with gentle agitation. 
After washing of the bead bed for three times with PBS, bound protein was eluted 
with 15 mM reduced glutathione, 50 mM Tris-HCl pH 8.0, and 2 μM FeSO4. Purity 
of recombinant fusion-proteins was routinely estimated by SDS-PAGE and coomassie 
blue staining. Immunization of mice and generation of hybridoma fusion was 
performed in the laboratory of Dr. Rene Fischer (ETH Zürich). 
 
Expression and purification of MBP.PHD3 for screening of hybridoma 
supernatants by ELISA 
Full-length MBP-tagged PHD3 was expressed in E. Coli TB.1 cells and purified using 
amylose resins. Briefly, 1L of o/n bacterial culture in the logarithmic growth phase 
(O.D at 600 nm between 0.4-0.6) was induced with 300 μM IPTG for 4 hours. Cells 
were collected, resuspended in 20 ml of lysis buffer (20 mM Tris/Cl, pH 7.4, 200 mM 
NaCl and 1 mM EDTA) and lysed at 2.7 kbar using a French press. Cleared lysate 
was incubated with equilibrated amylose resins for 2 hours at 4°C with gentle 
agitation. After washing three times with lysis buffer, bound protein was eluted with 
10 mM D-maltose in lysis buffer. Purity of the recombinant fusion-protein was 
routinely estimated by SDS-PAGE and coomassie blue staining.  
 
Subcloning of hybridoma clones 
Obtained fusion hybridoma cells were plated on a 96-well plate in chemically defined 
Turbudoma medium (www.cellculture.com) containing gentamycin (50 μg/ml), L-
glutamine (2 mM), Interleukin-6 (2%; vol/vol) and 1×hypoxanthine-aminopterin-
thymidine medium (HAT). 6.5×107 cells were plated on six  96-well plates 
(200μl/well). Hybridoma cultures were grown for 7-10 days and positive wells were 
visually screened for single cell clusters, before supernatants of the clones were tested 
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by ELISA. Positive clones were further subcloned by limited dilution on 96-well 
plates and subsequently tested by ELISA and immunoblotting.  
 
Cell culture for production of monoclonal antibodies 
Hybridoma clones were routinely maintained in Turbudoma (www.cellculture.com) 
medium and the supernatants were collected for analysis and purification. For high-
density antibody production, cells were grown in a BD CELLine 1000 flask. 2×106 
cells/ml were resuspended in 15 ml of Turbodoma medium and inoculated into the 
cell compartment of the BD CELLine flask. The nutrient compartment was filled with 
1L of Turbudoma medium and cells were grown for 7-14 days. Afterwards cells were 
collected from the cell compartment and the supernatant containing concentrated 
antibodies was tested by ELISA and immunoblotting. Antibodies were isotyped using 
a Mouse Monoclonal Antibody Isotyping Kit (Roche).  
 
ELISA 
To select for positive hybridoma supernatants, 96-well plates were coated with 3 
μg/ml (100μl/well) of either recombinant GST.PHD3 purified from infected Sf9 cells 
or bacterial recombinant MBP-PHD3 fusion protein. The coating was performed for 
2h at 37 ºC with protein diluted in PBS. To avoid unspecific binding, plates were 
blocked with blocking buffer containing 2% non-fat dry milk (weight/vol), 150 mM 
NaCl in 20 mM Tris buffer, pH 7.4. Subsequently, wells were washed five times with 
washing buffer containing 0.05% Tween 20 and 150 mM NaCl in 20 mM Tris, pH 
7.4. Hybridoma supernatants (100μl/well) were incubated for 3 hours at room 
temperature and afterwards plates were washed five times with washing buffer. 
Secondary HRP-conjugated anti-mouse antibodies (Pierce, dilution 1:1000) was 
added to each well and plates were incubated for 2 hours at room temperature 
followed by five washing steps. For detection, the 3,3’,5,5’-tetramethylbenzidine 
(TMB) substrate kit (Pierce) was used and blue color development was stopped by 
adding H2SO4 to 1 M. Absorbance was determined at 450 nm in a microplate reader. 
 
Purification of IgG molecules 
Supernatants of hybridoma clones were pooled and loaded with 0.5 – 0.8 ml/min on 
an equilibrated (PBS) Protein G column (HiTrap)  Afterwards the column was washed 
with PBS and antibodies were stepwise eluted with elution buffer (100 mM Glycine, 
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150 mM NaCl) at pH 2.6 and 2.2, respectively. Eluted fractions were immediately 
neutralized by addition of 1M Tris/Cl pH 8.0. Flow through and eluted fractions were 
analyzed by SDS-PAGE. 
 
Immunoblotting 
For a routine screen of hybridoma supernatants, 20ng/lane of recombinant GST or 
MBP-tagged PHD were subjected to SDS-PAGE and electrotransferred onto PVDF 
membranes. Subsequently, membranes were incubated with undiluted hybridoma 
supernatants or purified antibodies for at least 2h at room temperature. Secondary 
HRP-conjugated anti-mouse antibodies were used for detection. Endogenous and 
overexpressed PHD3 protein was detected in whole cell lysates of MCF-7 or HEK293 
cells transfected with 4 μg of pcDNA3.1-hPHD3. 
 
Immunohistochemistry 
Staining of human lung adenocarcinoma with supernatant of hybridoma subclone 
A1.10 was performed in cooperation with Dr. Peter Schraml (Clinical 
Pathology/University Hospital Zürich). 
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Results and discussion 
Recombinant GST.PHD3 protein purified from Sf9 insect cells was used for 
immunization of mice as described previously (Figure 1A) (Baggio et al., 2005). 
Supernatants from the obtained hybridoma fusion cells were tested for the reactivity 
with recombinant GST.PHD3 proteins. Several clones were positive for detection of 
recombinant antigen (Figure 1B) however, they were also positive for detection of 
GST protein, which was the fusion partner of PHD3 antigen used for immunization, 
(lower band, around 25 kDa (Figure 1A and C). Additionally, Sf9 lysates 
overexpressing His6–PHD3 were not detected by clone A5 supernatant, which readily 
detected GST-PHD3 (Figure 1B and C). In order to avoid false-positive signals, 
bacterially expressed MBP.PHD3 was purified and used for subsequent ELISA and 
immunoblot analyses (Figure 1D). Several clones were positive for anti-MBP.PHD3 
detection by ELISA, with clone A1 having the highest absorbance relative to the 
commercially available polyclonal antibody NB-100-303 (Novus Biologies) (Figure 
1E). Note, that affinity-purified NB-100-303 was used at a final concentration of 1 
ug/ml, which supposedly was much higher than the concentration of respective 
hybridoma supernatants. All positive clones were further tested by immunoblotting 
and clones A1, B3 and B4 were further subcloned.  
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Fig. 1. Generation of monoclonal antibodies against PHD3. (A) Purification of 
recombinant GST-PHD3 from Sf9 insect cells. Note the presence of the band at 
around 25 kDa corresponding to GST alone. (B) Testing hybridoma supernatants on 
recombinant GST-PHD3 by immunobloting using a multiple sera applicator. (C) 
Supernatant from hybridoma clone A5 detects recombinant GST protein and GST-
PHD3, but fails to detect His6-tagged PHD3 in transfected Sf9 cell lysates (upper 
panel). The commercially available anti-PHD3 antibodies were used as a control to 
detect His6-tagged as well as GST-PHD3 (lower panel). (D) Generation of bacterially 
purified MBP.PHD3. (E) ELISA using supernatants from hybridoma clones on 
MBP.PHD3 with clone A1 showing highest absorbance. 
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Supernatant from clone A1 was further collected for small-scale purification as shown 
in Figure 2. Binding of the heavy chains of the immunoglobulin to either Protein A or 
G greatly depends on the species and isotype of the antibodies (Harlow Ed, 1999). 
Accordingly, clone A1 was isotyped as IgG1 kappa and had higher affinity for protein 
G resins (Figure 2A). For purification of the antibodies from the beads, elution buffers 
with pH 2.7 and pH 2.2 were used. Antibodies were found to elute from the column 
more efficiently at lower pH (Figure 2B). Although elution with buffer pH 2.7 gave 
higher absorbances at the chromatogram, antibodies were found at higher 
concentration in the elution buffer at pH 2.2 (Figure 2B and C). After purification, 
fraction 32 and flow through were tested to detect recombinant MBP.PHD3 by 
immunoblotting. Immunoreactivity against MBP.PHD3 of fraction 32 was titered up 
to dilutions of 1:1000, with a titer of 1:100 giving similar results as undiluted cell 
culture supernatant of A1 hybridoma cells (Figure 2D). 
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Fig 2. Purification of monoclonal anti-PHD3 antibodies from A1 hybridoma 
supernatant. (A) Antibodies from hybridoma supernatants of clone A1 preferentially 
bind to Protein G. (B) SDS-PAGE of eluted fraction containing anti-PHD3 
immunoglobulin. (C) Chromatogram showing the elution profile of immunoglobulins 
with decreasing pH. (D) Titer analyses of eluted anti-PHD3 antibodies (fraction 32) 
on recombinant PHD3. Asterisk indicates protein present in the cell culture medium.  
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Further subcloning of the clone A1 resulted in a single subclone named A1.10, which 
had a high signal (O.D.450 nm = 1.255) in ELISA for detection of MBP.PHD3, which 
was roughly two-fold higher than the polyclonal control antibody NB-100-303 (1 
ug/ml) with an O.D. at 450 nm of 0.5955. Using N-terminally truncated PHD3 protein 
exogenously expressed in HEK293 cells, we observed that purified A1.10 antibodies 
preferentially detect the full-length protein, while all PHD truncations were readily 
expressed as determined by V5 immunoblotting (Figure 3A). Moreover A1.10 at a 
dilution of 1:50 detected endogenous PHD3 protein in lysates of DMOG and hypoxia 
treated MCF-7 cells, though strikingly high amounts (400 μg/lane) of total protein 
were required (Figure 3B).  
 
 
 
 
Fig. 3. Testing of supernatants from A1.10 for detection of overexpressed PHD3 
in HEK293 cells. (A) Immunoblot of truncated V5.PHD3 constructs exogenously 
expressed in HEK293 cells treated with 1 mM DMOG (upper panel). Immunoblot 
using anti-V5 antibodies served as control (lower panel). (B) Detection of endogenous 
PHD3 cells in lysates of MCF7 cells treated with 1 mM DMOG or 1% oxygen. 
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When tested in immunohistochemistry of human tissues assembled in tissue 
microarrays, subclone A1.10 was staining several lung adenocarcionoma paraffin 
sections of different patients (Figure 4A). If compared with the performance of the 
monoclonal antibodies A1 and A1.10 in immunoblotting, these results might suggest a 
preference of both immunoglobulins to native PHD3. As such, the antibodies could 
have an application for immunohistochemistry or presumably in immunofluorescence.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. Application of anti-PHD3 antibodies in immunohistochemistry and 
immunoblotting of exogenous PHD3. (A) Paraffin sections of human 
adenocarcinoma of the lung stained with supernatant of subclone A1.10. (B) 
Immunoblot of PHD3 overexpressed in MCF7 cells tested with supernatant of 
subclone A1.10. 
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10. Unpublished data: Compounds tested in the in vitro 
hydroxylation assay for the effect on HIF prolyl-4-
hydroxylases 
 
Several compounds were tested for their effect on PHD1-3 hydroxylation activity 
using a VBC-dependent hydroxylation assay as described (Nytko et al., 2007). 
Briefly, antioxidants, reactive oxygen species, transition metals and metal chelators 
were added to the standard assay. Metal chelators, such as desferoxamine and 
ciclopirox olamine are commonly used to stabilize HIF-1α protein levels via 
inhibition of PHDs (Linden et al., 2003; Melillo et al., 1997; Wang and Semenza, 
1993; Wanner et al., 2000). We wanted to test, whether other metal chelators like 
EDTA or NTA could affect PHDs activity. Indeed, EDTA was inhibiting all three 
PHDs but only at high concentrations of this compound (>100 μM). Surprisingly, 
EDTA was slightly increasing the activity of all three PHDs at concentrations  <10 
μM probably due to chelation of some metals present in the reaction buffer, which 
could inhibit PHDs. NTA was not affecting or in the case of PHD3 slightly inhibiting 
activity of PHDs. Both EDTA and NTA chelate ions such as Ca (II) or Fe (III) with 
high affinity. However, NTA is known to be less stable in complex solutions which 
could potentially explain the differences observed by us. Of note, the high affinity 
iron chelator DFX was the most potent inhibitor of PHDs (Table 1).  
 
Fig.  1. Effect of EDTA on hydroxylation activity of PHD1-3 as tested by in vitro 
hydroxylation assay. 
 
Besides metal chelators, also transition metals are potent inhibitors of PHDs 
hydroxylation activity (Hirsila et al., 2005). We tested cobalt (II) chloride (see 
Manuscript #2) and zinc (II) chloride (Figure 2). Both of them were efficient 
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inhibitors of all three PHDs, however PHD2 was more resistant to inhibition by both 
metals. Inhibition of PHDs by transition metals is a long-discussed effect but the 
mechanism is still not clear. It is suggested, that transition metals either replace iron 
(II) in the active center or cause oxidation of the enzyme or depletion of necessary co-
factors (ascorbate). 
 
Fig.  2. Effect of zinc chloride on hydroxylation activity of PHD1-3 as tested by in 
vitro hydroxylation assay.  
 
We were further testing effects of reactive oxygen species and antioxidants on 
hydroxylation activity of PHDs. As shown in manuscript #2, hydrogen peroxide was 
an efficient inhibitor of all three PHDs, though again rather high concentrations were 
needed for full inhibition of PHDs. We were interested though, if this effect could be 
reversed by addition of catalase, which is the main intracellular antioxidant 
responsible for dismutation of hydrogen peroxide to water and molecular oxygen. 
When enzymes were first incubated with hydrogen peroxide and subsequently with 
catalase before starting the hydroxylation reaction, the presence of catalase could 
reverse inhibitory effects of hydrogen peroxide (Figure 3). While this could be simply 
explained by detoxification of residual hydrogen peroxide by catalase, we could show  
that ROS modify the enzyme itself due to oxidative damage (manuscript #2). Whether 
such oxidative modifications (e.g. carbonylation) inhibit the specific activity of PHDs 
needs further investigation. 
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Fig.  3. Effect of hydrogen peroxide and catalase co-titration on PHD 1-3 as tested by 
in vitro hydroxylation assay. 
 
In addition. sodium azide, which acts as inhibitor of complex IV (cytochrom oxidase) 
of the respiratory chain was tested in the VBC-coupled hydroxylation assay . Even at 
a concentration of 1 mM this compound had no influence on the activity of PHD1 and 
only slight reduced hydroxylation activities of PHD2 and PHD3 (Figure 4). 
Obviously, these data suggest that inhibitors of respiratory chain require a cellular 
system to exert effects on the oxygen sensing pathway via PHDs.  
 
 
 
 
 
 
 
 
 
Fig. 4. Effect of sodium azide on hydroxylation activity of PHD 1-3 as tested by in 
vitro hydroxylation assay. 
 
A summary of the different types of compounds tested for putative inhibitory or 
stimulatory effects on PHD mediated HIF-1α hydroxylation is shown in Table 1. As 
expected, most of the metal chelators, with exception for the zinc preselective chelator 
TPEN (N,N,N′,N′-tetrakis (2-pyridylmethyl) ethylenediamine) were efficient 
inhibitors of all three PHDs. It has been shown that TPEN can increase the activity of 
PHD2, however with our settings we did not observe similar result (Choi et al., 2006). 
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Other compounds with antioxidative properties such as the food additive gallate or the 
superoxide dismutase mimetic Mn (MnTMPyP) had inhibitory effects on PHD 
activity, suggesting different ways of action of specific antioxidants. Hydrogen 
peroxide was efficiently reducing hydroxylation activity which could be restored by 
subsequent addition of catalase. These novel data provide further evidence that 
antioxidants and ROS are important factors affecting the HIF pathway by directly 
modulating the hydroxylation capacity of the oxygen-sensing PHD enzymes. 
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Table 1. Compilation of small molecules inhibitors of PHD1-3 activity in vitro. The 
range of concentrations used for in vitro assays is given. Arrows indicate inhibitory 
properties of the respective compound. 
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11.  Conclusions 
Oxygen sensing via the HIF-PHD pathway can be regulated at different levels and by 
different mechanisms. The primary factor regulating HIF protein level is oxygen, 
which drives the catalytic activity of HIF prolyl-4-hydroxylases (Epstein et al., 2001; 
Hirsilä et al., 2003). Besides oxygen, also the availability of co-factors as 2-
oxoglutarate, iron (II) and to some extent ascorbate can influence the hydroxylation 
capacity of PHDs (Hirsilä et al., 2003). Consequently, compounds which cause 
depletion of one of the co-factors can moduluate the HIF response. Amongst them, the 
most effective PHD inhibitors are 2-oxoglutarate analogons (e.g. N-oxalylglycin), 
metal chelators (DFX, CPX and EDTA), transition metals (cobalt (II), zinc (II) , 
nickel (II) , copper (II)) and reactive oxygen species (H2O2, NO) (Hirsila et al., 2005; 
Salnikow et al., 2004; Martin et al., 2005 ; Page et al., 2008; Oehme et al., 2004).  
Similarly, some antioxidants (gallate and n-propyl gallate) as well as 2-oxoacids 
(succinate, fumarate, pyruvate) affect the activity of PHDs (Nytko et al., 2007; Pan et 
al., 2007). Of note, most of these compounds can inhibit (or induce) PHD activity 
even under oxic conditions and therefore modulate HIF hydroxylation independently 
of the oxygen concentration. 
 
11.1 Role of ascorbate for PHD hydroxylation activity in vitro 
 
Even though ascorbate is frequently described in the literature as essential co-factor 
for the activity of prolyl-4-hydroxylases, it remains speculative what the specific 
function of ascorbate in the reaction catalyzed by PHDs actually is (Hirsilä et al., 
2003). We could show that besides ascorbate, also glutathione could induce 
hydroxylation activity of PHDs in vitro, even in the absence of ascorbate. While this 
work was in preparation, glutathione was shown to induce the activity of N-terminally 
truncated recombinant PHD2 at millimolar concentrations, which well reflects the 
intracellular glutathione content (Flashman et al., 2010). Moreover, glutathione was 
an efficient stimulator of FIH activity as shown by in vitro hydroxylation of an 
artificial consensus ankyrin peptide (Flashman et al., 2010). Glutathione, similarly to 
ascorbate could reduce the induction of a HIF-dependent luciferase reporter gene 
activity in hepatoma cells treated with the hypoxia-mimicking agent cobalt chloride. 
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Interestingly, neither ascorbate nor glutathione affected HIF activity induced by 
hypoxia or the iron chelator DFX (see Manuscript #2). Accordingly, glutathione could 
reduce carbonylation, which is the hallmark of protein oxidation, of recombinant 
PHD2 enzyme by Fenton reaction and cobalt chloride. It remains speculative, whether 
the function of ascorbate and glutathione on PHDs is mediated by the same 
mechanism. Ascorbate function in hydroxylation activity of PHDs is often suggested 
to maintain the active centre Fe (II) in the reduced state (Kaelin and Ratcliffe, 2008). 
The antioxidative function of glutathione in the cell is exerted mainly by serving as 
co-factor for glutathione peroxidases. Besides that, glutathione itself can scavenge a 
number of free radicals and other reactive compounds (OH˙, HOCl etc.), with 
exception for the superoxide anion (Halliwell and Gutteridge, 2007). Glutathione is 
also a potent reducing agent, regulating the redox state of thiol groups in proteins. 
Two cysteine residues in PHD2 (Cys201 and Cys208) were described as surface 
accessible and highly nucelophilic aminoacids (Mecinovic et al., 2009). We generated 
recombinant Cys201Ser mutant PHD2 protein, which surprisingly showed a higher 
specific activity than the wildtype preparations of the PHD2 enzyme. However, 
glutathione could re-activate both wt and Cys201Ser mutant PHD2 enzymes after 
complete inactivation of the enzymes by hydrogen peroxide, suggesting that 
glutathione effects on PHD2 activity involves other mechanisms which are 
independent of Cys201 redox state. Additionally, glutathione plays an important role 
in the recycling of intracellular ascorbate. The latter mechanism might be excluded in 
the case of PHDs, as we in vitro observed an increase of PHD hydroxylation activity 
even in the absence of ascorbate. Still, there could have been undetectable traces of 
dehydroascorbate co-purified with the enzymes preparations, which are then reduced 
by glutathione. In cellular systems, these two antioxidants are tightly connected by 
redox-mediated mechanisms, therefore any change in the concentration of either one 
can affect the over-all redox state of the cell and thus PHD activity. 
 
11.2 Role of ascorbate in oxygen sensing in vivo 
 
Using HeLa cells grown in the absence of ascorbate we could show that the response 
to hypoxia in these cells is fully functional. To study the hypoxic responses in vivo, 
we used Gulo-/- mice, which are unable to synthesize ascorbate, therefore dependent 
on its supplementation in the diet (Maeda et al., 2000). Ascorbate deficiency is known 
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to cause scurvy, a disease resulting from insufficient hydroxylation of collagen 
building connective tissues (Mandl et al., 2009). We found no evidence, that ascorbate 
deficiency affects oxygen sensing via the PHD-HIF pathway in Gulo-/- mice. 
Ascorbate depleted animals showed no changes in the expression of HIF-target genes 
in a variety of tissues, even after 5 weeks of ascorbate withdrawal which has been 
shown to sufficiently exhaust intracellular ascorbate stores. Moreover, the systemic 
response of Gulo-/- mice kept on ascorbate-free diet for 5 weeks to acute hypoxia (8% 
oxygen for 24h) was similar to Gulo-/- mice supplemeted with ascorbate, as measured 
by kidney Epo mRNA levels and plasma EPO protein levels. These data suggest that 
in vivo ascorbate is dispensible for functional oxygen sensing and possibly other 
antioxidants could compensate for the lack of ascorbate. Certainly further 
investigations are required to elucidate the molecular mechanism of glutathione (and 
other antioxidants) action on prolyl-4-hydroxylases activity. Of note, also other 
enzymes which depend on ascorbate supplementation for in vitro function like 
collagen prolyl-4-hydroxylases and enzymes involved in carnitine biosynthesis were 
reported to be independent of the ascorbate availability in vivo (Furusawa et al., 2008; 
Parsons et al., 2006).   
 
11.3 Clinical application of antioxidants in the context of the HIF-PHD pathway 
 
Besides their specific hydroxylation activity, also de novo expression and protein 
stability of PHDs are important factors that can influence overall oxygen sensing via 
the PHDs/HIF pathway. As it was shown previously, expression of PHD2 and PHD3 
can be transcriptionally induced by HIFs, thus establishing a negative feedback loop 
which allows cells/tissues to adapt to chronic oxygen deficiency  and still respond to a 
second insult of more severe hypoxia (Minamishima et al., 2009; Stiehl et al., 2006). 
Since PHDs and HIF are implicated in many pathological processes, modulation of 
their expression or activity would be of great interest in developing novel treatment 
regiments for these diseases. Many PHDs inhibitors could be used in treatment of 
disorders caused by insufficient EPO production. Administration of PHDs inhibitors 
to these patients could replace therapy using recombinant EPO injections as 
exogenous EPO often activates the immune system. Moreover, PHDs inhibitors can 
avoid parenteral EPO injections, as some of the new drugs might be applied orally.  
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In summary, we showed that oxygen sensing via PHDs is a tightly regulated process, 
which can be influenced by many extra- and intracellular factors. We could 
demonstrate that ascorbate is not essential for PHD activity in vitro and in vivo and 
can be replaced by glutathione. As ascorbate and N-acetyl-cysteine were proposed 
previously as antitumorigenic agents acting at least partially via the HIF pathway 
(Gao et al., 2007), glutathione might be similarly functional to modulate HIF activity 
in solid cancers. Moreover, combined treatment of different antioxidants could 
enhance their effects on PHDs and HIF. A drawback of antioxidants at 
pharmacological doses might be that most compounds - besides their considerably 
beneficial properties as radical scavengers - paradoxically also generate free radicals 
depending on concentration and the specific environment (Chen et al., 2005). 
Moreover, ascorbate and glutathione serve as co-factors for a number of enzymes in 
cellular systems, therefore their specificity towards PHDs is rather low. Nevertheless, 
the antioxidative properties of ascorbate or glutathione clearly affect PHD activity 
under certain conditions, and elucidating the underlying molecular events of PHD and 
ascorbate/glutathione interplay might open novel routes to specifically target the 
PHD/HIF oxygen sensing pathway. 
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